{
    "name": "cuad_rofr-rofo-rofn",
    "description": "",
    "keywords": [
        "legalbench",
        "cuad_rofr-rofo-rofn"
    ],
    "categories": [
        ""
    ],
    "examples": [
        {
            "input": "BP shall then have an optional prior right, for a period of fifteen (15) days after receipt of such written notice, to purchase for the stated consideration on the same terms and conditions the interest which Company proposes to sell.",
            "target": "Yes",
            "document_name": "TRUENORTHENERGYCORP_02_08_2007-EX-10.1-DEVELOPMENT AGREEMENT.PDF",
            "index": 0
        },
        {
            "input": "XSPA shall give prompt written notice to Calm each time it offers, proposes to offer, or has received an offer to enter into any agreement or arrangement under which XSPA or any of its affiliates would sell, offer for sale, market, promote or undertake any similar action with respect to any meditation or sleep digital products or similar products at any Store outside the Territory (each, a \"ROFR Notice\").",
            "target": "Yes",
            "document_name": "XpresspaGroupInc_20190401_10-K_EX-10.28_11599457_EX-10.28_Marketing Agreement.pdf",
            "index": 1
        },
        {
            "input": "At TPH's sole option, TPH or TPH-A may purchase the GaN Equipment by completion of payment of the purchase price or depreciation cost for such equipment as set forth in Appendix 2.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 2
        },
        {
            "input": "Prior to the IPO and during the term of the Strategic Alliance, Moelis General Partner shall not consent to a sale or transfer by a Partner of its Partnership Interests to an SMBC Competitor unless the Moelis General Partner caused the Partner proposing to sell or transfer its Partnership Interests to provide SMBC with a right to purchase, on the same terms and conditions, including price, all (but not less than all) of the Partnership Interests that such Partner proposes to sell or transfer to an SMBC Competitor.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 3
        },
        {
            "input": "We will have the right (but not the duty), to be exercised by notice of intent to do so within sixty (60) days after termination or expiration, to purchase for cash any or all assets of the Franchised Restaurant, including leasehold improvements, equipment, supplies, and other inventory, advertising materials, and all items bearing the Marks, at your cost or fair market value, whichever is less.",
            "target": "Yes",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 4
        },
        {
            "input": "In addition to and without limiting any other provision of this Agreement, in the event the Village Media Company or HOFV fails to pay the Annual Guarantee to PFHOF in accordance with Section 5.1 and such failure is not cured within thirty (30) days of notice thereof by PFHOF, then the rights of first offer granted to HOFV in Section 3.1 of the First Amended and Restated License Agreement, dated as of September 16, 2019 between PFHOF and HOFV (the \"License Agreement\") shall automatically and immediately terminate, regardless of whether PFHOF elects not to terminate this Agreement in accordance Section 4.2.",
            "target": "Yes",
            "document_name": "GpaqAcquisitionHoldingsInc_20200123_S-4A_EX-10.6_11951677_EX-10.6_License Agreement.pdf",
            "index": 5
        },
        {
            "input": "respect to a SHP1-SHP2 Dual Inhibitor during the SHP1-SHP2 Dual Inhibitor Licensing Negotiation Period. If (x) Sanofi does not provide a Notice of Interest within [***] or (y) Sanofi does provide a Notice of Interest within [***] but Parties have not entered into an agreement under which Sanofi is granted SHP1-SHP2 Dual Inhibitor License Rights prior to the expiration of the SHP1-SHP2 Dual Inhibitor Licensing Negotiation Period, then RevMed shall have no further obligations to Sanofi with respect to such SHP1-SHP2 Dual Inhibitor Products, and RevMed shall have the right to enter into negotiations and execute an agreement with a Third Party under which such Third Party is granted the SHP1-SHP2 Dual Inhibitor License Rights [***].",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 6
        },
        {
            "input": "If HOC, acting reasonably, determines that the Joint Venture Proposal Notice contains insufficient information to make a reasoned decision in respect of participating in the Proposed Joint Venture, it shall notify the Company of the information required to make such decision and thereafter shall have the greater of (i) five (5) Business Days from the receipt of such information from the Company, and (ii) the days remaining in the period specified in Section 6.2 to make such decision and deliver or refrain from delivering the HOC JV Acceptance Notice in accordance with such Section 6.2.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 7
        },
        {
            "input": "The purchase price shall be paid in cash at the closing of the purchase, which shall take place no later than ninety (90) days after receipt by Franchisee of Pretzel Time's notice of exercise of this option to purchase the Unit, at which time Franchisee shall deliver instruments transferring to Pretzel Time or its assignee good and merchantable title to the assets purchased, free and clear of all liens and encumbrances with all sales and other transfer taxes paid by Franchisee, and all licenses or permits of the Unit which may be assigned or transferred.",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 8
        },
        {
            "input": "In addition, and conditional on completion of a transaction on terms set out below, you will be granted a second option under the Option Plan, such option being one of: (a) an option to acquire 44,757 Shares (representing approximately 0.25% of the Company's issued share capital as at the Effective Date) granted as soon as practicable following the completion of a transaction approved by the Board on terms which include an upfront payment of at least USD30,000,000 and per product downstream milestone payments of at least USD300,000,000; or (b) an option to acquire 22,378 Shares (representing approximately 0.125% of the Company's issued share capital as at the Effective Date) granted as soon as practicable following the completion of a transaction approved by the Board on terms which include an upfront payment of USD24,000,000 and per product downstream milestone payments of USD240,000,000; or (c) an option to acquire such number of Shares (falling between 0.125% and 0.25% of the Company's issued share capital as at the Effective Date as the Board shall determine in its absolute discretion) granted as soon as practicable following completion of a transaction approved by the Board on terms which include an upfront payment greater than USD24,000,000 but less than USD 30,000,000, and per product downstream milestone payments greater than USD240,000,000 but less than USD 300,000,000.",
            "target": "Yes",
            "document_name": "BICYCLETHERAPEUTICSPLC_03_10_2020-EX-10.11-SERVICE AGREEMENT.PDF",
            "index": 9
        },
        {
            "input": "During the Term of this Agreement and for two (2) years thereafter, in the event that either Party decides to sell or convey its interest in or otherwise dispose of any Prior JDA Project Patent to any Non-Affiliated Third Party, such Party will inform the other Party, who will then have the right of first refusal to purchase or otherwise acquire the sole interest at same or better terms.",
            "target": "Yes",
            "document_name": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf",
            "index": 10
        },
        {
            "input": "If, during said ninety (90)-day period, Affiliate notifies Network in writing of its desire to add the New Channels to this Agreement, then both parties shall work diligently together and in good faith to enter into an agreement within ninety (90) days of such notice to include the terms and conditions pursuant to which the New Channels may be distributed by Affiliate.",
            "target": "Yes",
            "document_name": "TubeMediaCorp_20060310_8-K_EX-10.1_513921_EX-10.1_Affiliate Agreement.pdf",
            "index": 11
        },
        {
            "input": "TKCI will have First Right of Refusal with regard to any sale or disposition of any part or the whole of companies or projects developed in relationship with this alliance.",
            "target": "Yes",
            "document_name": "TURNKEYCAPITAL,INC_07_20_2017-EX-1.1-Strategic Alliance Agreement.PDF",
            "index": 12
        },
        {
            "input": "We have the right, exercisable by delivering written notice to the transferor within fifteen (15) days from the date of last delivery to us of the offer and any other documents we have requested, to purchase the Interest for the price and on the terms and conditions contained in the offer, except that we may substitute cash for any form of payment proposed in the offer, and will not be obligated to pay any \"finder's\" or broker's fees that are a part of the proposed Transfer.",
            "target": "Yes",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 13
        },
        {
            "input": "Calm shall have thirty (30) business days (the \"ROFR Period\") from receipt of a ROFR Notice to exercise its ROFR with respect to the region and/or Stores described in the ROFR Notice.",
            "target": "Yes",
            "document_name": "XpresspaGroupInc_20190401_10-K_EX-10.28_11599457_EX-10.28_Marketing Agreement.pdf",
            "index": 14
        },
        {
            "input": "The Rights Notice shall specify sufficient information regarding the particulars of the issuance or sale of the Additional Securities to allow HOC to make a reasoned decision in respect of making the investment, including to the extent any such terms are determinable at such time: (i) the total number of equity securities outstanding as of the date thereof; (ii) the total number of Additional Securities which are being offered; (iii) the rights, privileges, restrictions, terms and conditions of such Additional Securities; (iv) the amount payable by HOC for the Additional Securities to which it is entitled pursuant to Section 4.1(a); and (v) the proposed closing date, and thereafter, to the extent it is not included in the Rights Notice, the Company shall immediately provide notice to HOC of such information as it is determined.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 15
        },
        {
            "input": "Although Excite will not be required to disclose any information in violation of any nondisclosure agreement between Excite and any third party, the notice will include information sufficient to permit Sponsor to evaluate the requirements for meeting the competing offer for retail music store sponsorship of the Excite Site and to formulate a meaningful response.",
            "target": "Yes",
            "document_name": "N2KINC_10_16_1997-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 16
        },
        {
            "input": "If LKPL does not respond to an RFM within thirty (30) days, or cannot provide competitive terms (such as cost, credit, quality, schedule), Axiometric will be free to award the manufacturing contract to an alternate manufacturer.",
            "target": "Yes",
            "document_name": "LinkPlusCorp_20050802_8-K_EX-10_3240252_EX-10_Affiliate Agreement.pdf",
            "index": 17
        },
        {
            "input": "If during the term of this Agreement for any renewal of this Agreement (the \"Right of First Refusal Period\"), Affiliate shall receive (i) any Bona Fide Offer to purchase the revenue due Affiliate under this Agreement or Affiliate's company through an asset purchase or merger (in which case Network 1 shall be subordinate to the Checkfree first refusal right), or (ii) a Bona Fide Offer to acquire or merge with or into Affiliate (in which case Network 1 shall be subordinate to the Checkfree first refusal right), Affiliate shall immediately give written notice (the \"Offer Notice\") to Network 1 of the terms and conditions of the Bona Fide Offer, including without limitation the price.",
            "target": "Yes",
            "document_name": "UsioInc_20040428_SB-2_EX-10.11_1723988_EX-10.11_Affiliate Agreement 2.pdf",
            "index": 18
        },
        {
            "input": "eDiets.com will have the first right to substitute any of the following content features for any of the eight (8) content features selected above once inventory on such features becomes available.",
            "target": "Yes",
            "document_name": "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.pdf",
            "index": 19
        },
        {
            "input": "In addition, if BI has exercised its first right of negotiation in Section 5.2.2.a, XENCOR hereby grants and will make an eventual Business Partner do so, BII a first right to negotiate to manufacture and supply commercial Product as Principal Supplier for a period up to the [...***...], starting with the first commercial launch of the Product.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 20
        },
        {
            "input": "If the Company wishes to purchase (and/or cause a designee to purchase) all of the ROFR Shares at the ROFR Sale Price, the Company shall deliver a notice (a \"ROFR Purchase Notice\") to the Farids Group within three (3) business day after receipt of the ROFR Sale Notice. The closing of the purchase of such ROFR Shares by the Company and/or any such designee shall take place no later than the later of (i) the purchase date set forth in the ROFR Sale Documentation and (ii) five (5) business days after delivery of the ROFR Purchase Notice, with payment for such ROFR Shares being made concurrently with such purchase to the Farids Group's account designated in the ROFR Sale Notice.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 21
        },
        {
            "input": "Notwithstanding the foregoing, in the event that the applicable Party decides not to file at all or not to file a continuing or other application to maintain the viability of the U.S part of a family of patents to which an application belongs, or decides to abandon or discontinue the prosecution or maintenance of any of the Joint IP Rights, such Party shall notify the other Party thereof, and such other Party may elect to continue the prosecution (including non-provisional application and PCT entry) or maintenance of such Joint IP Rights at its sole expense and in the name(s) of both Stryker and Conformis",
            "target": "Yes",
            "document_name": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.pdf",
            "index": 22
        },
        {
            "input": "If (i) RevMed does not provide the above election notice in compliance with the requirements of this Section 8.7(b), or (ii) RevMed provides notice to Sanofi that it does not intend to exercise its one-time Co-Promotion Option, then RevMed shall be deemed to have waived such one-time right to co-promote any and all Products in the Co-Promotion Territory.",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 23
        },
        {
            "input": "If, at any time or from time to time during the term hereof, Licensor or any stockholder in Licensor shall have received a bona fide offer from any person or entity to sell, transfer or otherwise convey all or any stock in, or assets of, Licensor which Licensor or such stockholder, as the case may be (the \"Offeree\"), desires to accept, the Offeree shall first give written notice (the \"Offering Notice\") to Licensee of the financial and other terms and conditions (the \"Terms and Conditions\") of such offer.",
            "target": "Yes",
            "document_name": "NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.pdf",
            "index": 24
        },
        {
            "input": "The ROFO Sale Notice shall include: (i) (A) the number of Shares proposed to be sold (the \"ROFO Shares\"), (B) the per share purchase price in cash at which the Farids Group is prepared to Transfer such ROFO Shares (the \"ROFO Sale Price\") and (C) the date the Farids Group proposes to begin to effect such 144 Sale; and (ii) (ii) an offer to sell to the Company and/or a designee of the Company all or a portion of the ROFO Shares at the ROFO Sale Price.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 25
        },
        {
            "input": "Cargill shall have the first option to prepare, file, prosecute, and maintain patent applications and issued/granted patents on Bioamber Improvements and Joint Improvements, which option may be waived in whole or in part.",
            "target": "Yes",
            "document_name": "BIOAMBERINC_04_10_2013-EX-10.34-DEVELOPMENT AGREEMENT (1).pdf",
            "index": 26
        },
        {
            "input": "Upon the Effective Date, Harpoon hereby grants to AbbVie the exclusive right, but not the obligation, to obtain the licenses set forth in Section 5.1.3 (the \"License Option\").",
            "target": "Yes",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 27
        },
        {
            "input": "In the event Franchisee or the Principals wish to accept a bona fide offer from a third party to purchase all or substantially all of the assets constituting the Franchised Restaurant or of the majority of the voting stock of the Franchisee, the proposed transferor(s) shall give BKC written notice setting forth the name and address of the prospective purchaser, the price and terms of the offer together with a franchisee application completed by the prospective purchaser, a copy of the Purchase and Sale Agreement, executed by both the seller and purchaser, and all exhibits, copies of any real estate purchase agreement or agreements, proposed security agreements and related promissory notes, assignment documents, and any other information that BKC may request in order to evaluate the offer.",
            "target": "Yes",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 28
        },
        {
            "input": "CERES is hereby granted a first option, to be exercised by written notice within thirty (30) days from CERES-IGER Collaboration Agreement<omitted>IGER's aforementioned written report or such other time period as the Parties may agree to be granted the same right as set forth in Article 5.3 to commercialize any results of such activities.",
            "target": "Yes",
            "document_name": "CERES,INC_01_25_2012-EX-10.20-Collaboration Agreement.PDF",
            "index": 29
        },
        {
            "input": "pon Sanofi's exercise of the Option, [***] accordingly subject to the license granted to Sanofi under Section 3.1(a) and the payment obligations therefor pursuant to this Agreement.",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 30
        },
        {
            "input": "In the event HOC fails to provide the Financing Election as set forth above, the Company shall be free to obtain such financing from one or more additional parties, free of any obligation to HOC.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 31
        },
        {
            "input": "If BII provides XENCOR written notice of its exercise of the first right to negotiate within [...***...] after receipt of such written notice from XENCOR, then for a period of [...***...] following such written notice from BII or such longer period as agreed in writing by BII and XENCOR (or its Business Partner) (the \"Clinical Negotiation Period\"), XENCOR (or its Business Partner) and BII will negotiate in good faith an agreement for the manufacture and supply of Product for use in Phase 2 and 3 clinical trials, at market rate terms and conditions common for the contract manufacture of monoclonal antibodies within the contract manufacturing industry, to be mutually agreed in writing by the Parties.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 32
        },
        {
            "input": "We will not exercise a right of first refusal with respect to a proposed Transfer of less than a controlling interest to a member of a Principal Owner's immediate family or to your key employees.",
            "target": "Yes",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 33
        },
        {
            "input": "After the expiry of the five (5) year period, if a Party intends to sell any or all of its shares of the JVC (the \"Transferor\"), it shall first make an offer by a written notice to the other Parties (the \"Transferee\") to purchase such shares and the other Parties shall have the right to purchase the offered shares in proportion of their existing shareholding. .",
            "target": "Yes",
            "document_name": "IMPCOTECHNOLOGIESINC_04_15_2003-EX-10.65-JOINT VENTURE AGREEMENT.PDF",
            "index": 34
        },
        {
            "input": "Promptly upon receipt of notice from Pfizer, Exact and Pfizer shall engage in exclusive good faith negotiations to enter into a definitive written agreement for the Ex-US Commercial Rights.",
            "target": "Yes",
            "document_name": "ExactSciencesCorp_20180822_8-K_EX-10.1_11331629_EX-10.1_Promotion Agreement.pdf",
            "index": 35
        },
        {
            "input": "If, for any reason, this Agreement is not terminated pursuant to this Section 17, and the Agreement is assumed, or assignment of the same to any person or entity who has made a bona fide offer to accept an assignment of the Agreement is contemplated, pursuant to the U.S. Bankruptcy Code, then notice of such proposed assignment or assumption, setting forth: (a) the name and address of the proposed assignee; and (b) all of the terms and conditions of the proposed assignment and assumption; must be given to us within twenty (20) days after receipt of such proposed assignee's offer to accept assignment of the Agreement; and, in any event, within ten (10) days before the date application is made to a court of competent jurisdiction for authority and approval to enter into such assignment and assumption.",
            "target": "Yes",
            "document_name": "GOOSEHEADINSURANCE,INC_04_02_2018-EX-10.6-Franchise Agreement.PDF",
            "index": 36
        },
        {
            "input": "If AIRSOPURE fails to notify You of its election to exercise its right of first refusal granted herein within the thirty day period, then You may sell the franchise rights and license or the stock for the amount of the bona fide offer, subject to AIRSOPURE's rights under Section 12.02 above. Any material change in the terms or conditions of any offer prior to closing shall constitute a new offer subject to AIRSOPURE's right of first refusal described herein. If You fail to consummate the transaction within 30 days from the earlier of: (a) receipt of notice from AIRSOPURE that it elects not to exercise its right of first refusal, or (b) expiration of the 15 day period referred to herein, then You must resubmit the proposed transaction to AIRSOPURE, and AIRSOPURE shall have a new 15 day review period and right of first refusal.",
            "target": "Yes",
            "document_name": "AIRTECHINTERNATIONALGROUPINC_05_08_2000-EX-10.4-FRANCHISE AGREEMENT.PDF",
            "index": 37
        },
        {
            "input": "Once the Alternate Supplier is qualified pursuant to this Section 2.15, SutroVax shall have the first right (as between SutroVax and Sutro or Third Parties supplied or authorized by Sutro) to obtain Extract Manufactured by the Alternate Supplier up to the Capacity established pursuant to the Transfer Addendum for a period ending the later of [***] or [***], and provided SutroVax commits to [***] or [***].",
            "target": "Yes",
            "document_name": "VAXCYTE,INC_05_22_2020-EX-10.19-SUPPLY AGREEMENT.PDF",
            "index": 38
        },
        {
            "input": "If Hydraspin desires to enter a new territory in the United States, Hydraspin will offer Distributor the first opportunity to become the exclusive distributor for the new territory.",
            "target": "Yes",
            "document_name": "WaterNowInc_20191120_10-Q_EX-10.12_11900227_EX-10.12_Distributor Agreement.pdf",
            "index": 39
        },
        {
            "input": "Monsanto may consummate a Roundup Sale with any third party only if such Roundup Sale is made pursuant to the acceptance by Monsanto of a Roundup Superior Offer.",
            "target": "Yes",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 40
        },
        {
            "input": "SpinCo shall have the sole right to determine the content contained in future editions of the Steam Book, provided, however, that SpinCo will provide RemainCo with a right of first refusal to collaborate with SpinCo to provide content related to nuclear subject matter in the forty-third (43rd) edition of the Steam Book, with allocation of costs and revenues and any attribution and Copyright ownership with respect to RemainCo contributed content to be negotiated in good faith by the Parties.",
            "target": "Yes",
            "document_name": "BABCOCK_WILCOXENTERPRISES,INC_08_04_2015-EX-10.17-INTELLECTUAL PROPERTY AGREEMENT between THE BABCOCK _ WILCOX COMPANY and BABCOCK _ WILCOX ENTERPRISES, INC..PDF",
            "index": 41
        },
        {
            "input": "If by the expiration of the ROFO Transfer Period, the Farids Group has not completed the Transfer of any ROFO Shares at the ROFO Sales Price or a higher price, in order for the Farids Group to Transfer such ROFO Shares (or any other Shares) it shall be necessary for a new ROFO Sale Notice or ROFR Sale Notice to be delivered, and the terms and provisions of this Article VII to be again complied with.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 42
        },
        {
            "input": "Should Company introduce other products or devices as contemplated by recital paragraph \"A\", Distributor shall have the option of becoming Company's exclusive distributor of such other Products or devices within the Market.",
            "target": "Yes",
            "document_name": "LIMEENERGYCO_09_09_1999-EX-10-DISTRIBUTOR AGREEMENT.PDF",
            "index": 43
        },
        {
            "input": "You agree that, at our option, you will sell to us any or all your assets used to operate the Franchised Business (including equipment, fixtures, furnishings, Delivery Vehicles, supplies, and inventory) that we ask in writing to purchase. 16.2.1. The purchase price for such items will be equal to your depreciated cost (determined below) or fair market value, whichever is less. The cost will be determined based upon a five (5) year straight-line depreciation of original costs. For equipment that is five (5) or more years old, the parties agree that fair market value will be deemed to be ten percent (10%) of the equipment's original cost. The fair market value of tangible assets must be determined without reference to good will, going-concern value, or other intangible assets. Page 32 of 39 Source: PF HOSPITALITY GROUP INC., 10-12G, 9/23/2015 16.2.2. We may exercise this option by delivering a notice of intent to purchase to you within 30 days after the expiration or termination of this Agreement. During that 30-day period, you agree not to dispose of, transfer, or otherwise hinder our ability to exercise our rights with respect to your assets. 16.2.3. If we exercise our option to purchase, we may setoff all amounts due to us under this Agreement and the cost of the appraisal (if any), against any payment due to you. 16.2.4. If we do not exercise our rights to purchase your Delivery Vehicle(s), you must immediately make such modifications or alterations to the Delivery Vehicle(s) that may be needed to remove any Proprietary Marks and to otherwise distinguish the appearance of the vehicle(s) from those used by other Restaurants.",
            "target": "Yes",
            "document_name": "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.pdf",
            "index": 44
        },
        {
            "input": "The Parties shall then negotiate in good faith an agreement to exclusively license the particular PFHOF Work. If the Parties reach an agreement within thirty (30) days, then the applicable license shall be subject to the terms and conditions of this Agreement and the Village Media Company shall pay to PFHOF a License Fee for such license in accordance with this Agreement. If the Parties cannot reach an agreement within thirty (30) days, then PFHOF shall have the right to exploit or license the PFHOF Work itself.",
            "target": "Yes",
            "document_name": "GpaqAcquisitionHoldingsInc_20200123_S-4A_EX-10.6_11951677_EX-10.6_License Agreement.pdf",
            "index": 45
        },
        {
            "input": "Upon expiration or termination of this Agreement for any reason, Eutectix shall have the option to purchase some or all of the Licensed Equipment at fair market value, less any amounts owed to Eutectix by Liquidmetal, except the equipment listed under Section 2.1(b) above.",
            "target": "Yes",
            "document_name": "LiquidmetalTechnologiesInc_20200205_8-K_EX-10.1_11968198_EX-10.1_Development Agreement.pdf",
            "index": 46
        },
        {
            "input": "During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual sample of such new Product (the \"Sample\") and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written agreement of the parties hereto.",
            "target": "Yes",
            "document_name": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.pdf",
            "index": 47
        },
        {
            "input": "FSL and AFSL may not exercise the Put Option prior to the Option Starting Date nor more than one hundred eighty (180) days after the Option Starting Date.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 48
        },
        {
            "input": "FSL or AFSL may not exercise the Put Option for less than one hundred percent (100%) of the Shares held by both FSL and AFSL or any Affiliate of FSL or AFSL, as the case may be.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 49
        },
        {
            "input": "If COMPANY proposes to sell any equity securities or securities that are convertible into equity securities of COMPANY (collectively, \"Equity Securities\") in any new round of financing, then COMPANY shall offer JHU and/or its Assignee (as defined below) an opportunity to purchase either: (i) up to that portion of the Equity Securities that equals JHU's then current, fully-diluted percentage ownership interest in COMPANY, or (ii) if the percentage offered for sale by COMPANY is less, then up to five percent (5%) of the Equity Securities offered for sale.",
            "target": "Yes",
            "document_name": "VirtuosoSurgicalInc_20191227_1-A_EX1A-6 MAT CTRCT_11933379_EX1A-6 MAT CTRCT_License Agreement.pdf",
            "index": 50
        },
        {
            "input": "For the Term of this Agreement, Fox hereby grants to Licensee a right of first negotiation with respect to those theatrical motion pictures released during the Term of this Agreement (in addition to the Properties identified in Exhibit A) in which (i) Fox owns or controls licensing and merchandising rights, for which Fox determines in its sole discretion to grant to any third party any licensing rights for the development and distribution of wireless products, and (ii) which theatrical motion pictures Fox reasonably deems to be a Major Release consistent with its past practices.",
            "target": "Yes",
            "document_name": "GluMobileInc_20070319_S-1A_EX-10.09_436630_EX-10.09_Content License Agreement1.pdf",
            "index": 51
        },
        {
            "input": "If BII provides XENCOR written notice of its exercise of the first right to negotiate within [...***...] after receipt of such written notice from XENCOR, then for a period of [...***...] following such written notice, or such longer period as agreed in writing by BII and XENCOR (or its Business Partner) (the \"Commercial Negotiation Period\"), XENCOR (or its Business Partner) and BII will negotiate in good faith an agreement for the manufacture and supply of commercial Product as Principal Supplier, at market rate terms and conditions common for the contract manufacture of monoclonal antibodies within the contract manufacturing industry to be mutually agreed in writing by the Parties.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 52
        },
        {
            "input": "If the Company does not timely deliver a ROFO Purchase Notice it shall be deemed to have waived all of its rights with respect to the offer contained in the ROFO Sale Notice.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 53
        },
        {
            "input": "Throughout the Term and for a period of six (6) months after the expiration or termination of this Agreement, Calm shall have a right of first refusal to expand the rights and obligations described in this Agreement to any Stores outside the Territory (the \"ROFR\").",
            "target": "Yes",
            "document_name": "XpresspaGroupInc_20190401_10-K_EX-10.28_11599457_EX-10.28_Marketing Agreement.pdf",
            "index": 54
        },
        {
            "input": "The purchase price for the Call Shares (the \"Call Option Price\") shall be the greater of (x) the amount in Japanese Yen equal to the Net Book Value as of the most recently completed month end prior to the Call Closing Date, minus the Net Book Value as of the most recently completed month end prior to the Effective Date, multiplied by the number of Call Shares, or (y) one Japanese Yen (\u00a51).",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 55
        },
        {
            "input": "In the event that the Responsible Party elects to abandon any applicable Patent, the Responsible Party shall notify the Review Party in writing (such notice, an \"Abandonment Notice\") at least [***] ([***]) days prior to any filing or payment due date or any other due date that requires action to prevent loss of rights, and in the event that the Review Party provides the Responsible Party with written notice within [***] ([***]) days of receipt of the applicable Abandonment Notice, the Review Party shall thereafter have the right, [***], to conduct such filing, prosecution and maintenance for the applicable Patent.",
            "target": "Yes",
            "document_name": "Microgenics Corporation - Collaborative Development and Commercialization Agreement.PDF",
            "index": 56
        },
        {
            "input": "The Manufacturer agrees to offer the Customer the first right of refusal to purchase the intellectual property for the products listed in Schedule A of this agreement based upon agreed terms.",
            "target": "Yes",
            "document_name": "AgapeAtpCorp_20191202_10-KA_EX-10.1_11911128_EX-10.1_Supply Agreement.pdf",
            "index": 57
        },
        {
            "input": "If, however, Adaptimmune Limited timely exercises its option, but MD Anderson and Adaptimmune Limited are unable to agree upon the terms of the license during the Negotiation Period, Adaptimmune Limited's right to exclusively license such Invention will terminate, and MD Anderson will be free to enter into a license with any other party (subject to the grant of the non-exclusive license above).",
            "target": "Yes",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 58
        },
        {
            "input": "Richard Smith, MD will be given first consideration as a principal investigator for all new Product or Product- related clinical studies, in addition to other sites provided final site selection will be based on the best interest of the Project.",
            "target": "Yes",
            "document_name": "ArtaraTherapeuticsInc_20200110_8-K_EX-10.5_11943350_EX-10.5_License Agreement.pdf",
            "index": 59
        },
        {
            "input": "Should Licensee agree to be the vendor for an Additional Title, Licensor and Licensee will negotiate in good faith to mutually agree upon the pricing and terms for each Additional Title in an amendment to this Agreement.",
            "target": "Yes",
            "document_name": "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.pdf",
            "index": 60
        },
        {
            "input": "If King is interested in obtaining the Metformin Product Rights, it shall so notify Depomed in writing prior to the expiration of the Evaluation Period, and upon Depomed's receipt of such notice King and Depomed shall promptly commence good-faith negotiations, for a period of 30 days and such longer period as may be mutually agreed upon by the parties in writing in the event the parties have made material progress in the negotiations (the \"Negotiation Period\"), regarding the commercially reasonable terms of an agreement pursuant to which King shall obtain the Metformin Product Rights.",
            "target": "Yes",
            "document_name": "KINGPHARMACEUTICALSINC_08_09_2006-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 61
        },
        {
            "input": "Any sale, attempted sale, assignment, or other transfer of the interests described in Subparagraph 15.4.1 without first giving BKC the right of first refusal described above shall be void and of no force and effect, and shall constitute an Event of Default under Paragraph 17.1(k).",
            "target": "Yes",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 62
        },
        {
            "input": "If BII provides written notice of its exercise of the first right to negotiate within such [...***...] period but BII and XENCOR (or its Business Partner) do not enter into such a contract manufacturing agreement within the Commercial Negotiation Period, XENCOR and any Business Partner shall be free to enter into one or more agreements with third parties for the manufacture and supply, of commercial Product (which may include an agreement for any Business Partner or its affiliate to manufacture and supply commercial Product); provided that the supply price for Product is no more than [...***...] percent ([...***...]%) of the commercial supply price of Product last proposed by BII during the negotiations between the Parties (or BII and the Business Partner).",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 63
        },
        {
            "input": "As longs as TPH-A and TPH are not in material and continuing breach of this Agreement or the Ancillary Agreements, TPH-A or TPH may trigger the option to purchase the Call Shares (the \"Call Option\") by providing a written notice of the exercise of the Call Option (the \"Call Exercise Notice\") simultaneously to the Company, FSL and AFSL, which notice states (i) such Party's bona fide intention to exercise the Call Option, and (ii) the date on which such Party intends that the Call Closing Date occur.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 64
        },
        {
            "input": "If RevMed wishes to exercise its one-time Co-Promotion Option, it shall so notify Sanofi in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory.",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 65
        },
        {
            "input": "If the parties do not mutually agree to the terms of such potential acquisition within the Negotiation Period then the Exclusivity Period shall end and, subject to Sekisui's Right of First Refusal, Qualigen shall be free to negotiate the terms of a Sale Transaction with any Third Party.",
            "target": "Yes",
            "document_name": "RitterPharmaceuticalsInc_20200313_S-4A_EX-10.54_12055220_EX-10.54_Development Agreement.pdf",
            "index": 66
        },
        {
            "input": "In the event the closing of the purchase does not occur within said ninety (90) day period because Franchisee fails to act diligently in connection therewith, the purchase price shall be reduced by ten percent (10%).",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 67
        },
        {
            "input": "AFSL and TPH-A shall cause the Board to approve the share transfer of the Put Shares on or prior to the Put Closing Date.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 68
        },
        {
            "input": "If the Transfer is proposed to be made pursuant to a sale, we or our designee may purchase the interest proposed to be Transferred on the same economic terms and conditions offered by the third-party.",
            "target": "Yes",
            "document_name": "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.pdf",
            "index": 69
        },
        {
            "input": "The Product Offer shall be in writing, shall be in sufficient detail describing such New Product, and shall be made within sixty (60) days of the date of commercialization of such New Product for uses other than Lawn and Garden Use. In no event shall Monsanto, directly or indirectly, commercialize any New Product for Lawn and Garden Use in the Included Markets without first offering such New Product to the Agent pursuant to the terms of this Section 6.10.",
            "target": "Yes",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 70
        },
        {
            "input": "If BII does not provide written notice of its exercise of the first right to negotiate within such [...***...] period, XENCOR and any Business Partner shall be free to enter into one or more agreements with third parties for the manufacture and supply of Product for use in Phase 2 and 3 clinical trials",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 71
        },
        {
            "input": "If Sanofi provides a Notice of Interest to RevMed within [***], then (i) RevMed shall, upon request of Sanofi, provide Sanofi with reasonable access to all other then-existing Know-How in RevMed's Control that exists in either paper or electronic form and pertains to the relevant SHP1-SHP2 Dual Inhibitor and (ii) the Parties shall negotiate exclusively in good faith and on a commercially reasonable basis the terms of a definitive agreement under which Sanofi would be granted SHP1-SHP2 Dual Inhibitor License Rights for [***] after RevMed receives such Notice of Interest (such period, the \"SHP1-SHP2 Dual Inhibitor Licensing Negotiation Period\").",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 72
        },
        {
            "input": "Notwithstanding the foregoing, in the event ExxonMobil decides not to prosecute, defend, enforce, maintain or decides to abandon any Program Patent, then ExxonMobil will provide notice thereof to FCE, and FCE will then have the right, but not the obligation, to prosecute or maintain the Program Patent and sole responsibility for the continuing costs, taxes, legal fees, maintenance fees and other fees associated with that Program Patent.",
            "target": "Yes",
            "document_name": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf",
            "index": 73
        },
        {
            "input": "If AbbVie notifies Harpoon in writing within [***] after receipt of such copy that AbbVie wishes to receive a license or sublicense (as applicable) under, and be subject to the rights and obligations of, the Proposed Future In-Licensed Rights as they apply to AbbVie and this Agreement, then the Proposed Future In-Licensed Rights shall automatically be included in the Harpoon Patents and/or Harpoon Know-How (as applicable) hereunder and AbbVie agrees to abide by all applicable terms and conditions of such license, sublicense or other agreement, as it relates to AbbVie and this Agreement, including payment of any financial obligations based upon AbbVie's practice of such intellectual property rights.",
            "target": "Yes",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 74
        },
        {
            "input": "If Pretzel Time or its assignee exercises this option to purchase, pending the closing of such purchase, Pretzel Time may appoint a manager to maintain the operation of the Unit, at its option, require Franchisee to close the Unit during such time period without removing any asset",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 75
        },
        {
            "input": "If HOC fails to deliver the Option Exercise Notice on or before the Option Expiration Date, HOC shall be deemed to have waived its rights under this Section 2.1.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 76
        },
        {
            "input": "BKC shall have twenty (20) business days after receipt of the notice of offer and the furnishing of all reasonably requested information within which to notify Franchisee or the owners, as applicable, of BKC's intent to exercise its right hereunder.",
            "target": "Yes",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 77
        },
        {
            "input": "Subject to the provisions of subsection (g) of this Section 4.1 and Section 8.2 hereof, if at any time after the Closing Date, the Company proposes to issue or sell Equity Securities (\"Additional Securities\") other than (i) under any Stock Option Plan, (ii) pursuant to the exercise of options under any Stock Option Plan, (iii) upon the exercise, exchange or conversion of any Convertible Securities, or (iv) for property other than money, the HOC Entities shall have the right to subscribe for and purchase Additional Securities, at the price at which such Additional Securities are offered for sale to other purchasers (the \"Other Purchasers\"), up to its Pro Rata Interest (as defined below) prior to giving effect to the issuance or sale of such Additional Securities",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 78
        },
        {
            "input": "If you or any of your Principal Owners wishes to Transfer any Interest, we will have a right of first refusal to purchase that Interest as follows.",
            "target": "Yes",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 79
        },
        {
            "input": "If AbbVie does not provide a License Option Exercise Notice within the License Option Period, then (a) Harpoon shall have no further obligations to perform any Initial Development Activities, (b) AbbVie's License Option shall expire, and this Agreement shall terminate in accordance with Section 12.1.1, and (c) AbbVie shall have no further rights in connection with Licensed Compounds of the Licensed Products.",
            "target": "Yes",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 80
        },
        {
            "input": "If the Agent fails to agree in writing to accept the Product Offer within such ninety (90) days of receipt, then Monsanto shall have the exclusive right to manufacture, package, promote, distribute, and sell such New Product in the Included Markets, regardless of any actual or potential conflict with the terms of Agreement.",
            "target": "Yes",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 81
        },
        {
            "input": "Distributor shall exercise its option to become exclusive Distributor of other Products or devices by serving written notification on Company of its election to become exclusive distributor within thirty (30) days upon which Company informed Distributor in writing of Company's intention to introduce other Products or devices.",
            "target": "Yes",
            "document_name": "LIMEENERGYCO_09_09_1999-EX-10-DISTRIBUTOR AGREEMENT.PDF",
            "index": 82
        },
        {
            "input": "Completion of the sale and purchase of the Put Shares pursuant to the exercise of the Put Option by AFSL/FSL shall take place on the date specified in the Put Exercise Notice (which shall be a date after at least sixty (60) days from the date of the Put Exercise Notice) (the \"Put Closing Date\") and on which date: (i) TPH-A shall, or shall cause its designees to, and TPH shall cause TPH-A or TPH-A's designees to, pay to AFSL the Put Option Price for the Put Shares by way of a bank transfer to the bank account as separately designated by AFSL; and (ii) in exchange for which, AFSL shall deliver to TPH-A or its designees duly executed a letter of request to enter in the shareholder register of the Company the information that is required to be registered with regard to the Put Shares; and",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 83
        },
        {
            "input": "If Calm exercises its ROFR within the ROFR Period, the Parties shall enter into an amendment or addendum to this Agreement to include such additional region and/or Stores.",
            "target": "Yes",
            "document_name": "XpresspaGroupInc_20190401_10-K_EX-10.28_11599457_EX-10.28_Marketing Agreement.pdf",
            "index": 84
        },
        {
            "input": "If the Village Media Company does not exercise its right of first refusal, PFHOF shall have the right to grant a license with respect to such third party on the same terms originally provided to the Village Media Company.",
            "target": "Yes",
            "document_name": "GpaqAcquisitionHoldingsInc_20200123_S-4A_EX-10.6_11951677_EX-10.6_License Agreement.pdf",
            "index": 85
        },
        {
            "input": "CERES shall have the first option to pursue such protection in its best judgment in the joint names of both Parties.",
            "target": "Yes",
            "document_name": "CERES,INC_01_25_2012-EX-10.20-Collaboration Agreement.PDF",
            "index": 86
        },
        {
            "input": "If, during the Term, Licensor develops or obtains the rights to license any live action or animated feature-length motion picture (each an \"Additional Title\"), Licensor shall give Licensee the first right of negotiation for each Additional Title (i.e., the preferred vendor).",
            "target": "Yes",
            "document_name": "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.pdf",
            "index": 87
        },
        {
            "input": "If Pfizer and Exact are unable to reach agreement on the terms of such Product rights within forty-five (45) days of the commencement of negotiations, then Exact shall be free to enter into negotiations and consummate an agreement with any Third Party regarding such OB/Gyn Commercial Rights; provided that the economic terms of such agreement shall be no more favorable to such Third Party than those last offered to Pfizer.",
            "target": "Yes",
            "document_name": "ExactSciencesCorp_20180822_8-K_EX-10.1_11331629_EX-10.1_Promotion Agreement.pdf",
            "index": 88
        },
        {
            "input": "Following the expiration of such 10-day period, the Partner proposing to sell or transfer Partnership Interests shall have one hundred and eighty- (180-) days to sell or transfer, or enter into an agreement to sell or transfer the Partnership Interests with respect to which SMBC 's right under Section 12.3(a) was not exercised, at a price and upon terms no more favorable to the purchasers of such securities than specified in the Partner's notice.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 89
        },
        {
            "input": "If Party A indicates expressly in writing that it refuses or is unable to provide such services, Party B may turn to third parties for such other services; if, however, Party A agrees to provide such services, then the Parties shall<omitted>negotiate in good faith the content, method and fees of such services.",
            "target": "Yes",
            "document_name": "PhoenixNewMediaLtd_20110421_F-1_EX-10.17_6958322_EX-10.17_Content License Agreement.pdf",
            "index": 90
        },
        {
            "input": "Franchisee further agrees that the purchase price shall be further reduced by ten percent (10%) per month for each subsequent month Franchisee fails to act diligently to consummate this transaction. In the event that Franchisee cannot deliver clear title to all of the purchased assets as aforesaid, or in the event there are other unresolved issues, at Pretzel Time's option, the losing of the sale shall be accomplished through an escrow.",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 91
        },
        {
            "input": "Licensor will promptly provide written notice to Licensee in which Licensor lists each Additional Title.",
            "target": "Yes",
            "document_name": "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.pdf",
            "index": 92
        },
        {
            "input": "If the parties have not reached agreement in writing regarding the terms and conditions for the exploitation of the Opportunity within said time period, or if Licensee fails to submit a bid in a timely manner, Fox shall be free to accept any bid from any other party with respect to the Opportunity, or Fox shall be free not to exploit the Opportunity at all.",
            "target": "Yes",
            "document_name": "GluMobileInc_20070319_S-1A_EX-10.09_436630_EX-10.09_Content License Agreement1.pdf",
            "index": 93
        },
        {
            "input": "If, after the date of this Agreement and continuing as long as a Party is a partner, member, or shareholder of the Operating Company, the Joint Venture develops or completes the development of, or discovers, or acquires proprietary rights over, a process or product which at, or after, the time of its development, discovery or acquisition has, or might have, some application outside of the Field of Agreement, then the appropriate entity of the Joint Venture shall offer to license the use of the process or product (or the production thereof) for such application to each of the Parties on reasonable commercial terms (including, without limitation, the possible payment of royalties at market rates) taking into account the time and money spent by the Joint Venture and taking into account other relevant commercial factors.",
            "target": "Yes",
            "document_name": "IGENEBIOTECHNOLOGYINC_05_13_2003-EX-1-JOINT VENTURE AGREEMENT.PDF",
            "index": 94
        },
        {
            "input": "In the event the Licensor declines or fails to exercise in full the Right of First Refusal before the expiration of the Exercise Period, the Licensee shall have the right to consummate the transaction with the third party.",
            "target": "Yes",
            "document_name": "SFGFINANCIALCORP_05_12_2009-EX-10.1-SOFTWARE LICENSE AND MAINTENANCE AGREEMENT.PDF",
            "index": 95
        },
        {
            "input": "The Reseller shall have a right of first refusal to include within this Agreement any additional products developed, manufactured, or sold by the Company following the Effective Date that are not currently included in Exhibit A, and upon the exercise of such right, the term \"Products\" shall be expanded to mean such additional products as well.",
            "target": "Yes",
            "document_name": "TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.pdf",
            "index": 96
        },
        {
            "input": "In the event the Partner has not sold or transferred the Partnership Interests, or entered into an agreement to sell or transfer the Partnership Interests, within such one hundred and eighty- (180-) day period, Moelis General Partner shall not consent to the Partner's selling or transferring its Partnership Interests to an SMBC Competitor thereafter without first requiring the Partner to comply again with this Section 12.3.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 97
        },
        {
            "input": "Each Party's obligation to complete the Put Option or Call Option at the Put Closing Date or Call Closing Date, as applicable, is subject to the fulfillment on or before such Put Closing Date or Call Closing Date of each of the following conditions, unless waived in writing (where permissible) by the applicable party in such closing:",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 98
        },
        {
            "input": "The ROFR Sale Notice shall include: (i) (A) the identity of the proposed transferee, (B) the purchase agreement and other documentation for the proposed Transfer (the \"ROFR Sale Documentation\"), (C) the number of Shares proposed to be sold (the \"ROFR Shares\"), (D) the per share purchase price in cash at which the Farids Group is prepared to Transfer such ROFR Shares (the \"ROFR Sale Price\") and (E) the date the Farids Group proposes to effect such Transfer; and 28 (ii) an offer to sell to the Company and/or a designee of the Company all of the ROFR Shares at the ROFR Sale Price.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 99
        },
        {
            "input": "If Biocept does not obtain at least ten million dollars ($10,000,000) in equity financing by December 31, 2012, then Life Technologies shall have the non-exclusive option, exercisable by written notice to Biocept given no later than January 15, 2013, to negotiate with Biocept for a license (unless the parties mutually agree to a different transaction structure) to all necessary Intellectual Property<omitted>Rights and know-how to independently commercialize the Assay in accordance with applicable Laws.",
            "target": "Yes",
            "document_name": "BIOCEPTINC_08_19_2013-EX-10-COLLABORATION AGREEMENT.PDF",
            "index": 100
        },
        {
            "input": "Upon termination or expiration of this Agreement, if the parties do not enter into a successor Franchise Agreement whereby the Franchisee shall continue to be a franchisee and operate the Franchised Restaurant at the Location, BKC or its designee shall have the option subject to obtaining any necessary governmental consent: (a) To purchase the Location and/or any related equipment at fair market value, if the Franchisee, any of the Principals or an affiliate of the Franchisee owns the Location and/or related equipment. (b) If the Location is leased by the Franchisee, any of the Principals or an affiliate of the Franchisee, subject to obtaining any necessary landlord's consent, to obtain an assignment of the leasehold interest at a price equal to the fair market value of the leasehold interest.",
            "target": "Yes",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 101
        },
        {
            "input": "Notwithstanding the aforementioned requirement, before Promoter destroys any Safety Reports and associated source documents, or training records, it will notify SIGA of its intention to do so and afford SIGA the opportunity to retain such records if it so wishes.",
            "target": "Yes",
            "document_name": "SigaTechnologiesInc_20190603_8-K_EX-10.1_11695818_EX-10.1_Promotion Agreement.pdf",
            "index": 102
        },
        {
            "input": "eDiets shall have fifteen (15) days from the giving of such notice to agree to participate in the applicable Diet Promo upon the terms and conditions specified in the notice by giving written notice of its agreement to Women.com.",
            "target": "Yes",
            "document_name": "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.pdf",
            "index": 103
        },
        {
            "input": "XENCOR shall provide BII written notice (i) of the completion of the Phase 1 clinical trials of the Product, which notice shall include reasonable documentation of the results of such Phase 1 clinical trials of the Product or (ii) that XENCOR has entered into an agreement with at least one Business Partner, whichever of (i) and (ii) occurs earlier.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 104
        },
        {
            "input": "In case OntoChem finds a novel and unexpected antiviral use of those Rejected Hit Compounds during this 2-years period, it will notify Anixa about these findings and Anixa has the right of first negotiation during a period of 6 months after this notification.",
            "target": "Yes",
            "document_name": "ANIXABIOSCIENCESINC_06_09_2020-EX-10.1-COLLABORATION AGREEMENT.PDF",
            "index": 105
        },
        {
            "input": "Licensee's exercise of the Option is at its sole discretion. Licensee may exercise the Option by written notice to Licensor and Skunkware at any time during the Option Period.",
            "target": "Yes",
            "document_name": "NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.pdf",
            "index": 106
        },
        {
            "input": "If the Agent agrees in writing<omitted>within ninety (90) days of receipt of the Product Offer to accept the New Product, then such New Product shall be, without further action or amendment, included within the definition of Roundup Products and be subject to the terms and conditions of this Agreement.",
            "target": "Yes",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 107
        },
        {
            "input": "As the preferred manufacturer, LKPL shall have first right of refusal on all such RFMs.",
            "target": "Yes",
            "document_name": "LinkPlusCorp_20050802_8-K_EX-10_3240252_EX-10_Affiliate Agreement.pdf",
            "index": 108
        },
        {
            "input": "EFS agrees that it shall approach Licensees regarding any planned EFS Produced Merchandise and give such Licensees a seven (7) day right of first refusal with respect to the design and manufacture thereof, whereby EFS may set forth commercially reasonable requirements with respect to pricing, delivery and product specifications.",
            "target": "Yes",
            "document_name": "PlayboyEnterprisesInc_20090220_10-QA_EX-10.2_4091580_EX-10.2_Content License Agreement_ Marketing Agreement_ Sales-Purchase Agreement1.pdf",
            "index": 109
        },
        {
            "input": "Following the expiration of such 10-day period, Moelis Holdings shall have one hundred and eighty- (180-) days to sell or enter into an agreement to sell the Additional Units with respect to which SMBC's right of first refusal was not exercised, at a price and upon terms no more favorable to the purchasers of such securities than specified in Moelis Holdings' notice.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 110
        },
        {
            "input": "If, after the date of this Agreement and continuing as long as either Party is a partner, member, or shareholder of the Operating Company, such Party or any of its Affiliates receives or discovers any opportunity to use Astaxanthin as a Neutraceutical (a \"Neutraceutical Opportunity\"), including without limitation developing or completing the development of, or discovering, or acquiring proprietary rights over, a product or process that involves the use of Astaxanthin as a Neutraceutical, such Party shall (or shall cause its Affiliate to) present such opportunity to the Operating Company, providing the Operating Company with such narrative description and budgetary and other information as such Party (or its Affiliates) may have generated or gathered to the extent necessary to evaluate such Neutraceutical Opportunity.",
            "target": "Yes",
            "document_name": "IGENEBIOTECHNOLOGYINC_05_13_2003-EX-1-JOINT VENTURE AGREEMENT.PDF",
            "index": 111
        },
        {
            "input": "In the event that, during the Term of this Agreement, VS desires to enter into the same or substantially similar Commitments with a PPD Competitor for imaging services outside of the Designated Therapeutic Areas (defined herein or in any amendment hereto), VS shall first notify PPD regarding the same and PPD shall have a right, for a period of 45 days following receipt of such notice (the \"Election Period\"), to elect to include such imaging services as \"Preferred Services\" hereunder (the \"Right of First Refusal\").",
            "target": "Yes",
            "document_name": "VIRTUALSCOPICS,INC_11_12_2010-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 112
        },
        {
            "input": "HOC shall have ten (10) Business Days from delivery of such notice in which to notify the Company that it desires to provide all of such financing (the \"Financing Election\")",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 113
        },
        {
            "input": "Excite will offer Sponsor the right of first refusal to negotiate with Excite for renewal of this sponsorship.",
            "target": "Yes",
            "document_name": "N2KINC_10_16_1997-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 114
        },
        {
            "input": "During the Term, if Exact desires to grant an exclusive commercial license to a Third Party solely to Promote or sell the Product in the OB/Gyn Field in the Territory (the \"OB/Gyn Commercial Rights\"), Exact shall first notify Pfizer of such intent (a \"OB/Gyn Commercial Rights Transfer Notice\") and Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the OB/Gyn Commercial Rights that are the subject of the OB/Gyn Commercial Rights Transfer Notice.",
            "target": "Yes",
            "document_name": "ExactSciencesCorp_20180822_8-K_EX-10.1_11331629_EX-10.1_Promotion Agreement.pdf",
            "index": 115
        },
        {
            "input": "Upon termination, ENVISION shall have eighteen (18) months to exhaust any inventories, packaging and advertising materials bearing the \"SierraSil\" trademark and SIERRA shall have first option to buy back any inventory at ENVISION's net purchase price.",
            "target": "Yes",
            "document_name": "LEGACYTECHNOLOGYHOLDINGS,INC_12_09_2005-EX-10.2-DISTRIBUTOR AGREEMENT.PDF",
            "index": 116
        },
        {
            "input": "The right of first refusal granted hereunder may not be assigned or transferred, except that such right is assignable by SMBC to any of its respective Wholly-Owned Subsidiaries.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 117
        },
        {
            "input": "Application for our consent to a transfer and tender of the right of first refusal provided for in Paragraph XX, will be accompanied by the documents (including a copy of the proposed purchase or other transfer agreement) or other information required by us.",
            "target": "Yes",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 118
        },
        {
            "input": "In the event that the number of ROFO Shares offered to be purchased in the ROFO Purchase Notice is less than the number of ROFO Shares set forth in the Sale Notice (or the Company does not timely deliver a ROFO Purchase Notice), the Farids Group may sell the ROFO Shares that are not subject to any such ROFO Purchase Notice during the five (5) day business day period beginning on the date in the ROFO Sale Notice on which the Farids Group proposed to begin to effect such 144 Sale (the \"ROFO Transfer Period\"); provided that no such ROFO Share may be sold for less than the ROFO Sale Price.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 119
        },
        {
            "input": "hould Licensee agree to be the vendor for an Additional Title, Licensor and Licensee will negotiate in good faith to mutually agree upon the pricing and terms for each Additional Title in an amendment to this Agreement.",
            "target": "Yes",
            "document_name": "IdeanomicsInc_20151124_8-K_EX-10.2_9354744_EX-10.2_Content License Agreement.pdf",
            "index": 120
        },
        {
            "input": "Subject to the restrictions set forth in Section 5.1 of this Agreement and Section 2.3 of the Warrant, in the event any member of the Farids Group proposes to Transfer (other than a Permitted Transfer) (i) a Threshold Block, in a transaction or series of related transactions, that, to the Farids Group's knowledge (after due inquiry in connection with a private, non-open market transaction) is to a Person whom the Company reasonably determines is a direct or indirect material competitor of the Company or any Affiliate of such Person or (ii) a Significant Block, in a transaction or series of related transactions, that, to the Farids Group's knowledge (after due inquiry in connection with a private, non-open market transaction) is to a Person whom the Company reasonably determines is a direct or indirect material competitor of the Company or any Affiliate of such Person (in each case, regardless of whether such Transfer will constitute a 144 Sale), the Farids Group shall furnish to the Company a written notice of such proposed Transfer (a \"ROFR Sale Notice\") at least (5) business days prior to the business day that the Farids Group proposes to effect such Transfer.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 121
        },
        {
            "input": "In addition, no Technology Access Fee shall be due or payable in connection with XENCOR's election to use or have used (e.g. by a Business Partner) the Process if (i) BII does not exercise its first right to negotiate under either Section 5.2.2.a or 5.2.2.b, (ii) BII exercises its first right to negotiate but demands a supply price for clinical/commercial supply of Product that exceeds the bid price for the clinical/ commercial supply of Product of a comparable quantity and quality by a third party biopharmaceutical CMO of comparable size and respective activities to BII and with registered headquarters in the Major Territories, or (iii) XENCOR (or its Business Partner) has entered into a contract manufacturing agreement with BII, but BII is not able to supply XENCOR and its Business Partners [...***...] of the Product required.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 122
        },
        {
            "input": "If Licensee shall fail to give notice of the exercise of its right of first<omitted>refusal under this Section within such ninety (90) day period, or if Licensee shall notify the Offeree within such ninety (90) day period that Licensee has waived such right, then the Offeree shall have the right to sell, transfer or convey all or the applicable portion of the stock in, or assets of, Licensor (as specified in the Offering Notice) pursuant to the terms of the specific offer described in the applicable Offering Notice, but not otherwise.",
            "target": "Yes",
            "document_name": "NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.pdf",
            "index": 123
        },
        {
            "input": "For clarity, once RevMed has exercised its Co- Promotion Option pursuant to this Section 8.7(b), RevMed's right to co-promote Products shall apply to all other existing and subsequent Products in the Co-Promotion Territory.",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 124
        },
        {
            "input": "All of BII's rights of negotiation set forth in this Secti6n 5.2.2 shall terminate upon payment of the Technology Access Fee by XENCOR.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 125
        },
        {
            "input": "From and after the Closing Date and until 5:00 pm Denver time on the date which is eighty (80) days from the Closing Date (the \"Option Expiration Date\"), HOC shall have the option (the \"Option\"), at its sole discretion, to subscribe for all, but not less than all, of an additional 4,330,000 Shares from the Company (the \"Additional Shares\") at a price of US$3.00 per share, or a total of US$12,990,000.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 126
        },
        {
            "input": "To the extent permitted by Governmental Authorities, MPL will provide to each Shipper a first right, on terms and conditions specified by MPL that is consistent with this first right, to submit a binding nomination to ship, or otherwise pay for, a committed volume of Product on the expansion capacity (\"Requested Expansion Volume Commitment\").",
            "target": "Yes",
            "document_name": "MPLXLP_06_17_2015-EX-10.1-TRANSPORTATION SERVICES AGREEMENT.PDF",
            "index": 127
        },
        {
            "input": "If Women.com proposes to create and make available Diet Promos after the Effective Date, it shall give eDiets written notice of its intention, describing the terms and conditions of participation in the Diet Promos.",
            "target": "Yes",
            "document_name": "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.pdf",
            "index": 128
        },
        {
            "input": "In the event a Partner proposes to undertake a sale or transfer of Partnership Interests to which the foregoing right applies, and Moelis General Partner must consent to the sale or transfer, Moelis General Partner shall require that Partner to give SMBC written notice of its intention to sell or transfer Partnership Interests to an SMBC Competitor describing the price and terms upon which such Partner proposes to sell or transfer its Partnership Interests.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 129
        },
        {
            "input": "If Adaptimmune Limited timely exercises its option, the terms of the license shall be negotiated in good faith within six months of the date such option is exercised, or within such time the parties may mutually agree in writing (the \"Negotiation Period\").",
            "target": "Yes",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 130
        },
        {
            "input": "On or as soon as practicable following the Effective Date, it is intended that you will be granted an option under the Option Plan to acquire 107,417 ordinary shares in the capital of BTL (\"Shares\") (representing approximately 0.6% of the Company's issued share capital as at the Effective Date).",
            "target": "Yes",
            "document_name": "BICYCLETHERAPEUTICSPLC_03_10_2020-EX-10.11-SERVICE AGREEMENT.PDF",
            "index": 131
        },
        {
            "input": "If Sponsor rejects said offer or fails to notify Excite of its acceptance within the [****] period, Excite shall have the right thereafter to enter into the agreement with such third party, provided the terms and conditions of the agreement (if entered into within the subsequent ninety (90) days) are not less favorable to Excite than previously offered by Sponsor.",
            "target": "Yes",
            "document_name": "N2KINC_10_16_1997-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 132
        },
        {
            "input": "Notwithstanding anything to the contrary in this Agreement, Medica shall neither enter into an agreement to nor shall consummate (a) any Change of Control or (b) any sale of all or substantially all of its assets relating to the manufacture of the Cartridges unless (a) it provides Vapotherm written notice of any such proposed transaction, which notice shall include the specific terms and conditions of the proposed transaction, including the identify of the proposed acquirer, (b) Medica offers to enter into such transaction with Vapotherm on substantially the same terms and conditions, and (c) with [* * *] days of such notice, Vapotherm declines to accept such offer.",
            "target": "Yes",
            "document_name": "VAPOTHERM, INC. - Manufacturing and Supply Agreement.PDF",
            "index": 133
        },
        {
            "input": "Following the License Option Exercise Closing Date, if [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product, AbbVie shall have the first right, but not the obligation, to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right.",
            "target": "Yes",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 134
        },
        {
            "input": "If the Company or any of its Subsidiaries decides to seek a joint venture partner to develop, acquire or otherwise earn an interest in any Properties including the Existing Properties, in circumstances where the Company's participation in such joint venture is not dependent on the participation of a particular third party as joint venture partner (such as in the case of an earn-in) (each a \"Proposed Joint Venture\"), the Company shall immediately provide notice to HOC (the \"Joint Venture Proposal Notice\") specifying sufficient information regarding the particulars of the Proposed Joint Venture to allow HOC to make a reasoned decision in respect of participating in the Proposed Joint Venture, including to the extent any such terms are determinable at such time: (A) a description of the Property in respect of which the Proposed Joint Venture relates, and (B) the terms, including the purchase price, for the Proposed Joint Venture, and if applicable, a true copy of any related term sheet setting forth such terms.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 135
        },
        {
            "input": "The Creating Party grants to the other Party a time-limited first right to negotiate a commercial license to use, reproduce, display, and perform commercially valuable Copyright Materials for commercial purposes, and to distribute and/or sublicense such commercially valuable Copyright Materials to third parties.",
            "target": "Yes",
            "document_name": "IbioInc_20200313_8-K_EX-10.1_12052678_EX-10.1_Development Agreement.pdf",
            "index": 136
        },
        {
            "input": "If Franchisee (or its Owners) shall at any time determine to sell, assign or transfer for consideration this Agreement or an Ownership Interest in Franchisee or the Unit, Franchisee (or its Owners) shall obtain a bona fide, executed written offer and earnest money deposit from a responsible and fully disclosed purchaser (including lists of the Owners of record and beneficially of any corporate offeror and all general and limited partners of any partnership offeror and, in the case of a publicly-held corporation or limited partnership, copies of the most current annual and quarterly reports) and shall immediately submit to Pretzel Time a true and complete copy of such offer, which shall include details of the payment terms of the proposed sale and the sources and terms of any financing for the proposed purchase price.",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 137
        },
        {
            "input": "If BII does not provide written notice of its exercise of the first right to negotiate within such [...***...] period, XENCOR and any Business Partner shall be free to enter into one or more agreements with third parties for the manufacture and supply of commercial Product (which may include an agreement for any Business Partner or its affiliate to manufacture and supply commercial Product).",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 138
        },
        {
            "input": "XENCOR hereby grants and will make an eventual Business Partner do so, BII a first right to negotiate to manufacture and supply Product for use in Phase 2 and 3 clinical trials.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 139
        },
        {
            "input": "If Network 1 desires to exercise its rights under this Section it will give written notice to Affiliate within 15 business days of receipt of the Offer.",
            "target": "Yes",
            "document_name": "UsioInc_20040428_SB-2_EX-10.11_1723988_EX-10.11_Affiliate Agreement 2.pdf",
            "index": 140
        },
        {
            "input": "Upon FSL's or AFSL's exercise of the Put Option, TPH-A shall be obliged to purchase or cause TPH-A's designees to purchase, and TPH shall be obliged to cause TPH-A or TPH-A's designees to purchase, the Put Shares in accordance with this Section 9.1. For the avoidance of doubt, the Put Option is the right of AFSL/FSL, and AFSL/FSL is not obliged to exercise the Put Option.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 141
        },
        {
            "input": "TPH or TPH-A may not exercise the Call Option for less than one hundred percent (100%) of the Shares held by both FSL and AFSL or any Affiliate of FSL or AFSL, as the case may be.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 142
        },
        {
            "input": "If BKC does not exercise its option under Subparagraph 15.4.1, Franchisee may conclude the sale to the purchaser who made the offer provided BKC's consent to the assignment or sale be first obtained as provided below.",
            "target": "Yes",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 143
        },
        {
            "input": "The foregoing right of first refusal shall cease in the event of a Change of Control of either RemainCo or SpinCo, provided, however, that the Parties will discuss the feasibility of future collaboration, specifically related to the contribution of nuclear related subject matter by RemainCo, in good faith in the event of a Change of Control.",
            "target": "Yes",
            "document_name": "BABCOCK_WILCOXENTERPRISES,INC_08_04_2015-EX-10.17-INTELLECTUAL PROPERTY AGREEMENT between THE BABCOCK _ WILCOX COMPANY and BABCOCK _ WILCOX ENTERPRISES, INC..PDF",
            "index": 144
        },
        {
            "input": "If Calm does not exercise its ROFR within the ROFR Period, XSPA may enter into such agreement or arrangement with respect to the applicable region and/or Stores set forth in the ROFR Notice with any third party; provided that, such agreement or arrangement are on the same terms offered to Calm (it being understood that in the event XSPA modifies such terms, XSPA shall provide a new ROFR Notice to Calm in accordance with this Section \u200b3.02).",
            "target": "Yes",
            "document_name": "XpresspaGroupInc_20190401_10-K_EX-10.28_11599457_EX-10.28_Marketing Agreement.pdf",
            "index": 145
        },
        {
            "input": "Biocept grants to Life Technologies a non-exclusive option, exercisable during the two (2) year period beginning on the Effective Date, to develop plans, and negotiate with Biocept, for the co-development with Biocept of such systems for the Assay, employing or based on Biocept technologies.",
            "target": "Yes",
            "document_name": "BIOCEPTINC_08_19_2013-EX-10-COLLABORATION AGREEMENT.PDF",
            "index": 146
        },
        {
            "input": "AIRSOPURE shall have the option, within 15 days after receipt of such written notice, to notify You that AIRSOPURE elects to purchase the rights and license granted herein or stock ownership on the same terms and conditions as the bona fide written offer.",
            "target": "Yes",
            "document_name": "AIRTECHINTERNATIONALGROUPINC_05_08_2000-EX-10.4-FRANCHISE AGREEMENT.PDF",
            "index": 147
        },
        {
            "input": "In the event that Company does not timely delivery a ROFR Purchase Notice, the Farids Group may sell the ROFR Shares to the proposed transferee identified in the ROFR Sale Notice at the ROFR Sale Price and on the other terms and conditions set forth in the ROFR Sale Documentation no later than three (3) business days following the date the Farids Group proposed to effect such Transfer in the ROFR Sale Notice (the \"ROFR Transfer Period\").",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 148
        },
        {
            "input": "Sponsor shall have the opportunity to purchase the same seating package for the postseason at prevailing prices, as available: (i) *** with access to the \"West Legacy Club;\" (ii) *** on the 100 level with access to the \"Champions\" and \"Broadcast\" clubs; (iii) *** on the 200 level with access to the \"Loft\" club;",
            "target": "Yes",
            "document_name": "VIOLINMEMORYINC_12_12_2012-EX-10.14-SPONSORSHIP AGREEMENT.PDF",
            "index": 149
        },
        {
            "input": "AFSL and TPH-A shall cause the Board to approve the share transfer of the Call Shares on or prior to the Call Closing Date.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 150
        },
        {
            "input": "Similarly, if a third party (who is not an affiliate of Playa) approaches Playa during the Development Term with a proposed offer or arrangement, which Playa desires to accept, under which Playa or its affiliate would manage an all- inclusive resort in the Market Area for that third party, and if that third party has not then already designated a brand under which that all-inclusive resort would operate, then Playa agrees to provide notice to Hyatt and introduce Hyatt to that third party for purposes of enabling Hyatt (at its option) to negotiate for the opportunity to provide that third party franchise rights to brand that resort as a Hyatt All-Inclusive Resort.",
            "target": "Yes",
            "document_name": "PLAYAHOTELS&RESORTSNV_03_14_2017-EX-10.22-STRATEGIC ALLIANCE AGREEMENT (Hyatt Ziva Cancun).PDF",
            "index": 151
        },
        {
            "input": "In the event that, pursuant to this first right, MPL receives binding commitments for volumes that exceed the expansion capacity available for committed volumes, each Shipper that submitted a binding commitment pursuant to this first right procedure shall be allocated the lesser of: (i) its Requested Expansion Volume Commitment, or (ii) the Shipper's pro-rata share of the expansion capacity available for committed volumes, which shall be calculated by multiplying (1) the Shipper's Proportionate Share, times (2) the expansion capacity available for committed volumes (\"Expansion Volume Commitment\").",
            "target": "Yes",
            "document_name": "MPLXLP_06_17_2015-EX-10.1-TRANSPORTATION SERVICES AGREEMENT.PDF",
            "index": 152
        },
        {
            "input": "Upon the termination or expiration of the Franchise, we will have the option, but not the obligation, exercisable for thirty (30) days upon written notice to you, to purchase at fair market value all of the assets of the Franchise, including all approved equipment, fixtures, furniture and signs and all supplies, materials, and other items imprinted with any Mark, and to take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise.",
            "target": "Yes",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 153
        },
        {
            "input": "Upon TPH-A's or TPH's exercise of the Call Option, AFSL/FSL shall be obliged to sell, or cause the holder of the Call Shares to sell, the Call Shares to TPH-A or its designee in accordance with this Section 9.2. For the avoidance of doubt, the Call Option is the right of TPH-A and TPH-A is not obliged to exercise the Call Option.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 154
        },
        {
            "input": "Closing of the purchase and sale of the Additional Shares shall take place within ten (10) business days of the delivery of the Option Exercise Notice, such date being referred to as the \"Subsequent Closing Date\".",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 155
        },
        {
            "input": "If the conveyance of the Principal's interest to a party acceptable to BKC has not taken place within the twelve (12) month period, BKC shall have the option, to purchase the Principal's interest at fair market value.",
            "target": "Yes",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 156
        },
        {
            "input": "During the Term, Women.com agrees to give eDiets the right of first refusal to participate in all diet and diet-counseling related promotion opportunities created or otherwise made available by Women.com on channels or sub-channels created after the Effective Date of this Agreement, including sponsorships, anchor placements and any other content integration opportunities (\"Diet Promos\").",
            "target": "Yes",
            "document_name": "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.pdf",
            "index": 157
        },
        {
            "input": "DCL shall first offer all Surplus Vehicles that DCL wishes to sell for sale to SEV.",
            "target": "Yes",
            "document_name": "SMITHELECTRICVEHICLESCORP_04_04_2012-EX-10.26-FLEET MAINTENANCE AGREEMENT.PDF",
            "index": 158
        },
        {
            "input": "If the supply price for Product proposed by a third party (which may include a Business Partner or its affiliate) is more than [...***...] percent ([...***...]%) of the commercial supply price of Product last proposed by BII during the negotiations between the Parties (or BII and the Business Partner), XENCOR (or its Business Partner) shall provide written notice to BII that XENCOR (and its Business Partner) will accept the commercial supply price last proposed by BII, and BII and XENCOR (or its Business Partner) will enter into a contract manufacturing agreement reflecting such commercial supply price; provided that, if BII does not agree to enter into such contract manufacturing agreement within [...***...] after such written notice, XENCOR (or its Business Partner) shall be free to enter into an agreement with a third party (which may include an agreement for any Business Partner or its affiliate to manufacture and supply Product).",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 159
        },
        {
            "input": "If the Offering Party is required to offer the Receiving Party a Development Opportunity pursuant to this Section 1, the Offering Party must deliver written notice to the Receiving Party, together with reasonable due diligence information in the Offering Party's possession to enable the Receiving Party to evaluate the Development Opportunity (collectively, the \"Offer Notice\").",
            "target": "Yes",
            "document_name": "PLAYAHOTELS&RESORTSNV_03_14_2017-EX-10.22-STRATEGIC ALLIANCE AGREEMENT (Hyatt Ziva Cancun).PDF",
            "index": 160
        },
        {
            "input": "If the proposed Transfer includes assets not related to the operation of the Franchise, we may purchase only the assets related to the operation of the Franchise or may also purchase the other assets",
            "target": "Yes",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 161
        },
        {
            "input": "If the proposed sale includes assets of Franchisee not related to the operation of franchised Burger King Restaurants, BKC may, at its option, elect to purchase only the assets related to the operation of franchised Burger King Restaurants and an equitable purchase price shall be allocated to each asset included in the proposed sale.",
            "target": "Yes",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 162
        },
        {
            "input": "If [***] (such determination, the \"SHP1-SHP2 Dual Inhibitor Licensing Decision\" and such Third Party's rights, the \"SHP1-SHP2 Dual Inhibitor License Rights\"), then prior to commencing any negotiations with any Third Party with regard to any SHP1-SHP2 Dual Inhibitor License Rights, RevMed shall promptly notify Sanofi in writing of such SHP1-SHP2 Dual Inhibitor Licensing Decision and provide to Sanofi a detailed summary of the data then in RevMed's Control regarding the relevant SHP1-SHP2 Dual Inhibitor.",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 163
        },
        {
            "input": "Such option shall be exercisable during a period (the \"Option Period\") commencing on and including the earlier of (i) the date upon which Licensee shall have paid to Licensor, in any single fiscal year of Licensee, royalty payments hereunder in the aggregate amount of $10,000,000 or (ii) January 1, 2002, and ending upon the expiration or sooner termination of this Agreement.",
            "target": "Yes",
            "document_name": "NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.pdf",
            "index": 164
        },
        {
            "input": "The right set forth in Section 5.2.2.b shall automatically terminate if BII does not exercise the first right of negotiation set forth in Section 5.2.2.a.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 165
        },
        {
            "input": "Sponsor will have [****] after receipt of such written notice to provide notice to Excite that it is prepared to enter into an agreement with Excite on the same terms and conditions as Excite proposes to accept from such third party.",
            "target": "Yes",
            "document_name": "N2KINC_10_16_1997-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 166
        },
        {
            "input": "If the Company issues Equity Securities in circumstances that would not give rise to the rights of the HOC Entities pursuant to Section 4.1(a) (the \"Non-Participating Transaction\"), then in any concurrent or subsequent transaction which does give rise to the rights of the HOC Entities pursuant to Section 4.1(a) (the \"Participating Transaction\"), the Company shall allow the HOC Entities to subscribe for and purchase Additional Securities in an amount greater than HOC's Pro Rata Interest; provided that in the Participating Transaction, HOC shall not be entitled to purchase any more than its Pro Rata Interest of the securities sold collectively in the Non-Participating Transaction and the Participating Transaction.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 167
        },
        {
            "input": "The rights granted under this Section 12.3 may not be assigned or transferred, except that such right is assignable by SMBC to any of its respective Wholly-Owned Subsidiaries.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 168
        },
        {
            "input": "If either Party has received a Third Party Offer that it intends to accept (the \"Offer\"), such Party (the \"Selling Party\") shall notify the other Party (the \"Offeree\") of the Offer, which notice shall include a copy of the Offer and any other information necessary to enable the Offeree to evaluate reasonably the Offer and the potential purchaser.",
            "target": "Yes",
            "document_name": "IGENEBIOTECHNOLOGYINC_05_13_2003-EX-1-JOINT VENTURE AGREEMENT.PDF",
            "index": 169
        },
        {
            "input": "If CERES exercises its option to commercialize under Article 3.3, CERES and IGER shall negotiate the terms of a commercialization agreement that covers the reported result with reference to any commercialization agreement then in existence between the Parties or the model license agreement or remuneration principles included herein (as applicable).",
            "target": "Yes",
            "document_name": "CERES,INC_01_25_2012-EX-10.20-Collaboration Agreement.PDF",
            "index": 170
        },
        {
            "input": "If Licensee shall have exercised such right, the closing shall be held at the corporate offices of Licensee on the closing date specified in the Offering Notice or the date that is ninety (90) days after the date of Licensee's notice of its exercise of such right, whichever is later.",
            "target": "Yes",
            "document_name": "NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.pdf",
            "index": 171
        },
        {
            "input": "If Glamis and Western Copper are unable to negotiate an acceptable agreement with respect to the Designated Mineral Property within the 30 day period, Glamis may thereafter dispose of the Designated Mineral Property as it sees til in its absolute discretion.",
            "target": "Yes",
            "document_name": "WESTERN COPPER - NON-COMPETITION AGREEMENT.PDF",
            "index": 172
        },
        {
            "input": "During the Term prior to the Option exercise by Sanofi, RevMed shall provide to Sanofi any additional information Controlled by RevMed that is reasonably requested by Sanofi in order to assist Sanofi in determining whether to exercise its Option. If Sanofi so exercises its Option pursuant to this Section 3.1(b)(ii), [***]. U",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 173
        },
        {
            "input": "The closing of the purchase of such ROFO Shares by the Company and/or any such designee shall take place no later than five (5) business days after delivery of the ROFO Purchase Notice, with payment for such ROFO Shares being made concurrently with such purchase to the Farids Group's account designated in the ROFO Sale Notice.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 174
        },
        {
            "input": "If CERES declines to exercise the option under Article 3.3 or fails to respond within thirty (30) days of IGER's notice under Article 3.3, then IGER shall then be free to commercially exploit the results or offer rights in such results to third parties in any and all crops.",
            "target": "Yes",
            "document_name": "CERES,INC_01_25_2012-EX-10.20-Collaboration Agreement.PDF",
            "index": 175
        },
        {
            "input": "In the ease of a Designated Mineral Property that Glamis intends to dispose of for cash consideration, the parties will negotiate in good faith to reach a mutually agreeable agreement for the sale to Western Copper of the [Designated Mineral Property.",
            "target": "Yes",
            "document_name": "WESTERN COPPER - NON-COMPETITION AGREEMENT.PDF",
            "index": 176
        },
        {
            "input": "Upon receipt of such notice, DIALOG will have [***] to notify ENERGOUS in writing that it desires to add such New Product as Product under this Agreement.",
            "target": "Yes",
            "document_name": "ENERGOUSCORP_03_16_2017-EX-10.24-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 177
        },
        {
            "input": "Prior to the IPO and during the term of the Strategic Alliance, SMBC shall have the right of first refusal to purchase all (but not less than all) Additional Units that Moelis Holdings proposes to issue to an SMBC Competitor, including (x) in a proposed issuance that is excepted from Section 3.4.2 of the Moelis Holdings Agreement as an issuance to a Strategic Investor, and (y) in a proposed issuance that is subject to Section 3.4.2 of the Moelis Holdings Agreement, to the extent that the Partners do not exercise in full their right of first refusal thereunder.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 178
        },
        {
            "input": "No later than sixty (60) days following the date of MPL's Expansion Notice, Shipper must commit to, in a form acceptable to MPL in MPL's sole discretion, its Requested Expansion Volume Commitment (\"Election Deadline\").",
            "target": "Yes",
            "document_name": "MPLXLP_06_17_2015-EX-10.1-TRANSPORTATION SERVICES AGREEMENT.PDF",
            "index": 179
        },
        {
            "input": "During the period beginning on the Effective Date and ending on December 31, 2018 (the \"Development Term\"), each Party (the \"Offering Party\") agrees to provide to the other Party (the \"Receiving Party\") a right of first offer with respect to any proposed offer or arrangement, which the Offering Party (or its affiliate) desires to accept, under which the Offering Party or one of its affiliates would acquire the ownership of real property in the Market Area (the \"Development Property\") on which a Hyatt All-Inclusive Resort would operate (a \"Development Opportunity\").",
            "target": "Yes",
            "document_name": "PLAYAHOTELS&RESORTSNV_03_14_2017-EX-10.22-STRATEGIC ALLIANCE AGREEMENT (Hyatt Ziva Cancun).PDF",
            "index": 180
        },
        {
            "input": "XENCOR shall provide BII written notice (i) of the decision to have the Product manufactured at a commercial scale and to launch the Product commercially or (ii) that XENCOR has entered into an agreement with at least one Business Partner, whichever of (i) and (ii) occurs earlier.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 181
        },
        {
            "input": "PFHOF agrees that during the Term, except with respect to the categories identified on Exhibit A, it will not create new PFHOF Works without first granting the Village Media Company a right of first offer to create such PFHOF Work, subject to any Rights Restrictions.",
            "target": "Yes",
            "document_name": "GpaqAcquisitionHoldingsInc_20200123_S-4A_EX-10.6_11951677_EX-10.6_License Agreement.pdf",
            "index": 182
        },
        {
            "input": "Upon expiration of this Agreement, with all conditions being equal, Party B has the preferential right to continue Cooperation with Party A in respect of the real estate channel.",
            "target": "Yes",
            "document_name": "LEJUHOLDINGSLTD_03_12_2014-EX-10.34-INTERNET CHANNEL COOPERATION AGREEMENT.PDF",
            "index": 183
        },
        {
            "input": "Once presented with an opportunity, Hertz shall have five (5) business days in which to accept or reject such terms. If iVillage does not receive Hertz's acceptance or rejection of such within the allotted time, iVillage shall deem Hertz's silence as rejection.",
            "target": "Yes",
            "document_name": "IVILLAGEINC_03_17_1999-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 184
        },
        {
            "input": "In the event that ENERGOUS develops New Product, ENERGOUS will provide DIALOG with written notice describing the New Product before marketing, selling or distributing the New Product with or to any third party.",
            "target": "Yes",
            "document_name": "ENERGOUSCORP_03_16_2017-EX-10.24-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 185
        },
        {
            "input": "ENERGOUS may not negotiate with any third party the rights to market, sell or distribute any New Product until the earliest to occur of the following (a) DIALOG does not provide ENERGOUS with notice that it desires to add such New Product to this Agreement within the above-described [***] period, (b) ENERGOUS and DIALOG do not reach mutually agreeable terms for adding such New Product to this Agreement during the [***] negotiation period or (c) DIALOG provides ENERGOUS with written notice that it does not wish to negotiate with respect to such New Product.",
            "target": "Yes",
            "document_name": "ENERGOUSCORP_03_16_2017-EX-10.24-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 186
        },
        {
            "input": "MKOS will have 30-days from receipt of information to determine if they wish to go forward with the technology license. UTEK, after 30 days, shall have the right to present the technology to other clients.",
            "target": "Yes",
            "document_name": "MANAKOASERVICESCORP_11_21_2007-EX-7.5-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 187
        },
        {
            "input": "If King notifies Depomed in writing within 180 days after the Effective Date that King desires to exercise its option to obtain a Combination Product License, King and Depomed shall promptly commence good-faith negotiations regarding a definitive agreement providing for the Combination Product License, for a period of 60 days or such longer period as may be mutually agreed upon by the parties in writing; and it is agreed that, as part of such good faith negotiations, the parties will discuss, for inclusion in any definitive agreement, appropriate non-compete obligations for each party with respect to any product containing metformin hydrochloride as an active pharmaceutical ingredient.",
            "target": "Yes",
            "document_name": "KINGPHARMACEUTICALSINC_08_09_2006-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 188
        },
        {
            "input": "The rights granted to HOC under this Article 4 shall terminate and be of no further force or effect if HOC does not exercise Option and complete the purchase of the Additional Shares.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 189
        },
        {
            "input": "Qualigen shall provide Sekisui with at least 30 days prior written notice and access to all due diligence materials provided to any potential acquirer, such 30 day period to commence upon the notification to Sekisui that Qualigen's board of directors has approved such Proposed Sale Transaction (as set forth in a term sheet or draft definitive agreement provided to Sekisui), subject to Sekisui's Right of First Refusal.",
            "target": "Yes",
            "document_name": "RitterPharmaceuticalsInc_20200313_S-4A_EX-10.54_12055220_EX-10.54_Development Agreement.pdf",
            "index": 190
        },
        {
            "input": "If Harpoon decides not to prepare, file, prosecute, or maintain a Harpoon Patent or Joint Patent in a country or other jurisdiction in the Territory, Harpoon shall provide reasonable prior written notice to AbbVie of such intention (which notice shall, in any event, be given no later than [***] prior to the next deadline for any action that may be taken with respect to such Harpoon Patent or Joint Patent in such country or other jurisdiction), AbbVie shall thereupon have the option, in its sole discretion, to assume the control and direction of the preparation, filing, prosecution, and maintenance of such Harpoon Patent or Joint Patent at its expense in such country or other jurisdiction.",
            "target": "Yes",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 191
        },
        {
            "input": "If any of HOC Entities provides the Company an acceptance (the \"HOC JV Acceptance Notice\") in writing in respect of the Joint Venture Proposal Notice, within fifteen (15) Business Days of receipt thereof or such shorter period as may be specified in the Joint Venture Proposal Notice of a determination in respect of the Proposed Joint Venture, the Company shall negotiate exclusively in good faith with HOC to finalize terms of the Proposed Joint Venture acceptable to each of the Parties, acting reasonably, within a period of sixty days or such additional period as the Parties may from time to time agree in writing (the \"JV Negotiation Period\"), failing which the Company shall be entitled to pursue other partners for the Proposed Joint Venture.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 192
        },
        {
            "input": "Depomed shall notify King in writing in the event that Depomed desires to divest itself of its rights to the Product in the Territory (e.g., by asset sale or product license to a Third Party), or of its rights in the Territory to a product owned or controlled by Depomed containing metformin and another active pharmaceutical ingredient in combination with Depomed's proprietary drug delivery technology incorporated within the Product (currently referred to as the AcuForm technology) (a \"Combination Product\").",
            "target": "Yes",
            "document_name": "KINGPHARMACEUTICALSINC_08_09_2006-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 193
        },
        {
            "input": "Pursuant to Article 6.2, if a Transferee does not, in whole or in part, accept to purchase the shares offered in terms of Article 6.2 by the Transferor, the other Transferee may purchase all the shares offered by the Transferor at a price determined as per Article 6.3(c) hereof.",
            "target": "Yes",
            "document_name": "IMPCOTECHNOLOGIESINC_04_15_2003-EX-10.65-JOINT VENTURE AGREEMENT.PDF",
            "index": 194
        },
        {
            "input": "We have the right, exercisable within thirty (30) days after receipt of the notice specified in Section 14.2 [No Transfer without Our Prior Written Consent], to send written notice to you that we intend to purchase the interest proposed to be Transferred.",
            "target": "Yes",
            "document_name": "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.pdf",
            "index": 195
        },
        {
            "input": "If HOC does not provide HOC JV Acceptance Notice to the Company within fifteen (15) Business Days or such shorter period as may be specified in the Joint Venture Proposal Notice, of receiving of the Joint Venture Proposal Notice, the Company may enter into negotiations with any other person regarding the Proposed Joint Venture",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 196
        },
        {
            "input": "STW will have one year from completion of the last of the Post-Well Study (ies) completed on the Existing CRA Well or Replacement CRA Well to exercise its option to produce and transport the water produced from the CRA on the Property (\"Option to Produce\"). The AGREEMENT shall thereafter terminate as to both Parties if STW has not exercised its Option to Produce at the expiration of the one-year period unless STW pays as royalty on the first day of each month the sum of Five Hundred and 00/100 Dollars ($500.00) per month. STW shall have no right to maintain this AGREEMENT through payment of such a royalty for any one period greater than three consecutive years.",
            "target": "Yes",
            "document_name": "STWRESOURCESHOLDINGCORP_08_06_2014-EX-10.1-COOPERATION AGREEMENT.PDF",
            "index": 197
        },
        {
            "input": "In the case of a Designated Mineral Property that Glamis intends to abandon, Glamis wall, if requested by Western Copper, transfer such Designated Mineral Property to Western Copper at no cost save and except for the reasonable costs of transfer incurred by Glamis.",
            "target": "Yes",
            "document_name": "WESTERN COPPER - NON-COMPETITION AGREEMENT.PDF",
            "index": 198
        },
        {
            "input": "In the event Moelis Holdings has not sold the Additional Units or entered into an agreement to sell the Additional Units within such one hundred and eighty- (180-) day period, Moelis Holdings shall not thereafter issue or sell any Additional Units without first complying again with this Section 12.2.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 199
        },
        {
            "input": "HOC shall give notice (an \"Acceptance Notice\") to the Company not later than 5:00 p.m. (Denver time) on the tenth business day following the deemed receipt of any Rights Notice given under paragraph 4.1(c) setting out the number of Additional Securities, if any, which any of HOC Entities intends to subscribe for and purchase and, if applicable, the name and address of HOC Entity whose name in which such securities should be registered, provided that if HOC, acting reasonably, determines that it has insufficient information to make such investment decision, HOC shall notify the Company of the information required to make such investment decision and thereafter shall have the longer of (i) the remainder of the ten (10) Business Days set out in the first sentence of this paragraph; or (ii) two (2) Business Days from the receipt of such additional information to make the investment decision and deliver or refrain from delivering the Acceptance Notice. Notwithstanding the preceding sentence, the Rights Notice shall be deemed to include sufficient information to make such investment decision if it includes the information specified in items (i) to (iv) of Section 4.1(d). If no Acceptance Notice has been provided to the Company within the required time, HOC will be deemed to have elected not to subscribe for or purchase any such Additional Securities.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 200
        },
        {
            "input": "If any of the Transferees intends to purchase all or any portion of the said shares so offered, such Party shall dispatch a written notice of acceptance to the transferor describing the number of the shares it intends to purchase within three (3) weeks after the date of receipt of the offer. The sale price of the shares shall be determined in terms of Article 6.3(c) hereof.",
            "target": "Yes",
            "document_name": "IMPCOTECHNOLOGIESINC_04_15_2003-EX-10.65-JOINT VENTURE AGREEMENT.PDF",
            "index": 201
        },
        {
            "input": "If Intuit elects to provide advertising, sponsorship or other ------- promotional space on all or any portion of the Intuit Sites for a Client Competitor, Intuit agrees to negotiate with Client in good faith regarding such promotional opportunity.",
            "target": "Yes",
            "document_name": "STAMPSCOMINC_06_24_1999-EX-10.18-SPONSORSHIP AGREEMENT.PDF",
            "index": 202
        },
        {
            "input": "In both cases set forth above, in Section 5.2.2.a. and b., if BII exercises its first right of negotiation, BII and XENCOR (and/or its Business Partner, as applicable) will negotiate in good faith a respective contract manufacturing agreement based on the market rate<omitted>terms and conditions common for the contract manufacture of monoclonal antibodies within the contract manufacturing industry, it being understood that any such contract manufacturing agreement would provide for Technology transfer, payment of the Technology Access Fee (if applicable), and other terms set forth in Sections 5.2.3, 5.2.4 and 5.2.5 below.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 203
        },
        {
            "input": "If, during the Term, Aimmune (i) intends to allow any Xencor Product Specific Patent, Aimmune Patent Covering an Antibody or Product or Joint<omitted>Collaboration Patent to expire or intends to otherwise abandon any such Xencor Product Specific Patent, Aimmune Patent Covering an Antibody or Product or Joint Collaboration Patent, or (ii) decides not to prepare or file patent applications Covering Aimmune Inventions or Joint Inventions, Aimmune shall notify Xencor of such intention or decision at least [***] ([***]) days (or as soon as possible if less than [***] ([***]) days) prior to any filing or payment due date, or any other date that requires action, in connection with such Xencor Product Specific Patent, Aimmune Patent Covering an Antibody or Product or Joint Collaboration Patent, and Xencor shall thereupon have the right, but not the obligation, to assume responsibility for the preparation, filing, prosecution or maintenance thereof [***], in the name of Xencor or Aimmune, as applicable.",
            "target": "Yes",
            "document_name": "AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement.pdf",
            "index": 204
        },
        {
            "input": "TPH-A and TPH may not exercise the Call Option prior to the Option Starting Date nor more than one hundred eighty (180) days after the Option Starting Date.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 205
        },
        {
            "input": "If Depomed and King fail to enter into an agreement for the Metformin Product Rights prior to the expiration of the Negotiation Period, then Depomed shall thereafter have the right to negotiate and enter into an agreement with a Third Party granting the Metformin Product Rights to a Third Party; provided that, for a period of 6 months, any such agreement may not be on terms and conditions materially more favorable to the Third Party than the terms and conditions last offered by King prior to the termination of discussions with Depomed.",
            "target": "Yes",
            "document_name": "KINGPHARMACEUTICALSINC_08_09_2006-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 206
        },
        {
            "input": "Subject to the provisions of Section 8.2, if the Company determines to solicit additional equity financing subsequent to exercise of the Option but prior to Commencement of Production (hereinafter defined) at the El Aguila project, it shall provide written notice to that effect to HOC and HOC shall be entitled to exclusively provide such financing upon the terms and conditions hereinafter set forth.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 207
        },
        {
            "input": "If ANTHEMIC produces the Event in 2016 and seeks a sponsor in the category, ANTHEMIC will first contact the Sponsor and provide the Sponsor with written notice (the \"Notice) of the terms under which the Sponsor can be the category sponsor for the 2016 Event. The Sponsor will have 15 days from receipt of the Notice to accept the terms to be the category sponsor of the 2014 Event.",
            "target": "Yes",
            "document_name": "VNUE,INC_07_10_2015-EX-10.1-SPONSORSHIP AGREEMENT.PDF",
            "index": 208
        },
        {
            "input": "SMBC shall have ten (10) days from the date of delivery of any such notice to agree to purchase all, but not less than all, of such Additional Units, for the price and upon the terms specified in the notice, by delivering written notice to Moelis Holdings.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 209
        },
        {
            "input": "TELKOM hereby grants SAP AFRICA the right of first refusal to any licence to, or assignment of, such TELKOM extension or TELKOM modification and TELKOM agrees not to dispose<omitted>of or license, its rights thereto to any third party for a consideration not less than, and upon other terms not less favourable than those initially offered to SAP AFRICA.",
            "target": "Yes",
            "document_name": "TELKOMSALTD_01_30_2003-EX-10-LICENCE AND MAINTENANCE AGREEMENT.PDF",
            "index": 210
        },
        {
            "input": "If the Parties are unable to reach an agreement on the terms of exclusivity within ten (10) business days of the date the opportunity is presented to Distributor, Hydraspin shall have no obligation to enter into a contract with Distributor regarding the new territory.",
            "target": "Yes",
            "document_name": "WaterNowInc_20191120_10-Q_EX-10.12_11900227_EX-10.12_Distributor Agreement.pdf",
            "index": 211
        },
        {
            "input": "Notwithstanding the foregoing, Excite may make available opportunities on the Excite Site to purchase Music Products from parties other than Sponsor if such Music Products are not available from Sponsor so long as, prior to entering into arrangements to make available opportunities to purchase Music Products from parties other than Sponsor, Excite notifies Sponsor of its interest in the Music Products and gives Sponsor thirty (30) days to make the desired Music Products available through the Sponsor Site.",
            "target": "Yes",
            "document_name": "N2KINC_10_16_1997-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 212
        },
        {
            "input": "If the Company does not timely deliver a ROFR Purchase Notice it shall be deemed to have waived all of its rights with respect to the offer contained in the ROFR Sale Notice.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 213
        },
        {
            "input": "If the Sponsor decides not to be the category sponsor of the 2016 Event or fails to timely respond to the Notice, then ANTHEMIC may approach other parties to be the category sponsor.",
            "target": "Yes",
            "document_name": "VNUE,INC_07_10_2015-EX-10.1-SPONSORSHIP AGREEMENT.PDF",
            "index": 214
        },
        {
            "input": "Licensee shall have the right and a first opportunity to purchase, lease or otherwise acquire, as the case may be, all or the applicable portion of such stock or assets (as specified in the applicable Offering Notice) on the Terms and Conditions set forth in the Offering Notice, such right to be exercised by notice in writing to the Offeree within ninety (90) days after the giving of the Offering Notice.",
            "target": "Yes",
            "document_name": "NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.pdf",
            "index": 215
        },
        {
            "input": "At the end of such [*] ([*]) year period, HSWI shall have the right to renew the Agreement under materially the same terms or shall have an option to purchase the Translated Content outright to the extent rights permit and to the extent the parties mutually agree to terms for such sale.",
            "target": "Yes",
            "document_name": "RemarkHoldingsInc_20081114_10-Q_EX-10.24_2895649_EX-10.24_Content License Agreement.pdf",
            "index": 216
        },
        {
            "input": "PB shall not, without SFJ's prior written consent, enter into a Licensing Transaction unless such Licensing Transaction is an Excluded Licensing Transaction (in which case such prohibition shall not apply and no such consent of SFJ shall be required); provided that SFJ shall only be entitled to withhold such consent as to a Licensing Transaction other than an Excluded Licensing Transaction in the event SFJ reasonably determines, and provides PB with written notice of its determination within [***] of PB providing to SFJ a non-binding term sheet or comparable document summarizing the material terms of the proposed Licensing Transaction [***], that PB entering into such Licensing Transaction would [***] (\"Material Impact\").",
            "target": "Yes",
            "document_name": "PhasebioPharmaceuticalsInc_20200330_10-K_EX-10.21_12086810_EX-10.21_Development Agreement.pdf",
            "index": 217
        },
        {
            "input": "Subject to the restrictions set forth in Section 5.1 of this Agreement and Section 2.3 of the Warrant, in the event any member of the Farids Group proposes to Transfer (other than a Permitted Transfer) a Threshold Block, in a transaction or series of related transactions, of Shares in a 144 Sale, the Farids Group shall furnish to the Company a written notice of such proposed Transfer (a \"ROFO Sale Notice\") at least 48 hours prior to the opening of trading on the Nasdaq Global Market (or such other primary stock exchange upon which the Common Stock is listed) on the business day that the Farids Group proposes to begin to effect such 144 Sale.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 218
        },
        {
            "input": "VS shall not refer that opportunity to any other third party provider unless PPD declines to bid on such opportunity or does not offer the service in question.",
            "target": "Yes",
            "document_name": "VIRTUALSCOPICS,INC_11_12_2010-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 219
        },
        {
            "input": "If the Receiving Party declines its right of first offer with respect to any Development Opportunity, or fails to notify the Offering Party of its decision within the ten (10) business-day period described above, or if Hyatt's affiliate or Playa's affiliate (as applicable) fails to acquire the Development Property within the sixty (60)-day period described above, then the right of first offer with respect to that Development Opportunity shall expire, and the Offering Party thereafter may acquire, develop and/or operate (and/or grant any other person or entity the right to acquire, develop and/or operate) an all-inclusive resort or other business on the Development Property without any restriction under this Agreement, subject to any restrictions under any Existing Franchise Agreement or other agreement between Hyatt (or its affiliate) and Playa (or its affiliate).",
            "target": "Yes",
            "document_name": "PLAYAHOTELS&RESORTSNV_03_14_2017-EX-10.22-STRATEGIC ALLIANCE AGREEMENT (Hyatt Ziva Cancun).PDF",
            "index": 220
        },
        {
            "input": "If Distributor does not exercise its option as herein provided, Company may distribute the other Products or devices within the Market itself or through other distributors.",
            "target": "Yes",
            "document_name": "LIMEENERGYCO_09_09_1999-EX-10-DISTRIBUTOR AGREEMENT.PDF",
            "index": 221
        },
        {
            "input": "In the event of termination or expiration of this Agreement pursuant to Section 5.0 above, IBM shall have an option, which shall expire [*] days after such termination or expiration, to purchase from MSL, at a reasonable price agreeable to the Parties, all assets used by MSL to perform the manufacturing and fulfillment functions<omitted>outlined in Attachment 1: Statement of Work, to the extent owned or transferable by MSL, and required by IBM to perform such functions.",
            "target": "Yes",
            "document_name": "MANUFACTURERSSERVICESLTD_06_05_2000-EX-10.14-OUTSOURCING AGREEMENT.PDF",
            "index": 222
        },
        {
            "input": "The Farids Group shall not deliver more than one ROFR Sale Notice or ROFO Sale Notice in any thirty (30) day period.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 223
        },
        {
            "input": "In the event that BII elects not to exercise its first right of negotiation described in Section 5.2.2.a or 5.2.2.b, or, despite their commercially reasonably efforts and good faith negotiations the Parties (or BII and the Business Partner) are unable to agree upon a manufacturing agreement within the Clinical Negotiation Period or, Commercial Negotiation Period, as applicable; and/or XENCOR (and/or XENCOR's Business Partner) wishes to use the Process outside the terms and conditions set forth in a contract manufacturing agreement with BII, BII shall transfer the Process in accordance with Section 5.2.3 below.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 224
        },
        {
            "input": "In the event that Monsanto engages in a process in which it seeks bids or proposals from more than one third party in connection with a contemplated Roundup Sale, the Agent shall be entitled to a fifteen (15) day exclusive negotiation period following the receipt and review by Monsanto of all bids or proposals (the \"Roundup Quiet Period\"), provided that, in determining the value of the price terms of the Agent's bid, Monsanto shall not discount the Agent's bid as a result of the fact that the Termination Fee is an offset or credit against the total purchase price, and that, during the Roundup Quiet Period, the Agent shall have the right to revise its original bid but shall not have the right to review the terms of any other bids or proposals.",
            "target": "Yes",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 225
        },
        {
            "input": "You must immediately notify us of any changes in the terms of an offer.",
            "target": "Yes",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 226
        },
        {
            "input": "Prior to the earlier of Investor exercising the Option and the expiration of the Option Period, Company will not grant to any Third Party any rights to the Patents or to the Technical Information that extend beyond the expiration of the Option Period.",
            "target": "Yes",
            "document_name": "RareElementResourcesLtd_20171019_SC 13D_EX-99.4_10897534_EX-99.4_Intellectual Property Agreement.pdf",
            "index": 227
        },
        {
            "input": "If, having used good faith diligent efforts, Affiliate and Network have failed to enter into such an agreement within such ninety (90)-day period, then neither party shall have an obligation to continue such negotiations or enter into an agreement with respect to the New Channels.",
            "target": "Yes",
            "document_name": "TubeMediaCorp_20060310_8-K_EX-10.1_513921_EX-10.1_Affiliate Agreement.pdf",
            "index": 228
        },
        {
            "input": "As between the Parties, Adaptimmune will have the first right to prepare, file, prosecute, maintain, enforce and defend all U.S. and foreign patents, registrations and other forms of intellectual property in any jointly-owned Invention using patent counsel of its choice that is subject to the written approval of MD Anderson not to be unreasonably withheld and at the sole cost and expense of Adaptimmune, with accounting to MD Anderson.",
            "target": "Yes",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 229
        },
        {
            "input": "Adaptimmune Limited must exercise its option to negotiate a license to any Invention by notifying MD Anderson in writing within six months' of MD Anderson disclosing such Invention to Adaptimmune (the \"Option Period\").",
            "target": "Yes",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 230
        },
        {
            "input": "Biocept will provide notice to Life Technologies on December 31, 2012 if the conditions for the option apply, and if Life Technologies delivers written notice of exercise of such right of negotiation to Biocept on or before January 15, 2013, the parties will negotiate in good faith to conclude a license agreement no later than February 28, 2013.",
            "target": "Yes",
            "document_name": "BIOCEPTINC_08_19_2013-EX-10-COLLABORATION AGREEMENT.PDF",
            "index": 231
        },
        {
            "input": "If Depomed and King fail to enter into such a definitive agreement during such period, then Depomed shall thereafter have the right to negotiate and enter into one or more agreements with Third Parties related to Depomed's proprietary drug delivery technology in combination with both metformin hydrochloride and other active pharmaceutical ingredients; provided that, for a period of 6 months, any such agreement may not be on terms and conditions materially more favorable to the Third Party than the terms and conditions last offered by King prior to the termination of discussions with Depomed.",
            "target": "Yes",
            "document_name": "KINGPHARMACEUTICALSINC_08_09_2006-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 232
        },
        {
            "input": "Notwithstanding the foregoing, Wade agrees that for a period of ninety (90) days prior to the expiration of the Term (unless the Agreement is terminated by Wade as permitted hereunder), Naked shall have the exclusive right to negotiate for continued endorsement by Athlete of the Naked Products.",
            "target": "Yes",
            "document_name": "NakedBrandGroupInc_20150731_POS AM (on S-1)_EX-10.75_9196027_EX-10.75_Endorsement Agreement.pdf",
            "index": 233
        },
        {
            "input": "If Anixa decides to not license those uses or compounds for this novel antiviral use, OntoChem is free to develop those molecules further as its own intellectual property without any further restrictions.",
            "target": "Yes",
            "document_name": "ANIXABIOSCIENCESINC_06_09_2020-EX-10.1-COLLABORATION AGREEMENT.PDF",
            "index": 234
        },
        {
            "input": "If we do not exercise this right of first refusal, you may accept the offer, subject to our prior written approval, as provided in Paragraph XVIII hereof, provided that if such offer is not so accepted within six (6) months of the date thereof, we will again have the right of first refusal herein described.",
            "target": "Yes",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 235
        },
        {
            "input": "During the Term, if Exact (i) enters a formal process authorized or directed by its board of directors or CEO to seek and enter into an arrangement or (ii) intends to agree to a term sheet or seeks to sign a letter of intent or similar arrangement to grant an exclusive commercial license to a Third Party solely to promote or sell the Product outside the Territory (\"Ex-US Commercial Rights\"), Exact shall first notify Pfizer of such intent (a \"Ex-US Commercial Rights Transfer Notice\") and Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the Ex-US Commercial Rights that are the subject of the Ex-US Commercial Rights Transfer Notice.",
            "target": "Yes",
            "document_name": "ExactSciencesCorp_20180822_8-K_EX-10.1_11331629_EX-10.1_Promotion Agreement.pdf",
            "index": 236
        },
        {
            "input": "We may assign our right of first refusal to someone else either before or after we exercise it.",
            "target": "Yes",
            "document_name": "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.pdf",
            "index": 237
        },
        {
            "input": "Pretzel Time shall have the right, exercisable by written notice delivered to Franchisee (or its Owners) within sixty (60) days from the date of delivery of an exact copy of such offer to Pretzel Time, to purchase such interest for the price and on the terms and conditions contained in such offer, provided that Pretzel Time may substitute cash for any form of payment proposed in such offer, Pretzel Time's credit shall be deemed equal to the credit of any proposed purchaser and Pretzel Time shall have not less than sixty (60) days to prepare for closing.",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 238
        },
        {
            "input": "For a period of sixty (60) days from the last date of receipt by the Agent of the Roundup Sale Notice and any related Roundup Offering Materials as set forth in Section 10.6(a)(ii) (the \"Exclusive Roundup Sale Period\"), Monsanto agrees to negotiate in good faith with the Agent on an exclusive basis with respect to any potential Roundup Sale.",
            "target": "Yes",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 239
        },
        {
            "input": "If the Company truncates the period during which the HOC JV Acceptance Notice is required to be returned by HOC, it shall include in the Joint Venture Proposal Notice a statement certified by an officer of the Company that the Company has determined that it is necessary to truncate such period to avoid losing the opportunity to make such acquisition or other related transaction and that it has used commercially reasonable efforts to avoid truncating such period.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 240
        },
        {
            "input": "In the event of termination or expiration of this Agreement for other than a material breach of this Agreement by Sponsor, upon notice from Sponsor delivered to Snap at least forty-five (45) days prior to such expiration or termination, Snap shall negotiate in good faith an agreement providing Sponsor with sponsorship rights similar to those described herein on terms and conditions to be mutually agreed upon by the parties. In the event that an agreement<omitted>between the parties is not executed within thirty (30) days following delivery, of such notice to Snap, Snap shall be free thereafter to enter into an such an agreement with any third party.",
            "target": "Yes",
            "document_name": "EmbarkComInc_19991008_S-1A_EX-10.10_6487661_EX-10.10_Co-Branding Agreement.pdf",
            "index": 241
        },
        {
            "input": "In addition, in the event that iVillage desires to form a sponsorship relationship with an automobile rental company during the term of this Agreement, iVillage shall notify Hertz and provide Hertz with an opportunity to enter into such a relationship with iVillage, on not less favorable terms than those offered to any other automobile rental company.",
            "target": "Yes",
            "document_name": "IVILLAGEINC_03_17_1999-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 242
        },
        {
            "input": "If the Company wishes to purchase (and/or cause a designee to purchase) all or a portion of the ROFO Shares at the ROFO Sale Price, the Company shall deliver a notice (a \"ROFO Purchase Notice\") to the Farids Group no later 8:00 a.m. New York time on the business day that the Farids Group proposes to effect such 144 Sale specifying the number of ROFO Shares it wishes to purchase (and/or cause a designee to purchase) from the Farids Group",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 243
        },
        {
            "input": "If HOC wishes to exercise the Option, it shall give written notice to the Company (the \"Option Exercise Notice\") prior to the Option Expiration Date in the manner set forth in Section 12.1 of this Agreement.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 244
        },
        {
            "input": "Excite will not propose, solicit or negotiate offers from entities other than Sponsor for any retail music store sponsorships of the Excite Site, if at all, until [****] prior to the expiration of the term of this Agreement.",
            "target": "Yes",
            "document_name": "N2KINC_10_16_1997-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 245
        },
        {
            "input": "UTK agrees to provide the following distinct services to AVDU:<omitted>Present technology acquisition opportunities for AVDU. AVDU will have 30-days to determine if they want to go forward with the technology license. a. UTK after 30 days shall have the right to present the technology to other clients.",
            "target": "Yes",
            "document_name": "ORBSATCORP_08_17_2007-EX-7.3-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 246
        },
        {
            "input": "In the event Network decides to offer any new television programming channels (the \"New Channels\"), then Affiliate shall have ninety (90) calendar days from Affiliate's receipt of Network's comprehensive business plan for such New Channels to determine whether Affiliate desires to enter into an agreement with respect to the New Channels.",
            "target": "Yes",
            "document_name": "TubeMediaCorp_20060310_8-K_EX-10.1_513921_EX-10.1_Affiliate Agreement.pdf",
            "index": 247
        },
        {
            "input": "If BII provides written notice of its exercise of the first right to negotiate within such [...***...] period but BII and XENCOR (or its Business Partner) do not enter into such a contract manufacturing agreement within the Clinical Negotiation Period, XENCOR and any Business Partner shall be free to enter into one or more agreements with third parties for the manufacture and supply of Product for use in Phase 2 and 3 clinical trials (which may include an agreement for any Business Partner or its affiliate to manufacture and supply Product for clinical trials), provided that the supply price for Product is no more than [...***...] percent ([...***...]%) of the clinical supply price of Product last proposed by BII during the negotiations between the Parties (or BII and the Business Partner).",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 248
        },
        {
            "input": "If LKPL deems itself unable to continue to provide Axiometric work space without expanding LKPL's facilities, and if LKPL determines it will be in its own best interests to expand its facilities, then LKPL will afford Axiometric the opportunity to lease space in the new facilities under a mutually acceptable separate commercial rental agreement.",
            "target": "Yes",
            "document_name": "LinkPlusCorp_20050802_8-K_EX-10_3240252_EX-10_Affiliate Agreement.pdf",
            "index": 249
        },
        {
            "input": "In the event Moelis Holdings proposes to undertake any issuance of Additional Units to which clause (y) of Section 12.2(a) applies, SMBC shall specify in its notice delivered to Moelis Holdings pursuant to Section 3.4.2(b) of the Moelis Holdings Agreement, in addition to whether or not it elects to purchase its pro rata portion of such Additional Units, whether or not it shall exercise its right of first refusal to purchase all (but not less than all) of the Additional Units that other Partners do not purchase pursuant to their right of first refusal under Section 3.4.2 of the Moelis Holdings Agreement.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 250
        },
        {
            "input": "If no Transferee accepts to purchase the shares offered by the Transferor, in whole or in part, the Transferor may sell such shares to a third party on terms and conditions no more favourable than those offered to the Transferees, including the price of the shares.",
            "target": "Yes",
            "document_name": "IMPCOTECHNOLOGIESINC_04_15_2003-EX-10.65-JOINT VENTURE AGREEMENT.PDF",
            "index": 251
        },
        {
            "input": "If Pretzel Time exercises its right of first refusal, Franchisee (and its Owners) agrees that, for a period of twelve (12) months commencing on the date of the closing, neither Franchisee (nor its Owners) shall have any direct or indirect interest (through a member of the immediate families of Franchisee or its Owners of otherwise) as a disclosed or beneficial owner, investor, partner, director, officer, employee, consultant, representative, or agent or in any other capacity in any Competitive Business located or operating within three (3) miles of the Unit, and/or three (3) miles of any other Pretzel Time Unit.",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 252
        },
        {
            "input": "If you or your owners propose to sell the Franchised Restaurant (or its assets) or a controlling interest in the ownership of you as defined in Paragraph XVIII, you or your owners will obtain and deliver a bona fide, executed written offer to purchase same to us, which shall, for a period of thirty (30) days from the date of delivery of such offer to us, have the right, exercisable by written notice to you or your owners, to purchase the Franchised Restaurant, (its assets) or an ownership interest in you for the price and on the terms and conditions contained in such offer, provided that we may substitute cash for any form of payment proposed in such offer.",
            "target": "Yes",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 253
        },
        {
            "input": "The following additional terms shall apply to Eutectix's exercise of this option: (a) Eutectix's option hereunder shall be exercisable by providing Liquidmetal with written notice of its intention to exercise its chosen option no later than the effective date of termination. Such notice shall include a description of the assets Eutectix will purchase (the \"Optioned Assets\"). (b) In the event that Eutectix and Liquidmetal cannot agree to a fair market value for the Optioned Assets, then the fair market value shall be determined by an independent third-party appraisal. Eutectix and Liquidmetal shall each select one independent, qualified appraiser, and the two so selected shall select a third appraiser, all three to independently from one another determine the fair market value of the Optioned Assets. The purchase price shall be the mean of the fair market values as determined by the three appraisers. (c) The closing for the purchase of the Optioned Assets will take place no later than sixty (60) days after the termination, unless the Parties cannot agree on the price, in which case, closing will take place no later than sixty (60) days after the three independent appraisals have been received. Eutectix will pay the purchase price in full at the closing. Liquidmetal must sign all documents of assignment and transfer as are reasonably necessary for purchase of the Optioned Assets by Liquidmetal. (d) In the event that Eutectix does not exercise its right to purchase the Optioned Assets as set forth above, Liquidmetal will be free to keep or to sell, after such termination to any third party, all of the Optioned Assets and shall be responsible for timely removing equipment not purchased by Eutectix at Liquidmetal's own expense. In the event Liquidmetal fails to timely remove such Optioned Assets, in light of the periods for continued operation in Section 5.4(b)(ii) and closing in Section 5.5(c), Eutectix may dispose of them, at Liquidmetal's cost, with no liability to Eutectix.",
            "target": "Yes",
            "document_name": "LiquidmetalTechnologiesInc_20200205_8-K_EX-10.1_11968198_EX-10.1_Development Agreement.pdf",
            "index": 254
        },
        {
            "input": "If the Village Media Company elects to exercise its right of first refusal, the terms of the offer shall apply, the applicable license shall be subject to the terms and conditions of this Agreement and the Village Media Company shall pay to PFHOF a License Fee (as defined below) for such license in accordance with this Agreement.",
            "target": "Yes",
            "document_name": "GpaqAcquisitionHoldingsInc_20200123_S-4A_EX-10.6_11951677_EX-10.6_License Agreement.pdf",
            "index": 255
        },
        {
            "input": "Notwithstanding the foregoing, if Company elects to abandon any patent application, to not pay maintenance fees or annuities to keep a patent in force, or to otherwise take or fail to take any action that will result in a loss of patent rights, Company shall give Investor at least sixty (60) days prior written notice and an opportunity to take over the prosecution of the patent application that would be abandoned and/or pay the fees necessary to keep the patent in force and/or take any other action necessary to avoid the loss of patent rights.",
            "target": "Yes",
            "document_name": "RareElementResourcesLtd_20171019_SC 13D_EX-99.4_10897534_EX-99.4_Intellectual Property Agreement.pdf",
            "index": 256
        },
        {
            "input": "If Sanofi provides such Notice of Interest during [***], then RevMed shall not negotiate with any Third Party the terms under which such Third Party would obtain any development or commercialization rights with respect to a SHP1-SHP2 Dual Inhibitor during the SHP1-SHP2 Dual Inhibitor Licensing Negotiation Period.",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 257
        },
        {
            "input": "The purchase price for the Put Shares (the \"Put Option Price\") shall be the greater of (x) the amount in Japanese Yen equal to the Net Book Value as of the most recently completed month end prior to the Put Closing Date, minus the Net Book Value as of the most recently completed month end prior to the Effective Date, multiplied by the number of Put Shares, or (y) one Japanese Yen (\u00a51).",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 258
        },
        {
            "input": "If, after the Effective Date, TPH or TPH-A shall have materially breached any of its representations or warranties contained in this Agreement or shall have failed to comply in any material respect with any of the other covenants or agreements contained in this Agreement, which breach or failure shall not have been remedied within thirty (30) days after written notice thereof (the \"Default Notice\") has been given by AFSL to TPH/TPH-A, then AFSL shall have the option of purchasing from TPH-A, and TPH-A shall be obligated to sell, all of the Shares then owned by TPH-A at a purchase price per Share equal to the lesser of: (i) the Net Book Value as of the most recent month end (provided that, if the Net Book Value is a negative amount, the product of the Net Book Value multiplied by such Sale Shares shall be deemed to be one Japanese Yen (\u00a51)), or (ii) the Shares Purchase Price, divided by the number of Sale Shares. AFSL shall provide written notice of its election (the \"Election Notice\") to purchase the Shares owned by TPH-A within ten (10) Business Days following the expiration of the thirty (30) day cure period set forth in the Default Notice. The closing of the purchase of the Shares owned by TPH-A<omitted>shall take place within thirty (30) Business Days following the date of the Election Notice, or at such other time as the Parties may mutually agree. At such closing, AFSL shall deliver to TPH-A, by wire transfer, the full amount of the purchase price in Japanese Yen for such Shares as provided in this Section 7.5.1 against delivery by TPH-A of the following: (a) a sale agreement in form reasonably satisfactory to AFSL containing among other things, a representation and warranty of TPH-A that it is, and AFSL shall be, the beneficial owner of such Shares, with good title thereto, free and clear of all liens and other encumbrances; (b) documentary evidence reasonably satisfactory to AFSL of the transfer to it of all of TPH-A's Shares and (c) resignations of all Directors, if any, on the Board appointed by TPH-A. Notwithstanding the remedies provided in this Section 7.5.1, AFSL/FSL shall be entitled to all other remedies against TPH/TPH-A available at law or equity or under this Agreement.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 259
        },
        {
            "input": "If the Receiving Party and exercises its right of first offer hereunder, and: (a) if the Receiving Party is Playa, then Playa (or its affiliate) and Hyatt's affiliate shall negotiate in good faith the terms of a management agreement and related documents under which Playa (or its affiliate) would manage a Hyatt All-Inclusive Resort on the Development Property (subject to a franchise agreement between Hyatt and the affiliate of Hyatt that would own the Development Property), provided that Hyatt's affiliate acquires the Development Property on terms acceptable to it within sixty (60) days after delivery of the Offer Notice, and (b) if the Receiving Party is Hyatt, then Playa or its affiliate shall negotiate in good faith the terms of a franchise agreement and related documents for the operation (and, if applicable, development) of the Hyatt All-Inclusive Resort on the Development Property, provided that Playa's affiliate acquires the Development Property on terms acceptable to it within sixty (60) days after delivery of the Offer Notice.",
            "target": "Yes",
            "document_name": "PLAYAHOTELS&RESORTSNV_03_14_2017-EX-10.22-STRATEGIC ALLIANCE AGREEMENT (Hyatt Ziva Cancun).PDF",
            "index": 260
        },
        {
            "input": "If Adaptimmune elects not to file in the United States or not to maintain an application or patent arising from any jointly-owned Invention, Adaptimmune will promptly notify MD Anderson within reasonable time for MD Anderson to file, prosecute or maintain such application or patent, and MD Anderson will have the right to file, prosecute or maintain such application or patent, at MD Anderson's expense.",
            "target": "Yes",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 261
        },
        {
            "input": "If AbbVie provides the License Option Exercise Notice during the License Option Period, upon AbbVie's request, the Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act (the \"HSR Filing\") or any similar applicable foreign law or regulation in connection with AbbVie's exercise of the License Option.",
            "target": "Yes",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 262
        },
        {
            "input": "The Parties shall each, as soon as practicable after the date of Harpoon's receipt of the License Option Exercise Notice, file or cause to be filed with the U.S. Federal Trade Commission and the U.S. Department of Justice and any relevant foreign governmental authority any such notifications.",
            "target": "Yes",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 263
        },
        {
            "input": "If the supply price for Product proposed by a third party (which may include a Business Partner or its affiliate) is more than [...***...] percent ([...***...]%) of the clinical supply price of Product last proposed by BII during the negotiations between the Parties (or BII and the Business Partner) , XENCOR (or its Business Partner) shall provide written notice to BII that XENCOR (and its Business Partner) will accept the clinical supply price last proposed by BII, and BII and XENCOR (or its Business Partner) will enter into a contract manufacturing agreement reflecting such clinical supply price; provided that, if BII does not agree to enter into such contract<omitted>manufacturing agreement within [...***...] after such written notice, XENCOR (or its Business Partner) shall be free to enter into an agreement with a third party (or an agreement for the Business Partner or its affiliate to manufacture and supply Product).",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 264
        },
        {
            "input": "The Offeree shall have thirty (30) days after receipt of the notice from the Selling Party (the \"Option Period\") to elect either (i) to purchase the Selling Party's interest in the Operating Company or (ii) to sell the Offeree's interest in the Operating Company to the Selling Party, in either case on the same terms and conditions as those contained in the Offer.",
            "target": "Yes",
            "document_name": "IGENEBIOTECHNOLOGYINC_05_13_2003-EX-1-JOINT VENTURE AGREEMENT.PDF",
            "index": 265
        },
        {
            "input": "In the event that Qualigen nonetheless receives an unsolicited offer to engage in a Sale Transaction during such Exclusivity Period, Qualigen may engage with such party to the extent legally required to comply with its fiduciary duties, so long as Qualigen (i) promptly communicates to Sekisui the material terms of any proposal or offer or request for information which it may receive in respect of any such proposed Sale Transaction, including the purchase price, form and timing of consideration and the identity of the acquirer, and (ii) complies with Sekisui's Right of First Refusal (as defined below).",
            "target": "Yes",
            "document_name": "RitterPharmaceuticalsInc_20200313_S-4A_EX-10.54_12055220_EX-10.54_Development Agreement.pdf",
            "index": 266
        },
        {
            "input": "BKC or its designee shall then have the prior option to purchase the interests covered by the offer at the price and upon the same terms of the offer.",
            "target": "Yes",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 267
        },
        {
            "input": "If such sale, transfer or conveyance is not consummated in accordance with the offer and the Terms and Conditions specified in the applicable Offering Notice, the rights of Licensee to an Offering Notice shall be reinstated. No exercise or waiver by Licensee of any of its rights hereunder shall modify, abridge, impair or affect any of Licensee's rights under any of the other terms or provisions of this Agreement.",
            "target": "Yes",
            "document_name": "NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.pdf",
            "index": 268
        },
        {
            "input": "In the event of the death or incapacity of an individual franchisee, or any partner or shareholder of you which is a partnership or corporation, where the aforesaid provisions of Paragraph XVIII have not been fulfilled within the time provided, all rights licensed to you under this Agreement shall, at our option, terminate forthwith and we will have the option to purchase the assets of the Franchised Restaurant in accordance with Paragraph XVII.K. herein.",
            "target": "Yes",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 269
        },
        {
            "input": "Any later proposal to complete that proposed Transfer will be deemed a new offer, giving us a new right of approval and right of first refusal effective as of the day we receive formal notice of the new (or continuing) proposal.",
            "target": "Yes",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 270
        },
        {
            "input": "Additionally commencing on the Effective Date and continuing for eighteen (18) months, World Book shall offer HSWI a right of first refusal to create any paid-subscription Chinese language websites, which do not exist as of the date hereof, using the Content on equal or better terms as agreed to between World Book and a third party.",
            "target": "Yes",
            "document_name": "RemarkHoldingsInc_20081114_10-Q_EX-10.24_2895649_EX-10.24_Content License Agreement.pdf",
            "index": 271
        },
        {
            "input": "AIRSOPURE shall have the right, but not the duty, to be exercised by notice of intent to do so within 30 days after termination or expiration, to purchase any or all signs, advertising materials, supplies and inventory and any other items bearing AIRSOPURE's Licensed Marks, at Your cost or at fair market value, whichever is less.",
            "target": "Yes",
            "document_name": "AIRTECHINTERNATIONALGROUPINC_05_08_2000-EX-10.4-FRANCHISE AGREEMENT.PDF",
            "index": 272
        },
        {
            "input": "The rights set forth in Section 5.2.2.a and b shall automatically terminate if BII does not produce a viable Process for manufacture of Product as evidenced by failure to produce cGMP Product within a timeframe reasonably and customary in the biopharmaceutical industry for companies of comparable size and the respective activities.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 273
        },
        {
            "input": "Pretzel Time shall have the unrestricted right to assign this option to purchase.",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 274
        },
        {
            "input": "We may exercise this option by delivering a notice of intent to purchase to you within 30 days after the expiration or termination of this Agreement.",
            "target": "Yes",
            "document_name": "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.pdf",
            "index": 275
        },
        {
            "input": "Following delivery of the Acceptance Notice, if any, the HOC Entities shall pay for, and the Company shall issue to the relevant HOC Entities, free and clear of any liens, the number of Additional Securities specified in the Acceptance Notice and, except as otherwise agreed, the Company shall provide HOC with substantially the same closing documents, including opinions, if applicable, as are delivered to the other persons subscribing for Additional Securities on the closing date for such issuance.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 276
        },
        {
            "input": "Any sale, transfer or other conveyance of all or any part of the stock in, or assets of, Licensor in violation of this Section shall be null and void.",
            "target": "Yes",
            "document_name": "NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.pdf",
            "index": 277
        },
        {
            "input": "During the Term, Sekisui shall have a right of first refusal to match the terms of any arms length, bona fide proposed Sale Transaction with a Third Party (\"Sekisui's Right of First Refusal\").",
            "target": "Yes",
            "document_name": "RitterPharmaceuticalsInc_20200313_S-4A_EX-10.54_12055220_EX-10.54_Development Agreement.pdf",
            "index": 278
        },
        {
            "input": "During the term of this Agreement, the Licensor shall have the right (the \"Right of First Refusal\"), for a period (the \"Exercise Period\") expiring at 11:59 PM (Eastern Time) on the fifth (5th) business day after the giving of written notice by the Licensee that it has received a bonafide offer from a third party to (ii) purchase all or substantially all of the assets of Licensee; or (ii) to engage in a merger or consolidation in which Licensee is not the surviving corporation or in which, if Licensee is the surviving corporation, the owners of Licensee immediately prior to the consummation of such merger or consolidation do not, immediately after consummation of such merger or consolidation, own stock or other securities of Licensee that possess a majority of the voting power of all Licensee's outstanding stock and other securities and the power to elect a majority of the members of Licensee's board of directors.",
            "target": "Yes",
            "document_name": "SFGFINANCIALCORP_05_12_2009-EX-10.1-SOFTWARE LICENSE AND MAINTENANCE AGREEMENT.PDF",
            "index": 279
        },
        {
            "input": "Closing of the Transfer must occur within 60 calendar days of our election (or such longer period as applicable law may require); otherwise, the third-party's offer will be treated as a new offer subject to our right of first refusal.",
            "target": "Yes",
            "document_name": "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.pdf",
            "index": 280
        },
        {
            "input": "If any of the Securities remain available after the expiration of the Offerings, the Company agrees to offer the Agent the first right to act as lead managing underwriter for the Public Offering.",
            "target": "Yes",
            "document_name": "ALLIANCEBANCORPINCOFPENNSYLVANIA_10_18_2006-EX-1.2-AGENCY AGREEMENT.PDF",
            "index": 281
        },
        {
            "input": "If Monsanto (A) receives an unsolicited proposal with respect to a potential Roundup Sale and responds in any manner, other than rejecting such proposal, (B) solicits or makes a formal determination to solicit or make any proposal with respect to a potential Roundup Sale or (C) enters into an agreement relating to the provision of information with respect to a potential Roundup Sale (each a \"Roundup Sale Notice Trigger\"), the Agent shall have the rights as set forth in this Section 10.6 with respect to any such Roundup Sale and Monsanto shall promptly provide written notice to the Agent of such Roundup Sale as set forth<omitted>in Section 10.6(a)(ii) (a \"Roundup Sale Notice\").",
            "target": "Yes",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 282
        },
        {
            "input": "AbbVie shall have the right to exercise its License Option by providing written notice of such election to Harpoon (\"License Option Exercise Notice\") at any time on or after the Effective Date and on or prior to the date that is [***] from AbbVie's receipt of the Opt-In Development Report containing all items required pursuant to Section 1.112, as such period may be extended pursuant to Section 3.2.1 (the \"License Option Period\").",
            "target": "Yes",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 283
        },
        {
            "input": "In the event the parties fail to reach agreement within ten (10) business days following the commencement of such good faith negotiations (or such later date as the parties may agree to), Intuit may offer the opportunity to any third party on terms and conditions no less favorable then those offered to Client.",
            "target": "Yes",
            "document_name": "STAMPSCOMINC_06_24_1999-EX-10.18-SPONSORSHIP AGREEMENT.PDF",
            "index": 284
        },
        {
            "input": "If Adaptimmune Limited fails to timely exercise its option within the Option Period with respect to any Invention, Adaptimmune Limited's right to negotiate a license agreement with respect to such Invention will automatically terminate, and MD Anderson will be free to negotiate and enter into a license with any other party.",
            "target": "Yes",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 285
        },
        {
            "input": "If HOC delivers the Financing Election, the purchase price for each share shall be equal to eighty percent (80%) of the average closing price of the Shares during the thirty (30) calendar days preceding the date HOC delivers the Financing Election",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 286
        },
        {
            "input": "Notwithstanding the above, before Company destroys any safety records it will notify Janssen of its intention to do so, affording Janssen the opportunity to retain such records if it so wishes.",
            "target": "Yes",
            "document_name": "IMMUNOMEDICSINC_08_07_2019-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 287
        },
        {
            "input": "Skunkware and Licensor hereby grant to Licensee the exclusive and irrevocable right and option to purchase (the \"Option\"), at Licensee's election, either (i) all of the assets of Licensor or (ii) all of the issued and outstanding stock of Licensor.",
            "target": "Yes",
            "document_name": "NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.pdf",
            "index": 288
        },
        {
            "input": "of the data then in RevMed's Control regarding the relevant SHP1-SHP2 Dual Inhibitor. Sanofi shall notify RevMed in writing (a \"Notice of Interest\"), within [***] after Sanofi's receipt of such notice, if Sanofi desires to enter into negotiations with RevMed of the terms under which Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights.",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 289
        },
        {
            "input": "If Pretzel Time exercises its right of first refusal, Franchisee (and its Owners) further agrees that he will abide by the restrictions of Section 17.C.(13).",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 290
        },
        {
            "input": "If, for any reason, this Agreement is not terminated pursuant to Section 10.1 and this Agreement is assumed, or assignment of the same to any person or entity who has made a bona fide offer to accept an assignment of this Agreement is contemplated pursuant to the United States Bankruptcy Code, then notice of such proposed assignment or assumption setting forth: (a) the name and address of the proposed assignee, and (b) all of the terms and conditions of the proposed assignment and assumption shall be given to us within twenty (20) days after receipt of such proposed assignee's offer to accept assignment of this Agreement, and, in any event, within ten (10) days prior to the date application is made to a court of competent jurisdiction for authority and approval to enter into such assignment and assumption, and we shall thereupon have the prior right and option, to be exercised by notice given at any time prior to the effective date of such proposed assignment and assumption, to accept an assignment of this Agreement to us upon the same terms and conditions and for the same consideration, if any, as in the bona fide offer made by the proposed assignee, less any brokerage commissions which may be payable by you out of the consideration to be paid by such assignee for the assignment of this Agreement.",
            "target": "Yes",
            "document_name": "SoupmanInc_20150814_8-K_EX-10.1_9230148_EX-10.1_Franchise Agreement1.pdf",
            "index": 291
        },
        {
            "input": "Election. If HOC delivers the Financing Election, one or more of the HOC Entities shall pay the purchase price for, and the Company shall issue, additional Shares, free and clear of all liens and encumbrances.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 292
        },
        {
            "input": "If Pfizer and Exact are unable to reach agreement on the terms of such Product rights within forty-five (45) days of the commencement of negotiations, Exact shall be free to enter into negotiations and consummate an agreement with any Third Party regarding such Ex-US Commercial Rights; provided that the economic terms of such agreement shall be no more favorable to such Third Party than those last offered to Pfizer.",
            "target": "Yes",
            "document_name": "ExactSciencesCorp_20180822_8-K_EX-10.1_11331629_EX-10.1_Promotion Agreement.pdf",
            "index": 293
        },
        {
            "input": "The party proposing the Transfer (the \"transferor\") must obtain a bona fide, executed written offer (accompanied by a \"good faith\" earnest money deposit of at least five percent (5%) of the proposed purchase price) from a responsible and fully disclosed purchaser, and must submit an exact copy of the offer to us.",
            "target": "Yes",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 294
        },
        {
            "input": "If by the expiration of the ROFR Transfer Period, the Farids Group has not completed the Transfer of the ROFR Shares, in order for the Farids Group to Transfer such ROFR Shares (or any other Shares) it shall be necessary for a new ROFO Sale Notice or ROFR Sale Notice to be delivered, and the terms and provisions of this Article VII to be again complied with.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 295
        },
        {
            "input": "Commencing not later than [****] prior to the expiration of the term of the Agreement, Excite will negotiate with Sponsor in good faith with respect to the terms and conditions under which this Agreement would be renewed.",
            "target": "Yes",
            "document_name": "N2KINC_10_16_1997-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 296
        },
        {
            "input": "In the event that Excite intends to enter into an agreement with a third party with respect to retail music store sponsorships of the Excite Site before the expiration of the term of the Agreement, Excite will deliver to Sponsor a written notice describing the relevant opportunity.",
            "target": "Yes",
            "document_name": "N2KINC_10_16_1997-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 297
        },
        {
            "input": "If Glamis does not dispose of the Designated Mineral Property within a period of 3 months from the first to occur of the date that Glamis and Western Copper acknowledge failure to negotiate an acceptable agreement with respect to the Designated Mineral Property and the end of the 30 day period, the provisions of this section 2.2 will once again apply to any intended disposition of the Designated Mineral Property by Glamis.",
            "target": "Yes",
            "document_name": "WESTERN COPPER - NON-COMPETITION AGREEMENT.PDF",
            "index": 298
        },
        {
            "input": "Promptly upon receipt of notice from Pfizer, Exact and Pfizer shall engage in exclusive good faith negotiations to enter into a definitive written agreement for the OB/Gyn Commercial Rights.",
            "target": "Yes",
            "document_name": "ExactSciencesCorp_20180822_8-K_EX-10.1_11331629_EX-10.1_Promotion Agreement.pdf",
            "index": 299
        },
        {
            "input": "Notwithstanding the foregoing provision for arbitration concerning the terms of any purchase and sale agreement, and without limiting any other<omitted>conditions that may be included in any such purchase and sale agreement, Licensee shall have no obligation to consummate the acquisition of the assets of, or stock in, Licensor pursuant to its exercise of the Option if Licensee's board of directors should determine, in its sole discretion, that such acquisition would not be accretive to the value of Licensee.",
            "target": "Yes",
            "document_name": "NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.pdf",
            "index": 300
        },
        {
            "input": "In the event you are a corporation, partnership, limited liability company or other entity, any transfer of stock (or other form of ownership interest) constituting a controlling interest in you will be subject to the consent, right of first refusal, transfer fee and all other applicable provisions of this Agreement.",
            "target": "Yes",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 301
        },
        {
            "input": "In such a case, PFHOF shall promptly notify the Village Media Company and provide the Village Media Company with any bona fide third party offer to license such PFHOF Work that PFHOF is willing to accept, including any specific terms and proposed business plan relating to such offer.",
            "target": "Yes",
            "document_name": "GpaqAcquisitionHoldingsInc_20200123_S-4A_EX-10.6_11951677_EX-10.6_License Agreement.pdf",
            "index": 302
        },
        {
            "input": "We will then have the prior right and option, to be exercised by notice given at any time before the effective date of such proposed assignment and assumption, to accept an assignment of the Agreement to us upon the same terms and conditions, and for the same consideration, if any, as in the bona fide offer made by the proposed assignee, less any brokerage commissions that may be payable by you out of the consideration to be paid by such assignee for the assignment of the Agreement.",
            "target": "Yes",
            "document_name": "GOOSEHEADINSURANCE,INC_04_02_2018-EX-10.6-Franchise Agreement.PDF",
            "index": 303
        },
        {
            "input": "Excite will negotiate exclusively with Sponsor for the next [****] in good faith effort to negotiate and execute a written sponsorship renewal agreement.",
            "target": "Yes",
            "document_name": "N2KINC_10_16_1997-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 304
        },
        {
            "input": "If, [****] prior to the expiration of the term of the Agreement, the parties have not entered into a written sponsorship renewal agreement. Excite may enter into negotiations with any third party with respect to retail music store sponsorships of the Excite Site.",
            "target": "Yes",
            "document_name": "N2KINC_10_16_1997-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 305
        },
        {
            "input": "Glamis covenants and agrees with Western Copper that if at any time it intends to dispose of a Designated Mineral Property for cash consideration or by abandonment, it will give Western Copper notice (the ' Disposition Notice\") of the intended disposition.",
            "target": "Yes",
            "document_name": "WESTERN COPPER - NON-COMPETITION AGREEMENT.PDF",
            "index": 306
        },
        {
            "input": "Depomed agrees to grant and hereby grants to King an exclusive option (exercisable at King's sole discretion by providing written notice of intent at any time, but in no event later than 180 days after the Effective Date) to obtain an exclusive license in the Territory to certain of Depomed's proprietary drug delivery technology in combination with both metformin hydrochloride and any other active pharmaceutical ingredients (a \"Combination Product License\").",
            "target": "Yes",
            "document_name": "KINGPHARMACEUTICALSINC_08_09_2006-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 307
        },
        {
            "input": "PFHOF agrees not to grant licenses to create new PFHOF Works, except with respect to the categories identified on Exhibit A, to any third party during the Term without first offering to the Village Media Company the right of first refusal to create such PFHOF Works on equal terms, subject to any Rights Restrictions.",
            "target": "Yes",
            "document_name": "GpaqAcquisitionHoldingsInc_20200123_S-4A_EX-10.6_11951677_EX-10.6_License Agreement.pdf",
            "index": 308
        },
        {
            "input": "If DIALOG provides such a notice, for a period of [***] following ENERGOUS' receipt of such notice, ENERGOUS and DIALOG will negotiate in good faith the terms pursuant to which such New Product will be added as a Product to this Agreement.",
            "target": "Yes",
            "document_name": "ENERGOUSCORP_03_16_2017-EX-10.24-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 309
        },
        {
            "input": "The Receiving Party will have ten (10) business days after receiving the Offer Notice to notify the Offering Party whether the Receiving Party exercises its right of first offer for that Development Opportunity.",
            "target": "Yes",
            "document_name": "PLAYAHOTELS&RESORTSNV_03_14_2017-EX-10.22-STRATEGIC ALLIANCE AGREEMENT (Hyatt Ziva Cancun).PDF",
            "index": 310
        },
        {
            "input": "The Farids Group shall not deliver more than one ROFO Sale Notice or ROFR Sale Notice in any thirty (30) day period.",
            "target": "Yes",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 311
        },
        {
            "input": "In the event that the Agent develops, or obtains access to, any new natural nonselective weedkiller products (including, without limitation, any herbicidally active substances which are plant extracts, including those derived from oleic acid or which are derived from plant extracts by processing including active substances) in Canada during the respective term of this Agreement, the Agent will grant Monsanto a right of first refusal to include such new products in the Roundup P&L on the same terms as agreed for the current Natural Products, and if accepted, such new products will become Natural Products.",
            "target": "Yes",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 312
        },
        {
            "input": "For a period of 30 days from the time of delivery of the Disposition Notice Glamis will, if requested by Western Silver, entertain an offer from Western Copper to acquire the Designated Mineral Property.",
            "target": "Yes",
            "document_name": "WESTERN COPPER - NON-COMPETITION AGREEMENT.PDF",
            "index": 313
        },
        {
            "input": "SMBC shall have ten (10) days from the date of delivery of any such notice to agree to purchase all, but not less than all, of such Partnership Interests, for the price and upon the terms specified in the notice, by delivering written notice to such Partner and Moelis Holdings.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 314
        },
        {
            "input": "if this Agreement is terminated for any reason, Developer shall have the option, but not the obligation to<omitted>assume at no cost to Developer, any or all of Distributor's third party agreements (including End-User Agreements) relating to the Products and to receive any and all fees therefrom.",
            "target": "Yes",
            "document_name": "HYPERIONSOFTWARECORP_09_28_1994-EX-10.47-EXCLUSIVE DISTRIBUTOR AGREEMENT.PDF",
            "index": 315
        },
        {
            "input": "PFHOF agrees that during the Term, except with respect to the categories identified on Exhibit A, if PFHOF desires to either exploit itself or license a third party to exploit an existing PFHOF Work, it shall first give the Village Media Company a right of first offer to exclusively license such PFHOF Work, subject to any Rights Restrictions.",
            "target": "Yes",
            "document_name": "GpaqAcquisitionHoldingsInc_20200123_S-4A_EX-10.6_11951677_EX-10.6_License Agreement.pdf",
            "index": 316
        },
        {
            "input": "During the term of this Agreement, Monsanto covenants and agrees to first offer (the \"Product Offer\") to the Agent, with respect to the Included Markets, the exclusive agency and distribution rights to any newly created non-selective herbicide product, which is not marketed for Lawn and Garden Use as of the date of this Agreement, and which Monsanto, in its exclusive, reasonable discretion, determines to be suitable for sale as a new product for Lawn and Garden Use (the \"New Product\"); provided, however, that for the Lawn and Garden Market, that any new product containing Glyphosate or another non- selective herbicide shall be considered to be a New Product.",
            "target": "Yes",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 317
        },
        {
            "input": "At the expiration of the ninety (90)-day period, Affiliate's right of first refusal shall expire.",
            "target": "Yes",
            "document_name": "TubeMediaCorp_20060310_8-K_EX-10.1_513921_EX-10.1_Affiliate Agreement.pdf",
            "index": 318
        },
        {
            "input": "Sanofi may exercise its Option at any time during the Term by providing RevMed with written notice of such exercise",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 319
        },
        {
            "input": "As longs as AFSL and FSL are not in material and continuing breach of this Agreement or the Ancillary Agreements, FSL or AFSL may trigger the option to sell the Put Shares to TPH-A or its designee (the \"Put Option\") by providing a written notice of the exercise of the Put Option (the \"Put Exercise Notice\") simultaneously to the Company, TPH and TPH-A, which notice states (i) such Party's bona fide intention to exercise the Put Option, and (ii) the date on which such Party intends that the Put Closing Date occur.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 320
        },
        {
            "input": "If PFHOF desires to offer a license to any third party or if it receives any bona fide offer from a third party that it is willing to accept, it shall promptly communicate such offer, including the specific terms and business plan relating to such offer, to the Village Media Company and provide the Village Media Company with at least fourteen (14) days to exercise its right of first refusal.",
            "target": "Yes",
            "document_name": "GpaqAcquisitionHoldingsInc_20200123_S-4A_EX-10.6_11951677_EX-10.6_License Agreement.pdf",
            "index": 321
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, RevMed hereby grants to Sanofi an exclusive option, under the Patent Rights and Know-How claiming or embodied in the [***].",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 322
        },
        {
            "input": "Any material change in the terms of the offer from a third-party after we have elected not to purchase the seller's interest will constitute a new offer subject to the same right of first refusal as the third party's initial offer.",
            "target": "Yes",
            "document_name": "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.pdf",
            "index": 323
        },
        {
            "input": "Network 1 shall have the exclusive right of first refusal to purchase all or any part of the revenue due Affiliate or acquire Affiliate (as the case may be) on the same terms and conditions as the Bona Fide Offer.",
            "target": "Yes",
            "document_name": "UsioInc_20040428_SB-2_EX-10.11_1723988_EX-10.11_Affiliate Agreement 2.pdf",
            "index": 324
        },
        {
            "input": "If, after the Effective Date, FSL or AFSL shall have materially breached any of its representations or warranties contained in this Agreement or shall have failed to comply in any material respect with any of the other covenants or agreements contained in this Agreement, which breach or failure shall not have been remedied within thirty (30) days after the Default Notice has been given by TPH-A to FSL/AFSL, then TPH-A shall have the option of purchasing from AFSL, and AFSL shall be obligated to sell, all of the Shares then owned by AFSL at a purchase price per Share equal to the lesser of: (i) the Net Book Value as of the most recent month end (provided that, if the Net Book Value is a negative amount, the product of the Net Book Value multiplied by such Sale Shares shall be deemed to be one Japanese Yen (\u00a51)), or (ii) the Shares Purchase Price, divided by the number of Sale Shares. TPH-A shall provide the Election Notice to purchase the Shares owned by AFSL within ten (10) Business Days following the expiration of the thirty (30) day cure period set forth in the Default Notice. The closing of the purchase of the Shares owned by AFSL shall take place within thirty (30) Business Days following the date of the Election Notice, or at such other time as the Parties may mutually agree. At such closing, TPH-A shall deliver to AFSL, by wire transfer, the full amount of the purchase price in Japanese Yen for such Shares as provided in this Section 7.5.2 against delivery by AFSL of the following: (a) a sale agreement in form reasonably satisfactory to TPH-A containing among other things, a representation and warranty of AFSL that it is, and TPH-A shall be, the beneficial owner of such Shares, with good title thereto, free and clear of all liens and other encumbrances; (b) documentary evidence reasonably satisfactory to TPH-A of the transfer to it of all of AFSL's Shares and (c) resignations of all Directors, if any, on the Board appointed by AFSL. Notwithstanding the remedies provided in this Section 7.5.2, TPH/TPH-A shall be entitled to all other remedies against FSL/AFSL available at law or equity or under this Agreement.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 325
        },
        {
            "input": "If we do not exercise our right of first refusal, the transferor may complete the sale to the Proposed New Owner pursuant to and on the terms of the offer, as long as we have approved the Transfer as provided in this Section 14.",
            "target": "Yes",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 326
        },
        {
            "input": "If EFS desires to use any other domain names or Internet locators/designators in connection with the Websites, Micro Sites or otherwise utilizing PLAYBOY- or PLAYBOY-related marks, EFS shall so notify Client, which may at its sole discretion, choose to register the same at its expense.",
            "target": "Yes",
            "document_name": "PlayboyEnterprisesInc_20090220_10-QA_EX-10.2_4091580_EX-10.2_Content License Agreement_ Marketing Agreement_ Sales-Purchase Agreement1.pdf",
            "index": 327
        },
        {
            "input": "The election by BKC not to exercise its right of first refusal as to any offer shall not affect its right of first refusal as to any subsequent offer.",
            "target": "Yes",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 328
        },
        {
            "input": "If AbbVie [***] and does not subsequently exercise the License Option, then AbbVie shall [***].",
            "target": "Yes",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 329
        },
        {
            "input": "If AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory, AbbVie shall provide reasonable prior written notice to Harpoon of such intention (which notice shall, in any event, be given no later than [***] prior to the next deadline for any action that may be taken with respect to such Product-Specific Patent or Joint Patent in such country or other jurisdiction), and Harpoon shall thereupon have the option, in its sole discretion, to assume the control and direction of the preparation, filing, prosecution, and maintenance of such Product-Specific Patent or Joint Patent at its sole cost and expense in such country or other jurisdiction.",
            "target": "Yes",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 330
        },
        {
            "input": "Any changes in the terms of the Bona Fide Offer as well as any subsequent Bona Fide Offer received by Affiliate shall require full compliance by Affiliate with the procedures in this Section.",
            "target": "Yes",
            "document_name": "UsioInc_20040428_SB-2_EX-10.11_1723988_EX-10.11_Affiliate Agreement 2.pdf",
            "index": 331
        },
        {
            "input": "If a third party (who is not an affiliate of Hyatt) approaches Hyatt during the Development Term with a proposed offer or arrangement, which Hyatt desires to accept, under which the third party would operate a Hyatt All-Inclusive Resort in the Market Area, and if that third party has not then already designated a management company to operate that Hyatt All-Inclusive Resort, then Hyatt agrees to provide notice to Playa and introduce Playa to that third party for purposes of enabling Playa (at its option) to negotiate for the opportunity to manage that Hyatt All-Inclusive Resort for that third party.",
            "target": "Yes",
            "document_name": "PLAYAHOTELS&RESORTSNV_03_14_2017-EX-10.22-STRATEGIC ALLIANCE AGREEMENT (Hyatt Ziva Cancun).PDF",
            "index": 332
        },
        {
            "input": "If other services are required by Party B in Party B Business, Party B shall first provide Party A with the content and requirements of such services in writing.",
            "target": "Yes",
            "document_name": "PhoenixNewMediaLtd_20110421_F-1_EX-10.17_6958322_EX-10.17_Content License Agreement.pdf",
            "index": 333
        },
        {
            "input": "If the Company intends to authorize and/or issue equity securities that give rise to the rights of HOC pursuant to Section 4.1(a), the Company shall provide notice to HOC (the \"Rights Notice\") no less than ten (10) business days before the date on which the Company intends to issue equity securities giving rise to the rights of HOC in Section 4.1(a).",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 334
        },
        {
            "input": "Sanofi shall have the first right, but not the obligation, through counsel of its choosing, to negotiate and obtain a license with respect to such Third Party intellectual property right and shall provide RevMed with a copy of such license if it obtains such a license (to the extent permitted by the terms of such license, provided that Sanofi shall use Commercially Reasonable Efforts to obtain such permission to provide such copy).",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 335
        },
        {
            "input": "MD Anderson also hereby grants to Adaptimmune Limited an exclusive option to negotiate an<omitted>exclusive (subject to MD Anderson's perpetual, irrevocable, no-cost right to use such Invention for non-commercial internal research, academic and patient care purposes), royalty-bearing license to any Invention in which MD Anderson has an ownership interest, provided that Adaptimmune Limited pays all reasonably incurred patent expenses for such Invention in the event Adaptimmune Limited exercises its option.",
            "target": "Yes",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 336
        },
        {
            "input": "Upon any such exercise of the Option, Licensee and Licensor or Skunkware (as the case may be) shall proceed to diligently and in good faith negotiate and execute a definitive purchase and sale agreement for Licensor's acquisition of all of the assets of, or outstanding capital stock in, Licensor, as the case may be.",
            "target": "Yes",
            "document_name": "NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.pdf",
            "index": 337
        },
        {
            "input": "Unless otherwise required by a particular Sponsor, PPD shall not refer that opportunity to any other third party provider unless VS declines to bid on such opportunity or does not offer the service in question.",
            "target": "Yes",
            "document_name": "VIRTUALSCOPICS,INC_11_12_2010-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 338
        },
        {
            "input": "Closing of the subscription, purchase and sale shall be at such place and time as the Parties agree but not more than ten (10) days from delivery of the Financing Election.",
            "target": "Yes",
            "document_name": "GOLDRESOURCECORP_12_11_2008-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 339
        },
        {
            "input": "Sponsor shall have the opportunity to purchase the suite for the postseason at prevailing prices, as available.",
            "target": "Yes",
            "document_name": "VIOLINMEMORYINC_12_12_2012-EX-10.14-SPONSORSHIP AGREEMENT.PDF",
            "index": 340
        },
        {
            "input": "In the event that MSL owns the tooling and has received a bona fide third party offer to purchase any or all of the tooling, before MSL may accept such offer, MSL shall notify IBM in writing, and IBM shall have [*] Days after such notice to agree to purchase such tooling on the same terms and conditions as such third party offer.",
            "target": "Yes",
            "document_name": "MANUFACTURERSSERVICESLTD_06_05_2000-EX-10.14-OUTSOURCING AGREEMENT.PDF",
            "index": 341
        },
        {
            "input": "Completion of the sale and purchase of the Call Shares pursuant to the exercise of the Call Option by TPH- A/TPH shall take place on the date specified in the Call Exercise Notice (which shall be a date after at least sixty (60) days from the date of the Call Exercise Notice) (the \"Call Closing Date\") and on which date: (i) TPH-A shall, or shall cause its designees to, and TPH shall cause TPH-A or TPH-A's designees to, pay to AFSL the Call Option Price for the Call Shares by way of a bank transfer to the bank account as separately designated by AFSL; and (ii) in exchange for which, AFSL shall deliver to TPH-A or its designees duly executed a letter of request to enter in the shareholder register of the Company the information that is required to be registered with regard to the Call Shares.",
            "target": "Yes",
            "document_name": "TRANSPHORM,INC_02_14_2020-EX-10.12(1)-JOINT VENTURE AGREEMENT.PDF",
            "index": 342
        },
        {
            "input": "If Pretzel Time does not exercise its right of first refusal, Franchisee or its Owners may complete the sale to such purchaser pursuant to and on the exact terms of such offer, subject to Pretzel Time's approval of the Transfer as provided in Section 17, provided that if the sale to such purchaser is not completed within 120 days after delivery of such offer to Pretzel Time, or if there is a material change in the terms of the sale (which Franchisee shall promptly communicate to Pretzel Time), Pretzel Time's right to first refusal shall be extended for thirty (30) days after the expiration of such 120 day period or after the material change in the terms of the sale so communicated to Pretzel Time.",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 343
        },
        {
            "input": "If STW exercises its option to produce and transport the CRA water, STW will construct additional facilities or expand existing facilities, as necessary, to be able to produce and transport the CRA water for sale.",
            "target": "Yes",
            "document_name": "STWRESOURCESHOLDINGCORP_08_06_2014-EX-10.1-COOPERATION AGREEMENT.PDF",
            "index": 344
        },
        {
            "input": "Any attempt to assign this Agreement or assign, sublicense and/or transfer in any manner Licensee's license rights hereunder without such consent will be void and of no effect.",
            "target": "No",
            "document_name": "SFGFINANCIALCORP_05_12_2009-EX-10.1-SOFTWARE LICENSE AND MAINTENANCE AGREEMENT.PDF",
            "index": 345
        },
        {
            "input": "Go Call shall not engage in the same or similar promotions during the Term of this Agreement with any other entity providing paging services, equipment or other related products and services.",
            "target": "No",
            "document_name": "GOCALLINC_03_30_2000-EX-10.7-Promotion Agreement.PDF",
            "index": 346
        },
        {
            "input": "7) All covenants, promises and agreements by or on behalf of the parties contained in this Agreement shall be binding upon and shall inure to the benefit of the successors and assigns of the parties; but nothing in this Agreement, expressed or implied is intended to confer on any party the right to assign its rights or obligations hereunder.",
            "target": "No",
            "document_name": "PACIFICSYSTEMSCONTROLTECHNOLOGYINC_08_24_2000-EX-10.53-SPONSORSHIP AGREEMENT.PDF",
            "index": 347
        },
        {
            "input": "IN NO EVENT SHALL EITHER FMI OR ROCHE BE LIABLE FOR SPECIAL, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF THIS AGREEMENT BASED ON CONTRACT, TORT OR ANY OTHER LEGAL THEORY.",
            "target": "No",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 348
        },
        {
            "input": "To the extent needed to perfect AT&T's ownership in AT&T Derived Data, Vendor hereby assigns all right, title and interest in AT&T Derived Data to AT&T.",
            "target": "No",
            "document_name": "AtnInternationalInc_20191108_10-Q_EX-10.1_11878541_EX-10.1_Maintenance Agreement.pdf",
            "index": 349
        },
        {
            "input": "The construction and validity of this Agreement and the provisions hereof, and the rights and obligations of the Parties hereunder, will be governed by the internal laws of the State of Delaware, USA, and, to the extent applicable to Patents and Trademarks, the applicable federal laws of the USA, in each instance without regard to conflict of laws principles.",
            "target": "No",
            "document_name": "PhasebioPharmaceuticalsInc_20200330_10-K_EX-10.21_12086810_EX-10.21_Development Agreement.pdf",
            "index": 350
        },
        {
            "input": "During the Term, PaperExchange will not, directly or indirectly, design, host, operate, maintain or otherwise participate in a co-branded career center or a co-branded equipment listing Site with a Pulp and Paper Online Competitor or license a PaperExchange Link for use or display on any Pulp and Paper Online Competitor's Site.",
            "target": "No",
            "document_name": "PaperexchangeComInc_20000322_S-1A_EX-10.4_5202103_EX-10.4_Co-Branding Agreement.pdf",
            "index": 351
        },
        {
            "input": "The audit will be conducted during normal business hours, at convenient times.",
            "target": "No",
            "document_name": "KINGPHARMACEUTICALSINC_08_09_2006-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 352
        },
        {
            "input": "[***] hereby grants to [***] a non-exclusive, non-transferable (except in connection with a permitted assignment, sublicense or subcontract) \"right of reference\" (as defined in 21 CFR 314.3(b)) with respect to [***] clinical trial data (including [***]), information (including the [***], as applicable) and results related to [***], solely as necessary for [***] to prepare, submit and maintain regulatory submissions related to [***] and Regulatory Approvals for [***].",
            "target": "No",
            "document_name": "Microgenics Corporation - Collaborative Development and Commercialization Agreement.PDF",
            "index": 353
        },
        {
            "input": "IBM will give Customer a credit equal to the amount Customer paid IBM for the applicable Materials or for use of the applicable Base Components up to a maximum of twelve (12) months of applicable charges.",
            "target": "No",
            "document_name": "QuantumGroupIncFl_20090120_8-K_EX-99.2_3672910_EX-99.2_Hosting Agreement.pdf",
            "index": 354
        },
        {
            "input": "If Monsanto does not contest the occurrence of the alleged Brand Decline Event by submitting such alleged Brand Decline Event to resolution through<omitted>arbitration in accordance with the provisions of Section 10.4(g) of this Agreement within ninety (90) days of receipt of such notice from the Agent, then that Brand Decline Event shall be deemed to have occurred as of the date of such notice, and thereafter the Agent shall be entitled to either, as the Agent's sole remedy, (x) terminate this Agreement, which termination shall be effective at the end of the third (3rd) full Program Year following the Program Year in which the Agent delivers notice of termination pursuant to this Section 10.5(d)(ii), or (y) not terminate this Agreement and be entitled to the Additional Commission Amount (in addition to the Commission) set forth in Section 10.5(d)(iv) below, which Additional Commission Amount shall be subject to all other terms and conditions of this Agreement with respect to the Commission, except as otherwise expressly stated in this Section 10.5(d).",
            "target": "No",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 355
        },
        {
            "input": "In no event shall Cisco's or its suppliers' or licensors' liability to Customer, whether in contract, tort (including negligence), or otherwise, exceed the price paid by Customer for the Software that gave rise to the claim or if the Software is part of another Product, the price paid for such other Product.",
            "target": "No",
            "document_name": "ScansourceInc_20190822_10-K_EX-10.38_11793958_EX-10.38_Distributor Agreement2.pdf",
            "index": 356
        },
        {
            "input": "You shall not, without the prior written consent of the Company, either solely or jointly, directly or indirectly, carry on or be engaged, concerned or interested in any other trade or business, including, but not limited to, carrying on business with the Company's suppliers or dealers, save that nothing in this paragraph 13.2 shall prevent you from holding (with the prior written consent of the Company, which shall not be unreasonably delayed or withheld) up to three percent (3%) of the issued equity share capital of any company where those equity shares are listed on a recognised investment exchange (as defined in section 285 of the Financial Services and Markets Act 2000) or traded on the AIM market operated by the London Stock Exchange.",
            "target": "No",
            "document_name": "BICYCLETHERAPEUTICSPLC_03_10_2020-EX-10.11-SERVICE AGREEMENT.PDF",
            "index": 357
        },
        {
            "input": "Each Party, at its own expense, shall maintain comprehensive general liability, product liability and other appropriate insurance for the activities such Party undertakes pursuant to this Agreement, from reputable and financially secure insurance carriers in a form and at levels consistent with sound business practice and adequate in light of its obligations under this Agreement.",
            "target": "No",
            "document_name": "CytodynInc_20200109_10-Q_EX-10.5_11941634_EX-10.5_License Agreement.pdf",
            "index": 358
        },
        {
            "input": "Each Party agrees to assign and hereby assigns to the other Party such right title and interest it may have in any Other Improvements as necessary to effect joint ownership of the Other Improvements by BII and XENCOR.",
            "target": "No",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 359
        },
        {
            "input": "In connection with any Change in Circumstances (as defined below), and without limiting Seller's other rights under this Agreement or applicable law, Seller shall have the right: (i) to terminate this Agreement and accelerate all amounts due from Buyer hereunder, making them immediately payable; (ii) to modify the payment terms hereunder; and/or (iii) to require Buyer to pay in advance for shipments hereunder.",
            "target": "No",
            "document_name": "WestPharmaceuticalServicesInc_20200116_8-K_EX-10.1_11947529_EX-10.1_Supply Agreement.pdf",
            "index": 360
        },
        {
            "input": "In affording the right to review or audit, any such Party whose records are being reviewed or audited shall be permitted to recover, from the Party or Parties requesting the review or audit, the entire costs reasonably incurred in complying with the review or audit.",
            "target": "No",
            "document_name": "TELEGLOBEINTERNATIONALHOLDINGSLTD_03_29_2004-EX-10.10-CONSTRUCTION AND MAINTENANCE AGREEMENT.PDF",
            "index": 361
        },
        {
            "input": "The parties hereby agree that the copyright in the Product sound recording compilation will be jointly registered by Integrity in the names of Integrity and TL.",
            "target": "No",
            "document_name": "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.pdf",
            "index": 362
        },
        {
            "input": "At all times during the Term and for six (6) months following the termination of this Agreement, WYZZ shall have the right, upon prior written request to Nexstar, to review all of the books and records of Nexstar relating to the BCF Report and the Distributions.",
            "target": "No",
            "document_name": "NEXSTARFINANCEHOLDINGSINC_03_27_2002-EX-10.26-OUTSOURCING AGREEMENT.PDF",
            "index": 363
        },
        {
            "input": "During and after the Term, neither Party shall register, use or claim ownership or other rights in any logo, trade name, brand name or trademark of the other Party in existence during the Term (nor any logo, trade name, brand name or trademark confusingly similar to any logo, trade name, brand name or trademark of the other Party in existence during the Term), nor assist anyone else to do so, nor make or assist in any challenge to any logo, trade name, brand name or trademark of the other Party in existence during the Term.",
            "target": "No",
            "document_name": "RitterPharmaceuticalsInc_20200313_S-4A_EX-10.54_12055220_EX-10.54_Development Agreement.pdf",
            "index": 364
        },
        {
            "input": "Consolidated Artists agrees, if requested by TPC, to make Ogle available for one (1) day on behalf of TPC in each Contract Year during the Contract Period at times and places mutually convenient to Ogle and TPC for the purpose of taking still photographs for the preparation and production of advertising and promotional materials.",
            "target": "No",
            "document_name": "TEARDROPGOLFCO_10_23_1996-EX-10.12-ENDORSEMENT AGREEMENT.PDF",
            "index": 365
        },
        {
            "input": "During the Exclusive Roundup Sale Period, neither Monsanto nor any of its Affiliates shall, directly or indirectly through its or their agents, employees or representatives or otherwise, solicit, or cause the solicitation of, or in any way encourage the making of, any offer, proposal or indication of interest involving a Roundup Sale or negotiate with, respond to any inquiry from (except for \"no comment\" or another statement agreed to by the Agent), cooperate with or furnish or cause or authorize to be furnished any information to, any third party or its agents, employees or representatives with respect thereto, or disclose to any third party that a Roundup Sale Notice has been provided to the Agent.",
            "target": "No",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 366
        },
        {
            "input": "TO THE MAXIMUM EXTENT PERMITTED BY LAW, VOTOCAST'S AGGREGATE LIABILITY ARISING FROM OR RELATING TO THIS AGREEMENT OR THE USE OR INABILITY TO USE THE SERVICES SHALL BE LIMITED TO THE AMOUNT OF ALL FEES ACTUALLY RECEIVED BY VOTOCAST FROM LICENSEE UNDER THIS AGREEMENT.",
            "target": "No",
            "document_name": "VitalibisInc_20180316_8-K_EX-10.2_11100168_EX-10.2_Hosting Agreement.pdf",
            "index": 367
        },
        {
            "input": "HSNS agrees to allow E.piphany, directly or indirectly, to audit HSNS's business records as kept by HSNS in its normal course of business to ensure compliance with the terms and conditions of this Agreement.",
            "target": "No",
            "document_name": "OASYSMOBILE,INC_07_05_2001-EX-10.17-OUTSOURCING AGREEMENT.PDF",
            "index": 368
        },
        {
            "input": "Customer grants to Cisco and its independent accountants the right to examine Customer's books, records and accounts during Customer's normal business hours to verify compliance with this Agreement.",
            "target": "No",
            "document_name": "ScansourceInc_20190822_10-K_EX-10.38_11793958_EX-10.38_Distributor Agreement2.pdf",
            "index": 369
        },
        {
            "input": "All Intellectual Property during the project is owned by VAL, and will be turned over to VAL at the conclusion of the project by Developer and after the fulfillment of all commercial obligations by the VAL.",
            "target": "No",
            "document_name": "VgrabCommunicationsInc_20200129_10-K_EX-10.33_11958828_EX-10.33_Development Agreement.pdf",
            "index": 370
        },
        {
            "input": "THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REFERENCE TO ITS CONFLICT OF LAW PROVISIONS (OTHER THAN SECTION 5-1401 OF THE GENERAL OBLIGATIONS LAW), AND THE OBLIGATIONS, RIGHTS AND REMEDIES OF THE PARTIES HEREUNDER SHALL BE DETERMINED IN ACCORDANCE WITH SUCH LAWS.",
            "target": "No",
            "document_name": "CUROGROUPHOLDINGSCORP_05_04_2020-EX-10.3-SERVICING AGREEMENT.PDF",
            "index": 371
        },
        {
            "input": "Any deductibles for such insurance policies will be assumed by the insuring Party.",
            "target": "No",
            "document_name": "PhasebioPharmaceuticalsInc_20200330_10-K_EX-10.21_12086810_EX-10.21_Development Agreement.pdf",
            "index": 372
        },
        {
            "input": "The prices payable by Ultragenyx to Cremer for the Product (the \"Price\") shall be agreed [***] every contract year; provided, that the Price may not increase more than the [***] for such period or [***]%, whichever is higher.",
            "target": "No",
            "document_name": "ULTRAGENYXPHARMACEUTICALINC_12_23_2013-EX-10.9-SUPPLY AGREEMENT.PDF",
            "index": 373
        },
        {
            "input": "Make himself available for four (4) sessions for production of photographs, or radio, television, video or other multi-media programming for use in Bizzingo's advertising or promotional materials, with each such session not exceeding eight (8) hours.",
            "target": "No",
            "document_name": "BizzingoInc_20120322_8-K_EX-10.17_7504499_EX-10.17_Endorsement Agreement.pdf",
            "index": 374
        },
        {
            "input": "This Agreement and any claim, controversy or dispute arising out of or related to this Agreement, any of the transactions contemplated hereby and/or the interpretation and enforcement of the rights and duties of the Parties, whether arising in contract, tort, equity or otherwise, shall be governed by and construed in accordance with the domestic laws of the State of Israel (including in respect of the statute of limitations or other limitations period applicable to any such claim, controversy or dispute), without giving effect to any choice or conflict of law provision or rule (whether of the State of Israel or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Israel.",
            "target": "No",
            "document_name": "ABILITYINC_06_15_2020-EX-4.25-SERVICES AGREEMENT.PDF",
            "index": 375
        },
        {
            "input": "In order to preserve the goodwill of the System following termination, we (or our designee) have the right to enter the Premises (without liability to you, your Owners, or otherwise) for the purpose continuing the Franchised Business' operation and maintaining the goodwill of the business.",
            "target": "No",
            "document_name": "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.pdf",
            "index": 376
        },
        {
            "input": "In addition, the obligations of the Remarketing Agent hereunder may be terminated by it by notice given to the Company prior to 5:00 p.m. (New York City time) on the date immediately preceding the Commencement Date if, prior to that time, any of the events described in Sections 6(i), (j) or (k) shall have occurred.",
            "target": "No",
            "document_name": "Reinsurance Group of America, Incorporated - A&R REMARKETING  AGREEMENT.PDF",
            "index": 377
        },
        {
            "input": "EXCEPT FOR DAMAGES FOR WHICH A PARTY IS RESPONSIBLE PURSUANT TO ITS INDEMNIFICATION OBLIGATIONS SET FORTH IN SECTION 10 ABOVE, NO ACTION, REGARDLESS OF FORM, ARISING OUT OF OR RELATED TO THIS AGREEMENT MAY BE BROUGHT BY EITHER PARTY MORE THAN [***] AFTER SUCH PARTY HAS KNOWLEDGE OF THE OCCURRENCE THAT GAVE RISE TO THE CAUSE OF SUCH ACTION.",
            "target": "No",
            "document_name": "FUSIONPHARMACEUTICALSINC_06_05_2020-EX-10.17-Supply Agreement - FUSION.PDF",
            "index": 378
        },
        {
            "input": "Any Product quarantined at the time of expiration or termination of this Agreement shall be disposed of or destroyed by Manufacturer in accordance with Customer's instructions and at Customer's cost; provided that, to the extent (i) such quarantine is the result of Manufacturer's gross negligence, fraud, willful misconduct or breach of this Agreement or (ii) this Agreement is terminated in whole or in part with respect to such Product (including the termination of the applicable Facility Addendum) by Customer in accordance with Section 7.3, 7.4, 7.5 or 7.6, then Manufacturer shall be responsible for all costs incurred by Manufacturer in connection with disposing and destroying such quarantined Product.",
            "target": "No",
            "document_name": "UpjohnInc_20200121_10-12G_EX-2.6_11948692_EX-2.6_Manufacturing Agreement_ Supply Agreement.pdf",
            "index": 379
        },
        {
            "input": "Nantz Communications and Nantz expressly agree that the Endorsement will not be granted to anyone other than the Company for use during the Term in connection with the advertisement and promotion of sportswear apparel, hats and shoes.",
            "target": "No",
            "document_name": "ASHWORTHINC_01_29_1999-EX-10.(D)-PROMOTION AGREEMENT AND NANTZ COMMUNICATIONS, INC..PDF",
            "index": 380
        },
        {
            "input": "CAPSUGEL agrees to retain all such Records for a period of five (5) years after the expiration of the Term or after termination of this Agreement.",
            "target": "No",
            "document_name": "CARDAX,INC_08_19_2014-EX-10.1-COLLABORATION AGREEMENT.PDF",
            "index": 381
        },
        {
            "input": "\"Contract Period\" shall mean that period of time commencing on January 1, 2000 and concluding December 31, 2003, unless terminated sooner as provided herein.",
            "target": "No",
            "document_name": "MOSSIMOINC_04_14_2000-EX-10.14-ENDORSEMENT AGREEMENT.PDF",
            "index": 382
        },
        {
            "input": "Zogenix will have the right, upon reasonable prior written notice and during Distributor's regular business hours, to audit Distributor's and its Affiliates' books and records by an independent certified public accounting firm of recognized international standing, and Distributor shall ensure that Zogenix has the right to audit its Sub-distributors' and subcontractors' books and records, to investigation potential violations of any of the representations, warranties or covenants in this Section 10.2, the FCPA or other Applicable Laws or Distributor's compliance policies.",
            "target": "No",
            "document_name": "ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement.pdf",
            "index": 383
        },
        {
            "input": "In any event, the total liquidated damages as per this Section shall not exceed 5% of the Product Price.",
            "target": "No",
            "document_name": "NICELTD_06_26_2003-EX-4.5-OUTSOURCING AGREEMENT.PDF",
            "index": 384
        },
        {
            "input": "HEMISPHERX will be permitted to conduct periodic audits of the subcontractors to assure compliance to applicable GMP's, GLP's and federal regulations (CFR's).",
            "target": "No",
            "document_name": "HEMISPHERX - Sales, Marketing, Distribution, and Supply Agreement.PDF",
            "index": 385
        },
        {
            "input": "The Agreement shall commence on the Effective Date and remain in full force and effect for an initial term of **** from the Supply Commencement Date of the Product (\"Initial Term\").",
            "target": "No",
            "document_name": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement.pdf",
            "index": 386
        },
        {
            "input": "Upon Diplomat giving Tadeo at least sixty (60) days advance written notice of termination of this Agreement.",
            "target": "No",
            "document_name": "DYNTEKINC_07_30_1999-EX-10-ONLINE HOSTING AGREEMENT.PDF",
            "index": 387
        },
        {
            "input": "LICENSOR grants plan_b for the term of this Agreement the right to produce, market and distribute Content to End Users (in the territory specified in appendix 2) through its own and its partner's platform.",
            "target": "No",
            "document_name": "DataCallTechnologies_20060918_SB-2A_EX-10.9_944510_EX-10.9_Content License Agreement.pdf",
            "index": 388
        },
        {
            "input": "Subject to Section 20.2, neither Party shall, nor shall it purport to, assign, license, transfer or change any of its rights or obligations under this Agreement without the prior written consent of the other, such consent not to be unreasonably withheld conditioned or delayed; provided, however, that except as provided in Section 20.4 either Party may assign its rights hereunder to an Affiliate or to any successor by merger, consolidation, sale of stock or other equity interests or the sale of substantially all of the assets of such Party without the consent of the other Party.",
            "target": "No",
            "document_name": "PACIRA PHARMACEUTICALS, INC. - A&R STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT .PDF",
            "index": 389
        },
        {
            "input": "In the event that the Transfer License is granted, Achaogen shall owe no payments to Microgenics for the first [***] ([***]) months that any Assay commercialized under the Transfer License is commercialized and shall pay a [***] percent ([***]%) royalty on its net sales (i.e., gross sales less all deductions, reductions and offsets reasonably taken in accordance with generally accepted accounting principles in the United States) of Assays commercialized under the Transfer License following the end of such [***] ([***]) month<omitted>period.",
            "target": "No",
            "document_name": "Microgenics Corporation - Collaborative Development and Commercialization Agreement.PDF",
            "index": 390
        },
        {
            "input": "IN NO ONE EVENT SHALL EITHER PARTY'S AGGREGATE LIABILITY FOR DAMAGES OR LOSSES UNDER THIS AGREEMENT EXCEED THE AGGREGATE AMOUNT OF THE PRODUCT PRICES PAID BY BELLICUM FOR THE MILTENYI PRODUCT(S) DURING THE TWELVE (12) MONTH PERIOD IMMEDIATELY PRECEDING THE EVENT GIVING RISE TO SUCH LIABILITY; AND FURTHER PROVIDED THAT SUCH AGGREGATE LIABILITY DURING SUCH PERIOD ALSO SHALL NOT EXCEED THE AMOUNT OF SUCH PARTY'S INSURANCE COVERAGE FOR SUCH AGGREGATE LIABILITY.",
            "target": "No",
            "document_name": "BELLICUMPHARMACEUTICALS,INC_05_07_2019-EX-10.1-Supply Agreement.PDF",
            "index": 391
        },
        {
            "input": "Upon completion of the Initial Term, provided that the Reseller has achieved the Annual Milestones, the term of the Agreement shall be automatically renewed for an additional five (5) years.",
            "target": "No",
            "document_name": "TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.pdf",
            "index": 392
        },
        {
            "input": "In connection with the foregoing appointment, Supplier hereby grants Reseller a non-transferable, revocable, limited right to resell, market, promote, stimulate interest in, and solicit Orders by Customers and/or End Users in the Territory for the Products and to provide services in connection with those activities.",
            "target": "No",
            "document_name": "HealthcareIntegratedTechnologiesInc_20190812_8-K_EX-10.1_11776966_EX-10.1_Reseller Agreement.pdf",
            "index": 393
        },
        {
            "input": "If and when any such consent, substitution, approval, amendment or release shall be obtained or the Unreleased SpinCo IP Liabilities shall otherwise become assignable or able to be novated, Parent shall promptly assign, or cause to be assigned, and SpinCo or the applicable SpinCo Group member shall assume, such Unreleased SpinCo IP Liabilities without exchange of further consideration.",
            "target": "No",
            "document_name": "INGEVITYCORP_05_16_2016-EX-10.5-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 394
        },
        {
            "input": "TAG's indemnification obligations under this Section 5.3 will expire twelve (12) months after the Conversion Date.",
            "target": "No",
            "document_name": "REGANHOLDINGCORP_03_31_2008-EX-10-LICENSE AND HOSTING AGREEMENT.PDF",
            "index": 395
        },
        {
            "input": "During the Term, VerticalNet shall not share any revenue derived from advertisements hosted on Pulp and Paper Online or any other VerticalNet Site with PaperExchange; provided, however, that if PaperExchange brings VerticalNet a Qualified Lead<omitted>(as defined below) for a new customer that turns into a sale of advertising on Pulp and Paper. Online or Packaging Online, including, without limitation, the Co-Branded Sites, VerticalNet shall pay to PaperExchange a commission of ***** of the Net Advertising Revenue resulting from such sale of advertising, with the exception that if such advertising is on the Co-branded Career Center, VerticalNet shall pay PaperExchange a commission of ***** of the Net Advertising Revenue resulting from such sale of advertising.",
            "target": "No",
            "document_name": "PaperexchangeComInc_20000322_S-1A_EX-10.4_5202103_EX-10.4_Co-Branding Agreement.pdf",
            "index": 396
        },
        {
            "input": "Roche shall exclusively own all information, results, and intellectual property from Advanced Genomic Analyses performed on Roche samples (\"Roche-Owned Advanced Genomic Analysis Results\"), and any inventions arising from the Roche-Owned Advanced Genomic Analysis Results, and FMI will assign all rights to any such inventions to Roche (except for FMI Improvements).",
            "target": "No",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 397
        },
        {
            "input": "EXCEPT FOR INDEMNIFICATION OBLIGATIONS DUE TO LIABILITIES TO THIRD PARTIES, NOTWITHSTANDING ANY PROVISION CONTAINED IN THIS AGREEMENT TO THE CONTRARY, NO PARTY TO THIS AGREEMENT WILL BE LIABLE TO ANY OTHER PARTY TO THIS AGREEMENT FOR ANY INCIDENTAL, INDIRECT, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES (INCLUDING DAMAGES FOR LOSS OF USE, POWER, BUSINESS GOOD WILL, REVENUE OR PROFIT, NOR FOR INCREASED EXPENSES, OR BUSINESS INTERRUPTION) ARISING OUT OF OR RELATED TO THE PERFORMANCE OR NON PERFORMANCE OF THIS AGREEMENT UNLESS THE DAMAGES AROSE DUE TO A PARTY'S GROSS NEGLIGENCE OR WILLFUL BREACH OF THIS AGREEMENT.",
            "target": "No",
            "document_name": "VNUE,INC_07_10_2015-EX-10.1-SPONSORSHIP AGREEMENT.PDF",
            "index": 398
        },
        {
            "input": "UNDER NO CIRCUMSTANCES, INCLUDING NEGLIGENCE, SHALL XACCT BE LIABLE FOR ANY SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES INCLUDING, WITHOUT LIMITATION, DAMAGES FOR LOST PROFITS, LOSS OF DATA, OR COSTS OF PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES, ARISING IN ANY WAY OUT OF THIS AGREEMENT OR THE USE OF THE PRODUCT AND DOCUMENTATION EVEN IF XACCT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES OR LOSSES.",
            "target": "No",
            "document_name": "XACCT Technologies, Inc.SUPPORT AND MAINTENANCE AGREEMENT.PDF",
            "index": 399
        },
        {
            "input": "Turpin acknowledges and agrees that Turpin's employment with the Company may be succeeded by employment with a Company Affiliate, in which case the terms of this Agreement shall continue in effect with respect to such employment until an agreement relating to this subject matter is signed between Turpin and the Company Affiliate.",
            "target": "No",
            "document_name": "KNOWLABS,INC_08_15_2005-EX-10-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 400
        },
        {
            "input": "The Association is a member of the FHLBNY, and the deposit accounts of the Association are insured by the FDIC up to the maximum amount allowed under law and to the best of such counsel's knowledge no proceedings for the termination or revocation of such insurance are pending or threatened; and the description of the liquidation account as set forth in the Registration Statement and the Offering Prospectus under the caption \"The Conversion - Effects of Conversion to Stock Form on Depositors and Borrowers of the Bank - Liquidation Account\" has been reviewed by such counsel and is accurate in all material respects.",
            "target": "No",
            "document_name": "AFSALABANCORPINC_08_01_1996-EX-1.1-AGENCY AGREEMENT.PDF",
            "index": 401
        },
        {
            "input": "The Commercial General Liability insurance policy must: 1. include AT&T, its Affiliates, and their directors, officers, and employees as additional insureds. Vendor shall provide a copy of the additional insured endorsement to AT&T. The additional insured endorsement may either be specific to AT&T or may be \"blanket\" or \"automatic\" addressing any Person as required by contract. A copy of the additional insured endorsement must be provided within sixty (60) days of execution of this Agreement and within sixty (60) days of each Commercial General Liability policy renewal; 2. include a waiver of subrogation in favor of AT&T, its Affiliates, and their directors, officers and employees; and 3. be primary and non-contributory with respect to any insurance or self-insurance that is maintained by AT&T.",
            "target": "No",
            "document_name": "AtnInternationalInc_20191108_10-Q_EX-10.1_11878541_EX-10.1_Maintenance Agreement.pdf",
            "index": 402
        },
        {
            "input": "The term of the license for the Content delivered to HSWI as part of the Affinities, and the Affinities themselves, shall be perpetual, Exclusive, and irrevocable.",
            "target": "No",
            "document_name": "RemarkHoldingsInc_20081114_10-Q_EX-10.24_2895649_EX-10.24_Content License Agreement.pdf",
            "index": 403
        },
        {
            "input": "FG's sole obligation and Astellas' sole remedy with respect to Lead Compound which does not meet the warranty contained herein is limited to replacement of such Lead Compound and reimbursement of Astellas' out of pocket expenses for shipping to FG at the address designated by FG.",
            "target": "No",
            "document_name": "FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.PDF",
            "index": 404
        },
        {
            "input": "In addition, VerticalNet shall not now or in the future contest the validity of LeadersOnline's ownership of its Intellectual Property; provided, however, that VerticalNet may contest the validity of LeadersOnline's Intellectual Property in any proceeding brought against VerticalNet alleging infringement or misappropriation of LeadersOnline's Intellectual Property.",
            "target": "No",
            "document_name": "LeadersonlineInc_20000427_S-1A_EX-10.8_4991089_EX-10.8_Co-Branding Agreement.pdf",
            "index": 405
        },
        {
            "input": "Distributor shall not take any actions, or aid or assist any other party to take any actions that would infringe upon, harm or contest the proprietary rights of Company in and to the Brand and Products.",
            "target": "No",
            "document_name": "BLACKBOXSTOCKSINC_08_05_2014-EX-10.1-DISTRIBUTOR AGREEMENT.PDF",
            "index": 406
        },
        {
            "input": "The Parties acknowledge that Defra is expected to assign or license exclusively to IGER any rights in Intellectual Property which would vest in Defra or the Crown or the Secretary of State pursuant to the DEFRA agreement NF 0426.",
            "target": "No",
            "document_name": "CERES,INC_01_25_2012-EX-10.20-Collaboration Agreement.PDF",
            "index": 407
        },
        {
            "input": "Negotiating in good faith, the Parties shall agree to a reasonable minimum percentage of Product supply to [***] Import Alert.",
            "target": "No",
            "document_name": "FUSIONPHARMACEUTICALSINC_06_05_2020-EX-10.17-Supply Agreement - FUSION.PDF",
            "index": 408
        },
        {
            "input": "Further, during the Non-Competition Period, Rubicon shall not solicit any employee of ISA or any employee of any ISA Client.",
            "target": "No",
            "document_name": "DUOSTECHNOLOGIESGROUP,INC_04_21_2009-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 409
        },
        {
            "input": "Throughout the term of this Agreement, Developer shall obtain and maintain insurance coverage for public liability, including products liability, in the amount of at least One Million Dollars ($1,000,000) combined single limit.",
            "target": "No",
            "document_name": "ElPolloLocoHoldingsInc_20200306_10-K_EX-10.16_12041700_EX-10.16_Development Agreement.pdf",
            "index": 410
        },
        {
            "input": "Customer agrees to and hereby does irrevocably transfer, assign and convey, and shall cause its Personnel to irrevocably transfer, assign and convey, all rights, title and interest in and to each of the Manufacturer-Owned Improvements and Developments to Manufacturer free and clear of any encumbrances, and Customer agrees to execute, and shall cause its Personnel and subcontractors to execute, all documents necessary to do so. All such assignments shall include existing or prospective Intellectual Property rights therein in any country.",
            "target": "No",
            "document_name": "UpjohnInc_20200121_10-12G_EX-2.6_11948692_EX-2.6_Manufacturing Agreement_ Supply Agreement.pdf",
            "index": 411
        },
        {
            "input": "Such records shall be subject to inspection in accordance with Section 7.5.",
            "target": "No",
            "document_name": "ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement.pdf",
            "index": 412
        },
        {
            "input": "Kallo grants to Agent the non-exclusive and non-transferable right to distribute the use of the Kallo Mobile care suite of products to commercial end user customers.",
            "target": "No",
            "document_name": "KALLOINC_11_03_2011-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF'",
            "index": 413
        },
        {
            "input": "In addition, neither Party shall be liable for any claim under this Agreement which is capable of remedy, unless and until the other Party has given such Party written notice containing full details of the breach and such Party has failed to remedy the breach within sixty (60) days of receipt of the notice.",
            "target": "No",
            "document_name": "NlsPharmaceuticsLtd_20200228_F-1_EX-10.14_12029046_EX-10.14_Development Agreement.pdf",
            "index": 414
        },
        {
            "input": "A Facility Addendum may be extended for up to three (3) additional periods of twelve (12) months (each, an \"Extension Period\") by written notice given by Customer to Manufacturer not less than twelve (12) months prior to the expiration of the Initial Term or the applicable Extension Period, as the case may be.",
            "target": "No",
            "document_name": "UpjohnInc_20200121_10-12G_EX-2.6_11948692_EX-2.6_Manufacturing Agreement_ Supply Agreement.pdf",
            "index": 415
        },
        {
            "input": "By the dates specified below, an approved insurance company must issue a certificate of insurance showing compliance with the insurance requirements in this Section 6.19 [Insurance] and you must furnish us with a paid receipt showing the certificate number: (a) 30 days before beginning construction of the Premises; (b) if the Premises are constructed and presently owned or leased by you, 10 days from the Agreement Date; or (c) if the Premises are not presently owned or leased, 10 days after ownership of the Premises is conveyed to you or you sign a lease for the Premises. The certificate of insurance must include a statement by the insurer that the policy or policies may not be canceled, subject to nonrenewal, or materially altered without at least 30 days' prior written notice to us. Upon our request, you must supply us with copies of all insurance policies and proof of payment. Every year, you must send us current certificates of insurance and copies of all insurance policies.",
            "target": "No",
            "document_name": "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.pdf",
            "index": 416
        },
        {
            "input": "The terms of this Agreement shall be governed by and construed in accordance with the laws of England.",
            "target": "No",
            "document_name": "LIGHTBRIDGECORP_11_23_2015-EX-10.26-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 417
        },
        {
            "input": "If the Payor audit confirms the report of the Payee's auditor, then the Payor will pay the deficiency within fifteen (15) days from the time Payee invoices for the deficiency.",
            "target": "No",
            "document_name": "LinkPlusCorp_20050802_8-K_EX-10_3240252_EX-10_Affiliate Agreement.pdf",
            "index": 418
        },
        {
            "input": "Upon expiration or termination of this Agreement, you shall allow our employees or agents to remove the required software from the information system, shall immediately return to us the software, each component thereof, any data generated by the use thereof, all documentation for the software and other materials or information that relate to or reveal the software and its operation.",
            "target": "No",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 419
        },
        {
            "input": "This Agreement shall be governed by and construed in accordance with the internal laws of the State of Nevada without giving effect to any choice or conflict of law provision or rule.",
            "target": "No",
            "document_name": "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.pdf",
            "index": 420
        },
        {
            "input": "The engagement letters will (unless otherwise agreed) provide that payments would be made to either SMBC/Nikko or Moelis Holdings and SMBC/Nikko and Moelis Holdings will split the fees pursuant to this Agreement.",
            "target": "No",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 421
        },
        {
            "input": "Distributor shall have the exclusive right to market, promote, sell, offer for sale, import, package and otherwise Commercialize the Product in the Field in the Territory, at its sole cost and expense, in accordance with Applicable Laws and the Commercialization Plan and subject to the terms and conditions of this Agreement.",
            "target": "No",
            "document_name": "ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement.pdf",
            "index": 422
        },
        {
            "input": "This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada, USA in force therein without regard to its conflict of law rules.",
            "target": "No",
            "document_name": "HUBEIMINKANGPHARMACEUTICALLTD_09_19_2006-EX-10.1-OUTSOURCING AGREEMENT.PDF",
            "index": 423
        },
        {
            "input": "In the event that (i) TouchStar terminates this Agreement in accordance with any one or more of the provisions of Section 8.2 or (ii) Reseller elects not to enter into a new agreement with TouchStar pursuant to Section 8.1, all Customer Agreements with Customers shall be transferred by Reseller to TouchStar.",
            "target": "No",
            "document_name": "WORLDWIDESTRATEGIESINC_11_02_2005-EX-10-RESELLER AGREEMENT.PDF",
            "index": 424
        },
        {
            "input": "The Developer expressly acknowledges and agrees that any all proprietary materials prepared by the Developer under this Agreement shall be considered \"works for hire\" and the exclusive property of the Client unless otherwise specified.",
            "target": "No",
            "document_name": "ClickstreamCorp_20200330_1-A_EX1A-6 MAT CTRCT_12089935_EX1A-6 MAT CTRCT_Development Agreement.pdf",
            "index": 425
        },
        {
            "input": "Within sixty (60) days of the Effective Date, Changepoint agrees to execute an escrow agreement by and among Corio, Changepoint and a mutually acceptable escrow agent (the \"ESCROW AGENT\").",
            "target": "No",
            "document_name": "CHANGEPOINTCORP_03_08_2000-EX-10.6-LICENSE AND HOSTING AGREEMENT.PDF",
            "index": 426
        },
        {
            "input": "As applicable to and appropriate for a Clinical Study, Adaptimmune may monitor the conduct of a Clinical Study in accordance with Good Clinical Practice requirements of FDA Regulations, and may visit MD Anderson for the purpose of such monitoring.",
            "target": "No",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 427
        },
        {
            "input": "The expiration or termination of the Agreement shall have the following consequences: (i) The Licensee shall cease to use the License and cease to conduct any activities that would require the License, unless explicitly stated otherwise in this Article. (ii) Licensee or Affiliates or Distributors may sell off all previously purchased Licensed Products still in their warehouses within a period of six (6) months of the effective date of such termination (the \"Sell-Off Period\") provided that the sale of such Licensed Products by Licensee or Affiliates or Distributors of the Licensee shall be subject to the terms of this Agreement, including but not limited to the rendering of reports and payment of royalties required under this Agreement. (iii) Promptly upon the request of Licensor, the Licensee shall, at the Licensor's sole discretion and election for each country of the Territory and each Licensed Product either withdraw or transfer all Marketing Authorizations in the Territory to the Licensor (or to a third party as the Licensor directs). Licensee shall take the required steps without any delay and the withdrawal or transfer shall be completed in maximum 90 days after the notification of the request; if the Licensor does not decide and inform within this period to whom the Marketing Authorizations and documents shall be transferred, then the Licensee shall have no obligation to keep them active",
            "target": "No",
            "document_name": "NlsPharmaceuticsLtd_20200228_F-1_EX-10.14_12029046_EX-10.14_Development Agreement.pdf",
            "index": 428
        },
        {
            "input": "In addition, such license for Translated Content shall be Exclusive for Display on the Open Free Web.",
            "target": "No",
            "document_name": "RemarkHoldingsInc_20081114_10-Q_EX-10.24_2895649_EX-10.24_Content License Agreement.pdf",
            "index": 429
        },
        {
            "input": "Where a Party or any member of its Group is required by this Agreement to reimburse or indemnify the other Party or any member of its Group for any cost or expense, the reimbursing or indemnifying Party (or the applicable member of its Group) shall reimburse or indemnify the other Party (or the applicable member of its Group) for the full amount of the cost or expense, inclusive of any amounts in respect of VAT imposed on that amount to the extent properly reflected on a valid invoice, except to the extent that the reimbursed or indemnified Party reasonably determines that it (or such member of its Group), or a member of the same group as it (or such member of its Group) for VAT purposes, is entitled to credit for or repayment of that VAT from any relevant taxing authority.",
            "target": "No",
            "document_name": "UpjohnInc_20200121_10-12G_EX-2.6_11948692_EX-2.6_Manufacturing Agreement_ Supply Agreement.pdf",
            "index": 430
        },
        {
            "input": "If the Remaining Exposure shown on such final detailed ledger Statement is less than zero then Vertex shall pay [****] percent ([****]%) of such amount to Bunker One",
            "target": "No",
            "document_name": "VertexEnergyInc_20200113_8-K_EX-10.1_11943624_EX-10.1_Marketing Agreement.pdf",
            "index": 431
        },
        {
            "input": "This Agreement shall be construed, and the respective rights of the Parties determined, according to the substantive law of the State of Delaware notwithstanding the provisions governing conflict of laws under such Delaware law to the contrary, except matters of intellectual property law which shall be determined in accordance with the intellectual property laws relevant to the intellectual property in question.",
            "target": "No",
            "document_name": "INNOVIVA,INC_08_07_2014-EX-10.1-COLLABORATION AGREEMENT.PDF",
            "index": 432
        },
        {
            "input": "The term of this Agreement shall begin on the Effective Date and continue in effect for a period of five (5) years (the \"Initial Term\"), unless sooner terminated in accordance with the provisions set out herein.",
            "target": "No",
            "document_name": "DIVERSINETCORP_03_01_2012-EX-4-RESELLER AGREEMENT.PDF",
            "index": 433
        },
        {
            "input": "This Agreement shall be governed by and construed in accordance with the internal laws of the State of California applicable to agreements made and to be performed entirely within such state, without regard to the conflicts of law principles of such state; provided that any matters relating to the construction or effect of any Patent will be governed by the patent laws of the relevant jurisdiction in which such Patent is granted.",
            "target": "No",
            "document_name": "AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement.pdf",
            "index": 434
        },
        {
            "input": "BNL shall have no liability with respect to its obligations under this agreement or otherwise for consequential, exemplary, special, indirect, incidental or punitive damages even if it has been advised of the possibility<omitted>of such damages. in any event, other than claims covered by the next sentence, the liability of BNL to VIP for any reason and upon any cause of action and claim in contract, tort or otherwise shall be limited to the amounts paid by BNL to VIP in the twelve (12) month period prior to the accrual of the action or claim for the specific service which is the subject of the action or claim (or, if such accrual occurs during the first twelve (12) months of the initial term, then the liability shall be limited to the minimum fees payable by BNL to VIP during the first twelve (12) months of the initial term) claims by VIP for the minimum fees and other fees and expenses owing by BNL under paragraphs 5, 15(a) and 15(c), or for a breach by BNL of VIP's proprietary rights as set forth in paragraph 13 are excluded from this paragraph II limitation except for the claims excluded by the preceding sentence, this limitation applies to all causes of action or claims in the aggregate including without limitation breach of contract, breach of warranty, negligence, strict liability, misrepresentation and other torts.",
            "target": "No",
            "document_name": "BNLFINANCIALCORP_03_30_2007-EX-10.8-OUTSOURCING AGREEMENT.PDF",
            "index": 435
        },
        {
            "input": "The Agreement may be terminated by both Parties with a notification period of *** before the end of the Initial Term of the Agreement.",
            "target": "No",
            "document_name": "PareteumCorp_20081001_8-K_EX-99.1_2654808_EX-99.1_Hosting Agreement.pdf",
            "index": 436
        },
        {
            "input": "HCI agrees: (i) that MLX is the owner of the MLX Marks and the goodwill and reputation associated therewith; (ii) not to contest the validity of the MLX Marks or MLX's title thereto;",
            "target": "No",
            "document_name": "HealthcentralCom_19991108_S-1A_EX-10.27_6623292_EX-10.27_Co-Branding Agreement.pdf",
            "index": 437
        },
        {
            "input": "This Agreement shall be governed by and interpreted in accordance with the laws of the State of Delaware without regard to its conflicts of law principles.",
            "target": "No",
            "document_name": "ArconicRolledProductsCorp_20191217_10-12B_EX-2.7_11923804_EX-2.7_Trademark License Agreement.pdf",
            "index": 438
        },
        {
            "input": "Upon termination or expiration, this Agreement and all rights granted hereunder to you will forthwith terminate, and:<omitted>B. Upon our demand, you will assign to us your interest in any lease then in effect for the Franchised Restaurant premises.",
            "target": "No",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 439
        },
        {
            "input": "This license expressly prohibits any pass-through rights or the use of the HOF Entity Marks by any third party, except (x) to Constellation's subsidiaries and brands for use in a manner consistent with clauses (i) through (iii) hereof or (y) with the express written consent of the HOF Entities (or the appropriate HOF Entity).",
            "target": "No",
            "document_name": "GpaqAcquisitionHoldingsInc_20200123_S-4A_EX-10.8_11951679_EX-10.8_Service Agreement.pdf",
            "index": 440
        },
        {
            "input": "Certegy hereby grants to Equifax a fully paid, non-exclusive, perpetual, worldwide license to use, modify, copy, improve and create Derivative Works and enhancements from, in source code and object code format, processes or procedures developed by Equifax in support to the Paynet Secure software product that have applicability independent of or from the Paynet Secure software product.",
            "target": "No",
            "document_name": "FIDELITYNATIONALINFORMATIONSERVICES,INC_08_05_2009-EX-10.3-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 441
        },
        {
            "input": "Unless otherwise terminated as provided herein, the initial term of this Agreement shall be three (3) years from the Effective Date and shall thereafter be automatically renewed for subsequent one (1) year periods unless either party notifies the other in writing of its election not to renew the Agreement at least one hundred twenty (120) days prior to the expiration of the then-current term.",
            "target": "No",
            "document_name": "VISIUMTECHNOLOGIES,INC_10_20_2004-EX-10.20-DISTRIBUTOR AGREEMENT.PDF",
            "index": 442
        },
        {
            "input": "Neither party may assign this Agreement or any of its rights or delegate any of its duties under this Agreement without the prior written consent of the other party, not to be unreasonably withheld; except that either party may, without the other party's consent, assign this Agreement or any of its rights or delegate any of its duties under this Agreement: (a) to any corporate affiliate of such party; or (b) to any purchaser of all or substantially all of such party's assets or to any successor by way of merger, consolidation or similar transaction.",
            "target": "No",
            "document_name": "EmbarkComInc_19991008_S-1A_EX-10.10_6487661_EX-10.10_Co-Branding Agreement.pdf",
            "index": 443
        },
        {
            "input": "In consideration of the license of Liquidmetal Technical Information and the Licensed Equipment granted by Liquidmetal, Eutectix agrees to pay Liquidmetal a cash royalty based on a percentage of the invoice price of any Licensed Products (but not including Liquidmetal Products) sold by Eutectix or its permitted sublicensees and for which payment was actually received by Eutectix.",
            "target": "No",
            "document_name": "LiquidmetalTechnologiesInc_20200205_8-K_EX-10.1_11968198_EX-10.1_Development Agreement.pdf",
            "index": 444
        },
        {
            "input": "Harpoon shall not, and shall not permit its Affiliates to, attack, dispute, or contest the validity of or ownership of such Product Trademark anywhere in the Territory or any registrations issued or issuing with respect thereto or use in their respective businesses, any Trademark that is confusingly similar to, misleading or deceptive with respect to or that dilutes any (or any part) of the Product Trademarks.",
            "target": "No",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 445
        },
        {
            "input": "Strategic Programs may not be made on an exclusive basis. No more than one Strategic Program may be run in any Theatre at any time.",
            "target": "No",
            "document_name": "DigitalCinemaDestinationsCorp_20111220_S-1_EX-10.10_7346719_EX-10.10_Affiliate Agreement.pdf",
            "index": 446
        },
        {
            "input": "TL will hold exclusive worldwide rights to promote and sell the product through the following distribution channels: Outgoing telemarketing, General Market retail, and General Market catalogs, and exclusive rights within the United States for Television Direct response.",
            "target": "No",
            "document_name": "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.pdf",
            "index": 447
        },
        {
            "input": "Upon termination or expiration of this Agreement, if specifically requested by MBRK, DD shall provide originals or copies of such records to MBRK.",
            "target": "No",
            "document_name": "MIDDLEBROOKPHARMACEUTICALS,INC_03_18_2010-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 448
        },
        {
            "input": "PivX may terminate this Agreement for convenience by giving at least thirty (30) days written notice of termination to Detto.",
            "target": "No",
            "document_name": "ADIANUTRITION,INC_04_01_2005-EX-10.D2-RESELLER AGREEMENT.PDF",
            "index": 449
        },
        {
            "input": "EXCEPT FOR DAMAGES ARISING FROM BREACH OF SECTIONS 6.C AND 12,13 OR 17, IN NO EVENT WELL DISTRIBUTOR's TOTAL LIABILITY FOR ANY DAMAGES IN ANY ACTION BASED ON OR ARISING OUT OF OR IN CONNECTION WITH THE AGREEMENT EXCEED THE [*] TO NETGEAR PURSUANT TO THE AGREEMENT.",
            "target": "No",
            "document_name": "NETGEAR,INC_04_21_2003-EX-10.16-DISTRIBUTOR AGREEMENT.pdf",
            "index": 450
        },
        {
            "input": "This Agreement shall inure to the benefit of and be binding upon the successors and assigns of the Parties hereto; provided, however, that neither Party shall transfer or assign this Agreement without the prior written consent of the other Party, such consent not to be unreasonably withheld, except where such assignment is by CPDC to any successor or subsidiary organization created within [***] of the Effective Date of this Agreement, which assignment may be completed without the prior written consent of FUSION.",
            "target": "No",
            "document_name": "FUSIONPHARMACEUTICALSINC_06_05_2020-EX-10.17-Supply Agreement - FUSION.PDF",
            "index": 451
        },
        {
            "input": "The first year limited warranty starts on the day of the activation of the Unit on a wireless network.",
            "target": "No",
            "document_name": "VISIUMTECHNOLOGIES,INC_10_20_2004-EX-10.20-DISTRIBUTOR AGREEMENT.PDF",
            "index": 452
        },
        {
            "input": "RemainCo shall have, and SpinCo hereby grants to RemainCo, an unlimited, non-exclusive, perpetual, irrevocable, royalty free, worldwide right and license to use the content contained in the Steam Book, including the current edition and any past edition and any future edition to which RemainCo makes a contribution, for any purpose, including, without limitation, to reproduce, publicly display, modify, make derivative works, distribute, publicly perform and distribute for RemainCo's internal business purposes, including in connection with customer related activities, provided, however, that RemainCo shall (i) not use any non-nuclear content contained in the Steam Book in connection with publishing or distributing a publication which competes with the Steam Book and (ii) provide attribution and accreditation using a copyright notice having the format required by law in connection with the use of any protectable expression of the non-nuclear content contained in the Steam Book",
            "target": "No",
            "document_name": "BABCOCK_WILCOXENTERPRISES,INC_08_04_2015-EX-10.17-INTELLECTUAL PROPERTY AGREEMENT between THE BABCOCK _ WILCOX COMPANY and BABCOCK _ WILCOX ENTERPRISES, INC..PDF",
            "index": 453
        },
        {
            "input": "EKR shall maintain and shall procure the maintenance of accurate and up to date records and books of account showing the quantity, description and value of the Products supplied in each country of the Territory during the previous six (6) Calendar Years.",
            "target": "No",
            "document_name": "PACIRA PHARMACEUTICALS, INC. - A&R STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT .PDF",
            "index": 454
        },
        {
            "input": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-sub- licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non-transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in Carbon Capture Applications, solely to conduct Authorized Work with Authorized Third Parties.",
            "target": "No",
            "document_name": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf",
            "index": 455
        },
        {
            "input": "Company's representatives will make themselves available three days per month in the first Product Year to consult with and train Distributor.",
            "target": "No",
            "document_name": "LIMEENERGYCO_09_09_1999-EX-10-DISTRIBUTOR AGREEMENT.PDF",
            "index": 456
        },
        {
            "input": "NFLA agrees not to grant the right to use the NFLAs Identification to anyone other than Company in connection with the advertisement and promotion of Products.",
            "target": "No",
            "document_name": "GridironBionutrientsInc_20171206_8-K_EX-10.1_10972555_EX-10.1_Endorsement Agreement.pdf",
            "index": 457
        },
        {
            "input": "If DIALOG decides to discontinue Sales of any Product, it will notify ENERGOUS at least [***] prior to such discontinuance, and following such notification, the exclusivity rights, if any, associated with that Product will cease; provided, however, this provision will not apply in the event that DIALOG continues Sales of Product Updates, repackaged Product Dies or MCMs.",
            "target": "No",
            "document_name": "ENERGOUSCORP_03_16_2017-EX-10.24-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 458
        },
        {
            "input": "No party may assign its rights or delegate its obligations hereunder, either in whole or in part, without the prior written consent of the other party, other than an assignment by Sonos or IAC of its rights and obligations hereunder to a wholly-owned subsidiary.",
            "target": "No",
            "document_name": "Sonos, Inc. - Manufacturing Agreement .PDF",
            "index": 459
        },
        {
            "input": "All claims by Sanofi Pasteur for breach or default under this Agreement shall be brought within [***] year after the cause of action comes into existence or otherwise shall be waived.",
            "target": "No",
            "document_name": "ADMA BioManufacturing, LLC -  Amendment #3 to Manufacturing Agreement .PDF",
            "index": 460
        },
        {
            "input": "Unless this Agreement is terminated pursuant to Section 25, this Agreement will automatically renew for additional successive [***] terms (each a \"Renewal Term\" and together with the Initial Term, the \"Term\") unless and until either Party provides written notice of non-renewal to the other Party at least [***] prior to the end of the then-current Term.",
            "target": "No",
            "document_name": "PHREESIA,INC_05_28_2019-EX-10.18-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 461
        },
        {
            "input": "EXCEPT FOR [**], IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER PARTY FOR [**], EVEN IF SUCH PARTY WAS ADVISED OR AWARE OF THE POSSIBILITY OF SUCH DAMAGES.",
            "target": "No",
            "document_name": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.pdf",
            "index": 462
        },
        {
            "input": "For OEM Products, Tripath warrants that the Products will be free of manufacturing and workmanship defects for one year from the date of shipment by Distributor to a customer, or eighteen months from the date of shipment to Distributor, whichever is sooner.",
            "target": "No",
            "document_name": "ETELOS,INC_03_09_2004-EX-10.8-DISTRIBUTOR AGREEMENT.PDF",
            "index": 463
        },
        {
            "input": "Term: twelve (12) months from the date of the Agreement which term shall automatically renew for an additional twelve (12) months on such date if the Agreement is not otherwise terminated according to Section 8 of the Agreement.",
            "target": "No",
            "document_name": "MEDALISTDIVERSIFIEDREIT,INC_05_18_2020-EX-10.1-CONSULTING AGREEMENT.PDF",
            "index": 464
        },
        {
            "input": "During the Termination Period and thereafter, and notwithstanding any other provision of this Agreement, MBE will be free to use its own personnel, and/or engage or contract with any third party to use the Specifications to design, develop and market an Internet-based manifest system similar to the Manifest (including products that contain functionality similar to the Service and which have a \"look and feel\" similar or identical to the Manifest), in each case solely for the benefit of MBE and the MBE Centers and international franchisees or licensees of MBE.",
            "target": "No",
            "document_name": "StampscomInc_20001114_10-Q_EX-10.47_2631630_EX-10.47_Co-Branding Agreement.pdf",
            "index": 465
        },
        {
            "input": "NEITHER PARTY WILL BE LIABLE FOR ANY SPECIAL, INDIRECT, CONSEQUENTIAL OR INCIDENTAL DAMAGES ARISING OUT OF OR RELATED TO THIS AGREEMENT, HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY (INCLUDING NEGLIGENCE), AND EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.",
            "target": "No",
            "document_name": "CYBERIANOUTPOSTINC_07_09_1998-EX-10.13-PROMOTION AGREEMENT.PDF",
            "index": 466
        },
        {
            "input": "This Agreement (and any question about its subsistence, effect or termination) is to be interpreted in accordance with the laws of India, save for that body of law which governs the conflict of laws.",
            "target": "No",
            "document_name": "OPERALTD_04_30_2020-EX-4.14-SERVICE AGREEMENT.PDF",
            "index": 467
        },
        {
            "input": "Party B shall pay one-month freight as liquidated damages in case of termination of the Agreement without consent.",
            "target": "No",
            "document_name": "ZtoExpressCaymanInc_20160930_F-1_EX-10.10_9752871_EX-10.10_Transportation Agreement.pdf",
            "index": 468
        },
        {
            "input": "This Agreement will come into effect on the Effective Date and shall continue in full force for ten (10) years from the Launch (the \"Initial Term\"), or the date of expiry of the last valid patent of the Licensed Product, whichever comes later, subject to clauses 19.2, 19.3, 19.4 and 19.5 hereunder",
            "target": "No",
            "document_name": "NlsPharmaceuticsLtd_20200228_F-1_EX-10.14_12029046_EX-10.14_Development Agreement.pdf",
            "index": 469
        },
        {
            "input": "The term of this Agreement shall commence on the Effective Date and terminate in _____________, on _____________, unless terminated earlier pursuant to the terms of this Agreement; provided, however, that this Agreement may be renewed for successive one (1) year periods if STAAR and Distributor expressly agree in writing and in their sole discretion to renew this Agreement prior to the foregoing termination date or any successive renewal term.",
            "target": "No",
            "document_name": "StaarSurgicalCompany_20180801_10-Q_EX-10.37_11289449_EX-10.37_Distributor Agreement.pdf",
            "index": 470
        },
        {
            "input": "This Agreement may not be assigned or otherwise transferred, nor may any right or obligations hereunder be assigned or transferred, by either Party without the prior written consent of the other Party; provided, however, that Licensor may, without such consent, assign this Agreement and its rights and obligations hereunder, in whole or in part, to an Affiliate or in connection with the transfer or sale of all or substantially all of its assets related to the Licensed Product or the business relating thereto, or in the event of its merger or consolidation or change in control or similar transaction.",
            "target": "No",
            "document_name": "NlsPharmaceuticsLtd_20200228_F-1_EX-10.14_12029046_EX-10.14_Development Agreement.pdf",
            "index": 471
        },
        {
            "input": "Schoolpop shall, during the term of this Agreement, at its own cost and expense, procure with sound and reputable insurers, the following insurance coverage's: (i) Workers' Compensation Insurance in an amount not less than the statutory limits for the state(s), country or province in where the services are to be performed; (ii) Employer's Liability Insurance not less than (a) $100,000 per occurrence, and not less than $100,000 aggregate limit of liability per policy year for disease, including death at any time resulting therefrom, not caused by accident or (b) such amount as required by law, whichever is higher; (iii) Comprehensive General Liability Insurance, including blanket extended coverage against all hazards, including personal injury and death resulting therefrom, for not less than $1,000,000 per occurrence, and not less than $2,000,000 aggregate; (iv) Automobile Liability insurance against liability arising from the maintenance or use of all owned, non-owned and hired automobiles and trucks used to provide services, with (a) a minimum limit of liability for bodily injury of $1,000,000 in the aggregate, and with a minimum limit of liability for property damage of $500,000 per accident, or (b) amount as required by law, whichever is higher; and (v) fidelity or crime policy of not less than $3,000,000 in the aggregate against misappropriation and/or destruction of Cards.",
            "target": "No",
            "document_name": "LOYALTYPOINTINC_11_16_2004-EX-10.2-RESELLER AGREEMENT.PDF",
            "index": 472
        },
        {
            "input": "The term of this Agreement (the \"Term\") shall commence as of April 1, 2018 (the \"Effective Date\") and shall expire upon the later of: (a) the conclusion of the 2022/23 NFL season and (b) the last day in February, 2023 (such expiration date, the \"Scheduled Expiration Date\"), unless sooner terminated pursuant to the terms of this Agreement.",
            "target": "No",
            "document_name": "ArcGroupInc_20171211_8-K_EX-10.1_10976103_EX-10.1_Sponsorship Agreement.pdf",
            "index": 473
        },
        {
            "input": "Accordingly, neither this Agreement nor any part of your interest in it, nor any Interest (as defined in Paragraph 14.2) of Franchise Owner or a Principal Owner, may be transferred (see definition below) without our advance written approval if such transfer will result in the Principal Owner(s) set forth in Exhibit 4 holding less than a seventy-five percent (75%) Interest in Franchise Owner.<omitted>As used in this Agreement the term \"Transfer\" means any voluntary, involuntary, direct or indirect assignment, sale, gift, exchange, grant of a security interest, or occurrence of any other event which would or might change the ownership of any Interest, and includes, without limitation: (1) the Transfer of ownership of capital stock, partnership interest or other ownership interest (including the granting of options (such as stock options or any option which give anyone ownership rights now or in the future); (2) merger or consolidation, or issuance of additional securities representing an ownership interest in Franchise Owner; (3) sale of common stock of Franchise Owner sold pursuant to a private placement or registered public offering; (4) Transfer of an Interest in a divorce proceeding or otherwise by operation of law; or (5) Transfer of an Interest by will, declaration of or transfer in trust, or under the laws of intestate succession.",
            "target": "No",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 474
        },
        {
            "input": "In any action or proceeding between the Parties (including any arbitration proceeding) arising under or with respect to this Agreement or in any manner pertaining to the Hyatt All-Inclusive Resorts or to the relationship of the Parties under this Agreement, each Party hereby unconditionally and irrevocably waives and releases any right, power or privilege either may have to claim or receive from the other Party any punitive or exemplary damages, each Party acknowledging and agreeing that the remedies herein provided and other remedies at law or in equity will in all circumstances be adequate.",
            "target": "No",
            "document_name": "PLAYAHOTELS&RESORTSNV_03_14_2017-EX-10.22-STRATEGIC ALLIANCE AGREEMENT (Hyatt Ziva Cancun).PDF",
            "index": 475
        },
        {
            "input": "The Procurement Group shall ensure that the Supply Contract shall afford its designated representatives reasonable rights of access to examine, test and inspect the submarine cable, land cable, submarine cable and land cable equipment, material, supplies and installation activities.",
            "target": "No",
            "document_name": "STARTECGLOBALCOMMUNICATIONSCORP_11_16_1998-EX-10.30-CONSTRUCTION AND MAINTENANCE AGREEMENT.PDF",
            "index": 476
        },
        {
            "input": "Neither this Agreement nor any interest hereunder shall be assignable by a Party without the prior written consent of the other Party, except as follows: (a) such Party may assign its rights and obligations under this Agreement to any of its Affiliates, provided that the assignee shall expressly agree to be bound by such Party's obligations under this Agreement and that such Party shall remain liable for all of its rights and obligations under this Agreement, and (b) either Party may assign its rights and obligations hereunder to a Third Party in connection with a permitted assignment or other permitted transfer of the License Agreement. Each Party shall promptly notify the other Party of any assignment or transfer under the provisions of this Section 11.1.",
            "target": "No",
            "document_name": "VERICELCORP_08_06_2019-EX-10.10-SUPPLY AGREEMENT.PDF",
            "index": 477
        },
        {
            "input": "This Agreement will be deemed entered into in Arizona and will be governed by and interpreted in accordance with the internal substantive laws of the State of Arizona without reference to conflicts of law provisions.",
            "target": "No",
            "document_name": "HALITRON,INC_03_01_2005-EX-10.15-SPONSORSHIP AND DEVELOPMENT AGREEMENT.PDF",
            "index": 478
        },
        {
            "input": "In addition, Licensee shall pay to Bioeq the following royalties on Licensee's and its Affiliates' Gross Margins (calculated in accordance with Section 7.3.3) generated through the sale of Licensed Products in the Field in the Territory: (a) Prior to [***], Licensee shall pay to Bioeq royalties in the amount of [***] percent ([***]%) on Licensee's and its Affiliates' Gross Margins (calculated in accordance with Section 7.3.3) generated through the sale of Licensed Products in the Field in the Territory, payable on a Licensed Product-by-Licensed Product basis, and subject to Section 7.3.1(c) hereunder. (b) Starting [***], Licensee shall pay to Bioeq royalties in the amount of [***] percent ([***]%) on the Licensee's and its Affiliates' Gross Margins generated through the sale of Licensed Products in the Field in the Territory, payable on a Licensed Product\u2011by\u2011Licensed Product basis, and subject to Section 7.3.1(c) hereunder.",
            "target": "No",
            "document_name": "CoherusBiosciencesInc_20200227_10-K_EX-10.29_12021376_EX-10.29_Development Agreement.pdf",
            "index": 479
        },
        {
            "input": "In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort, strict liability or otherwise regardless of whether the possibility of such losses or damages have been made known to the first Party, and each Party hereby expressly waives all such rights and remedies, except for breach of any confidentiality or restricted use provisions of this Agreement and except as provided in Paragraph 11.04 (Exceptions to Limitations of Liability).",
            "target": "No",
            "document_name": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf",
            "index": 480
        },
        {
            "input": "Notwithstanding the preceding sentences, this Subsection will not limit the liability of a Party for any amount or type of damages for: (1) the defense and indemnification of an Indemnified Claim on which the Party is the Indemnifying Party; (2) infringement by the Party on the intellectual property of the other Party; (3) the unauthorized disclosure or use by the Party of the Confidential Information of the other Party; (4) payment or reimbursement of any amount expressly required to be paid or reimbursed by the Party under a provision of this Agreement; or (5) the intentional misconduct of the Party in violation of Applicable Laws.",
            "target": "No",
            "document_name": "ReynoldsConsumerProductsInc_20191115_S-1_EX-10.18_11896469_EX-10.18_Supply Agreement.pdf",
            "index": 481
        },
        {
            "input": "This Agreement is not assignable by the Professional but is assignable by the Company to any affiliate or successor entity. Any attempted assignment by the Professional without the prior written consent of the Company shall be void.",
            "target": "No",
            "document_name": "WOMENSGOLFUNLIMITEDINC_03_29_2000-EX-10.13-ENDORSEMENT AGREEMENT.PDF",
            "index": 482
        },
        {
            "input": "HSI will, subject to compliance with the terms of this Agreement, grant a royalty-free, non-exclusive worldwide license to HERC to use the mark/name HERTZ as part of company names for the Interim Period, as more fully set forth in the Trademark, Trade Name, Domain and Related Rights License Agreement attached as Exhibit A.",
            "target": "No",
            "document_name": "HERTZGLOBALHOLDINGS,INC_07_07_2016-EX-10.4-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 483
        },
        {
            "input": "As between the Parties, Dova shall own all right, title and interest in and to any Product Materials (and all content contained therein) and any Product Labeling (and all content contained therein), including applicable copyrights and trademarks (other than any name, trademark, trade name or logo of Valeant or its Affiliates that may appear on such Product materials or Product Labeling), and to the extent Valeant (or any of its Affiliates) obtains or otherwise has a claim to any of the foregoing, Valeant hereby assigns (and shall cause any applicable Affiliate to assign) all of its right, title and interest in and to such Product Materials (and content) and Product Labeling (and content) (other than any name, trademark, trade name or logo of Valeant or its Affiliates that may appear on such Product materials or Product Labeling) to Dova and Valeant agrees to (and shall cause its applicable Affiliate to) execute all documents and take all actions as are reasonably requested by Dova to vest title to such Product Materials (and content) and Product Labeling (and content) in Dova (or its designated Affiliate).",
            "target": "No",
            "document_name": "DovaPharmaceuticalsInc_20181108_10-Q_EX-10.2_11414857_EX-10.2_Promotion Agreement.pdf",
            "index": 484
        },
        {
            "input": "MusclePharm agrees that any copyrights in works created based upon the Trademarks and/or Name and Appearance Rights shall become the rights of the AS Parties (as among them to be determined among them)",
            "target": "No",
            "document_name": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.pdf",
            "index": 485
        },
        {
            "input": "Upon expiration or termination of this Agreement for any reason, Eutectix shall have the option to purchase some or all of the Licensed Equipment at fair market value, less any amounts owed to Eutectix by Liquidmetal, except the equipment listed under Section 2.1(b) above",
            "target": "No",
            "document_name": "LiquidmetalTechnologiesInc_20200205_8-K_EX-10.1_11968198_EX-10.1_Development Agreement.pdf",
            "index": 486
        },
        {
            "input": "IN ADDITION, NOTWITHSTANDING ANYTHING TO THE CONTRARY HEREIN OR OTHERWISE, THE PARTIES ACKNOWLEDGE THAT AS AN ELECTRONIC MANUFACTURING SERVICES PROVIDER WORKING ON A COST PLUS BASIS SUPPLIER MUST LIMIT ITS LIABILITY IN CONNECTION HEREWITH AND THEREFORE, CONTRACTOR'S LIABILITY IS FURTHER LIMITED IN ANY EVENT, UNDER ANY LAW, RULE OR REGULATION, TO ANY AMOUNT IT ACTUALLY RECEIVED IN CONSIDERATION OF THE MANUFACTURING SUBJECT MATTER OF THE RESPECTIVE CLAIM OR DEMAND BY CUSTOMER OR ANY THIRD PARTY.",
            "target": "No",
            "document_name": "InmodeLtd_20190729_F-1A_EX-10.9_11743243_EX-10.9_Manufacturing Agreement.pdf",
            "index": 487
        },
        {
            "input": "NETGEAR reserves the right to change a warranty period for a specific Product but only for orders placed after the effective date of such change, provided that the minimum warranty period for all Products is ninety days, except for those Products specifically identified in the Price List as provided \" AS IS\" with no warranties.",
            "target": "No",
            "document_name": "NETGEAR,INC_04_21_2003-EX-10.16-DISTRIBUTOR AGREEMENT.pdf",
            "index": 488
        },
        {
            "input": "Distributor shall pay WGT fifty percent (50%) of the unpaid balance of cumulative Guaranteed Minimum Purchase amounts as liquidated damages.",
            "target": "No",
            "document_name": "EUROPEANMICROHOLDINGSINC_03_06_1998-EX-10.6-DISTRIBUTOR AGREEMENT.PDF",
            "index": 489
        },
        {
            "input": "EFS and its affiliates conduct their activities, both relating to the Playboy Commerce Business and otherwise, in a way that does not jeopardize the Playboy Marks or the reputation and image of any Playboy entity or activity.",
            "target": "No",
            "document_name": "PlayboyEnterprisesInc_20090220_10-QA_EX-10.2_4091580_EX-10.2_Content License Agreement_ Marketing Agreement_ Sales-Purchase Agreement1.pdf",
            "index": 490
        },
        {
            "input": "This duty continues to apply to any transactions undertaken after the Joint Venture has been dissolved but before the affairs of the Joint Venture have been completely wound up by the surviving Participant or Participants or their agent or agents.",
            "target": "No",
            "document_name": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT.PDF",
            "index": 491
        },
        {
            "input": "During the period beginning on the Effective Date and ending on the later of (i) the end of the Initial Term and (ii) the date falling two years after completion of the most recent services provided by Rubicon under clause 7 (the \"Non-Competition Period\") and in the Rubicon Geographic Area, as defined below, ISA agrees not to in any capacity, engage or have a financial interest in any Rubicon Competing Business, as defined below, or provide managerial, supervisory, administrative, or financial services relating to any Rubicon Competing Business, including making available any information or funding to any such Rubicon Competing Business.",
            "target": "No",
            "document_name": "DUOSTECHNOLOGIESGROUP,INC_04_21_2009-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 492
        },
        {
            "input": "NICE shall have the rights to conduct audits of the Manufacturing Outsourcing Services and related facilities, systems, and records as set forth in this Section 10 for the purpose of auditing Contractor's compliance with the provisions of this Agreement, all subject to the limitations below.",
            "target": "No",
            "document_name": "NICELTD_06_26_2003-EX-4.5-OUTSOURCING AGREEMENT.PDF",
            "index": 493
        },
        {
            "input": "Unless this Agreement is terminated earlier in accordance with the terms of Section \u200b12, the term of this Agreement shall commence on the Effective Date and shall continue until July 31, 2019 (the \"Initial Term\").",
            "target": "No",
            "document_name": "XpresspaGroupInc_20190401_10-K_EX-10.28_11599457_EX-10.28_Marketing Agreement.pdf",
            "index": 494
        },
        {
            "input": "This Agreement and all related business transactions will be governed by the laws of the Commonwealth of Massachusetts (without reference to principles of conflicts or choice of law which would cause the application of the internal laws of any other jurisdiction).",
            "target": "No",
            "document_name": "BIOPURECORP_06_30_1999-EX-10.13-AGENCY AGREEMENT.PDF",
            "index": 495
        },
        {
            "input": "Assignment Without the express prior written consent of Diversinet (not to be unreasonably refused), Reseller may not assign this Agreement or its interest herein in whole or in part but Reseller shall continue to be responsible should the assignee fail to perform. Diversinet may assign this Agreement at any time and in such event, this Agreement shall continue in full force and effect as if the assignee were named as the licensor in the first instance but Diversinet shall continue to be responsible should the assignee fail to perform.",
            "target": "No",
            "document_name": "DIVERSINETCORP_03_01_2012-EX-4-RESELLER AGREEMENT.PDF",
            "index": 496
        },
        {
            "input": "1.1.2 XLI grants WCC a limited, non-exclusive, royalty-free license to use the registered trademark \"Light Sheets\" during the term of this Agreement in connection with national, regional or local print advertising, together with Internet, television, video and on-site advertising, for WCC and its Event(s) during the term of this Agreement, subject to all of the terms and conditions hereof.",
            "target": "No",
            "document_name": "XLITECHNOLOGIES,INC_12_11_2015-EX-10.1-Sponsorship Agreement.PDF",
            "index": 497
        },
        {
            "input": "Subject to the limitations set forth in this Agreement, the Joint IP may be used freely by either Party or its Affiliates and licensed to Third Parties by Conformis and its Affiliates, on the one hand, outside of the Buyer Field or by Stryker and its Affiliates, on the other hand, within the Buyer Field, in each case, without the consent of, or duty to account to or notify, the other Party, but, except with respect to external licenses of the Improved Conformis Background IP by Conformis or its Affiliates to Third Parties, any external Third Party license shall be governed in accordance with the last sentence of Section 4.3(c) of the APA.",
            "target": "No",
            "document_name": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.pdf",
            "index": 498
        },
        {
            "input": "This Agreement shall be governed and construed according to the law of Tennessee.",
            "target": "No",
            "document_name": "WARNINGMANAGEMENTSERVICESINC_12_10_1999-EX-10-ENDORSEMENT AGREEMENT.PDF",
            "index": 499
        },
        {
            "input": "In the event of termination in accordance with Section 5.1, PivX shall not be liable to Detto because of such termination for compensation, reimbursement or damages on account of the loss of prospective profits or anticipated sales or on account of expenditures, inventory, investments, leases or commitments in connection with the business or goodwill of Detto.",
            "target": "No",
            "document_name": "ADIANUTRITION,INC_04_01_2005-EX-10.D2-RESELLER AGREEMENT.PDF",
            "index": 500
        },
        {
            "input": "Company hereby appoints Distributor as Company's exclusive distributor within the Market and grants to Distributor the exclusive right to sell and distribute Products within the Market, and Distributor hereby accepts such appointment and such grant, in accordance with the terms and conditions of this Agreement.",
            "target": "No",
            "document_name": "LIMEENERGYCO_09_09_1999-EX-10-DISTRIBUTOR AGREEMENT.PDF",
            "index": 501
        },
        {
            "input": "MA may not assign, sell, lease or otherwise transfer in whole or in party any of the rights granted pursuant to this Agreement without prior written approval of Company.",
            "target": "No",
            "document_name": "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.pdf",
            "index": 502
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, WGT grants to Distributor a nontransferable license to do the following in the Territory during the Term: (a) market and distribute the Product to resellers; (b) demonstrate the Product to potential resellers; (c) use the Product internally for the sole purpose of providing this product support specified in paragraph 4.1(c); (d) use and display the Trademarks in connection with marketing and distributing the Product in the Territory pursuant to paragraphs (a) and (b) above.",
            "target": "No",
            "document_name": "EUROPEANMICROHOLDINGSINC_03_06_1998-EX-10.6-DISTRIBUTOR AGREEMENT.PDF",
            "index": 503
        },
        {
            "input": "In connection with any construction, renovation, refurbishment, or remodeling of the Premises, you must cause the general contractor to maintain commercial general liability insurance (with comprehensive automobile liability coverage for both owned and non-owned vehicles, builder's risk, product liability, and independent contractors coverage) with a reputable insurer.",
            "target": "No",
            "document_name": "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.pdf",
            "index": 504
        },
        {
            "input": "Supplier shall have Buyer named as an additional insured on its insurance policies in subparts 7.5.1 and 7.5.2 above.",
            "target": "No",
            "document_name": "BELLRINGBRANDS,INC_02_07_2020-EX-10.18-MASTER SUPPLY AGREEMENT.PDF",
            "index": 505
        },
        {
            "input": "Without limiting SAP AFRICA'S liabilities or responsibilities in terms of the AGREEMENT, SAP AFRICA will provide and maintain insurance to cover its liability and responsibilities in terms of this AGREEMENT.",
            "target": "No",
            "document_name": "TELKOMSALTD_01_30_2003-EX-10-LICENCE AND MAINTENANCE AGREEMENT.PDF",
            "index": 506
        },
        {
            "input": "Customer is granted a nonexclusive, nontransferable (except to permitted assigns of this Agreement) limited license to use the Licensed Software during the term of this Agreement. Customer shall not sell, lease, copy, distribute, transfer, assign or sublicense the Licensed Software to any third party.",
            "target": "No",
            "document_name": "OFGBANCORP_03_28_2007-EX-10.23-OUTSOURCING AGREEMENT.PDF",
            "index": 507
        },
        {
            "input": "Licensee agrees not to do anything inconsistent with such ownership, including (i) filing to register any trademark or service mark containing the Brand or (ii) directly or indirectly challenging, contesting or otherwise<omitted>disputing the validity, enforceability or Licensor's ownership of the Brand (and the associated goodwill), including without limitation, in any claim, allegation, action, demand, proceeding or suit (\"Action\") regarding enforcement of this Agreement or involving any third party.",
            "target": "No",
            "document_name": "MorganStanleyDirectLendingFund_20191119_10-12GA_EX-10.5_11898508_EX-10.5_Trademark License Agreement.pdf",
            "index": 508
        },
        {
            "input": "You receive a Designated Area within which we and our affiliates shall not operate or grant to anyone else a franchise to operate a Buffalo Wild Wings or bw-3 Restaurant so long as this Agreement is in force and effect.",
            "target": "No",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 509
        },
        {
            "input": "The initial term of this Agreement shall be one (1) year from the Effective Date (the \"Initial Term\").",
            "target": "No",
            "document_name": "KUBIENT,INC_07_02_2020-EX-10.14-MASTER SERVICES AGREEMENT_Part1.pdf",
            "index": 510
        },
        {
            "input": "The maximum amount of information downloaded from the Company's server to the counter manifest station will be 15 kilobytes or less per package processed.",
            "target": "No",
            "document_name": "StampscomInc_20001114_10-Q_EX-10.47_2631630_EX-10.47_Co-Branding Agreement.pdf",
            "index": 511
        },
        {
            "input": "Neither party shall be liable to the other party for any special, incidental, or consequential damages arising in connection with, or out of termination of, this agreement.",
            "target": "No",
            "document_name": "VISIUMTECHNOLOGIES,INC_10_20_2004-EX-10.20-DISTRIBUTOR AGREEMENT.PDF",
            "index": 512
        },
        {
            "input": "The following events shall constitute \"Source Code Access Conditions\": (i) D2's insolvency, general assignment for the benefit of creditors, or ceasing to do business, or (ii) D2's failure or inability to meet its warranty, maintenance and support obligations under Article 6, or its warranty obligations under Article 8.3, within fifteen days after written notice by LICENSEE to D2 of D2's failure to meet such obligations, or (iii) termination of this Agreement by LICENSEE pursuant to Articles 9.3 and 9.4, or (iv) as needed by LICENSEE for fault isolation.",
            "target": "No",
            "document_name": "SUMMAFOURINC_06_19_1998-EX-10.3-SOFTWARE LICENSE AND MAINTENANCE AGREEMENT.PDF",
            "index": 513
        },
        {
            "input": "This Agreement shall be governed by the laws of the province of Ontario, Canada, without regard to its conflict of laws principles.",
            "target": "No",
            "document_name": "DIVERSINETCORP_03_01_2012-EX-4-RESELLER AGREEMENT.PDF",
            "index": 514
        },
        {
            "input": "In the event of (a) a termination by Astellas under Section 18.6 during the period from the execution of this Agreement until the last to expire of the FG Patents, or (b) by FG under Section 18.2.1, 18.2.2, 18.2.4 or 18.2.5 hereof, Astellas shall, upon the effective date of such termination, pay to FG (i) a termination fee of $[ * ] U.S. dollars and (ii) any payments to which FG is otherwise entitled to receive hereunder in the period from the date of such termination notice until the [ * ].",
            "target": "No",
            "document_name": "FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.PDF",
            "index": 515
        },
        {
            "input": "Notwithstanding the foregoing:<omitted>(2) Subject to Agent's rights set forth in Section 10.6, Monsanto shall have the right to transfer and assign all or a portion of its rights, interests and obligations hereunder to a Person that acquires all or a portion of Monsanto's business related to the Lawn and Garden<omitted>Market (whether by sale or transfer of equity interests or assets, merger or otherwise); provided, that any such assignee shall be subject to the provisions of this Agreement as if it were the original party hereto, including, without limitation, this Section 11.8;<omitted>(4) the Agent shall be entitled to transfer and assign its rights, interests and obligations hereunder and under the License Agreement with respect to the Included Markets; provided, that (A), the Agent may only make one (1) assignment pursuant to this Section 11.8(b)(4) with respect to the North America Territories and one (1) assignment pursuant to this Section 11.8(b)(4) with respect to any Other Included Markets, (B) the Agent determines in its reasonable commercial opinion that the assignee of such rights pursuant to this Section 11.8(b)(4) can and will fully perform the duties and obligations under the License Agreement and with respect to the Roundup L&G Business in such Included Markets as specified in the License Agreement and this Agreement and (C) that any such assignee shall be subject to the provisions of the License Agreement and this Agreement as if it were an original party to each agreement.",
            "target": "No",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 516
        },
        {
            "input": "This Agreement shall be construed and governed in accordance with the laws of the State of Maryland regardless of the place or places of its physical execution and performance.",
            "target": "No",
            "document_name": "LinkPlusCorp_20050802_8-K_EX-10_3240252_EX-10_Affiliate Agreement.pdf",
            "index": 517
        },
        {
            "input": "Skype hereby grants to Online BVI and the Company a limited, non-exclusive, non-sublicensable (except as set forth herein), non-transferable, non-assignable (except as provided in Section 14.4), royalty-free (but subject to the provisions of Section 5), license during the Term to use, market, provide access to, promote, reproduce and display the Skype Intellectual Property solely (i) as incorporated in the Company-Skype Branded Application and/or the Company-Skype Toolbar, and (ii) as incorporated in, for the development of, and for transmission pursuant to this Agreement of, the Company-Skype Branded Content and the Company-Skype Branded Web Site, in each case for the sole purposes (unless otherwise mutually agreed by the Parties) of promoting and distributing, pursuant to this Agreement, the Company-Skype Branded Application, the Company-Skype Toolbar, the Company-Skype Branded Content and the Company-Skype Branded Web Site in the Territory; (a) provided, that it is understood that the Company-Skype Branded Customers will have the right under the EULA to use the Company- Skype Branded Application and the Company-Skype Toolbar and will have the right to access the Company-Skype Branded Content, the Company-Skype Branded Web Site and the Online BVI Web Site through the Internet and to otherwise receive support from the Company anywhere in the world, and that the Company shall be permitted to provide access to and reproduce and display the Skype Intellectual Property through the Internet anywhere in the world, and (b) provided further, that Online BVI and the Company shall ensure that no Company-Skype Branded Customer (or potential Company-Skype Branded Customer) shall be permitted to access, using the Company-Skype Branded Application or the Company-Skype Toolbar or through the Company-Skype Branded Web Site, any Skype premium features requiring payment by the Company-Skype Branded Customer (or potential Company-Skype Branded Customer), including, but not limited to, SkypeIn, SkypeOut, or Skype Plus, unless such Company-Skype Branded Customer (or potential Company-Skype Branded Customer) uses the payment methods made available by the Company pursuant to Section 2.5 for the purchase of such premium features.",
            "target": "No",
            "document_name": "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.pdf",
            "index": 518
        },
        {
            "input": "The Company shall not tarnish or bring into disrepute the reputation of or goodwill associated with the Seller Licensed Trademarks or Arizona.",
            "target": "No",
            "document_name": "ArmstrongFlooringInc_20190107_8-K_EX-10.2_11471795_EX-10.2_Intellectual Property Agreement.pdf",
            "index": 519
        },
        {
            "input": "Throughout the term of this Agreement, Contractor shall maintain workers compensation insurance in the amount required by statute, comprehensive general liability insurance with coverage of at least one million dollars ($1,000,000) and professional errors and omissions insurance for bodily injury, property damage or other losses with coverage of at least one million dollars ($1,000,000), in connection with the provision of Services by Contractor pursuant to the terms of this Agreement. At Company's request, Contractor shall provide Company with certificates or other acceptable evidence of insurance or self-insurance evidencing the above coverage and shall provide Company with prompt written notice of any material change.",
            "target": "No",
            "document_name": "MERITLIFEINSURANCECO_06_19_2020-EX-10.(XIV)-MASTER SERVICES AGREEMENT.PDF",
            "index": 520
        },
        {
            "input": "In the case that either company is acquired by, or merges with, another company which has reason to not wish to continue the relationship, that company may make a contract buyout payment [*] for the [*], with a [*] buyout payment amount of [*].",
            "target": "No",
            "document_name": "INTERSECTENT,INC_05_11_2020-EX-10.1-SUPPLY AGREEMENT.PDF",
            "index": 521
        },
        {
            "input": "Honeywell agrees that it will not, and agrees to cause each member of the Honeywell Group not to, (i) initiate any Action against any member of the SpinCo Group or its Affiliates for infringement, misappropriation or other violation of any Honeywell IP, (ii) oppose, challenge, petition to cancel, contest or threaten in any way, or assist another party in opposing, challenging, petitioning to cancel, contesting or threatening in any way, any application or registration by SpinCo or its Affiliates or their respective licensees for any SpinCo IP, the use of which is consistent with the use of such SpinCo IP in connection with the SpinCo Business as of immediately prior to the Distribution Date, (iii) engage in any act, or purposefully omit to perform any act, that impairs or adversely affects the rights of SpinCo or any member of the SpinCo Group in and to any SpinCo IP or (iv) apply for any registration with respect to the SpinCo IP (including federal, state and national registrations), in each case of the foregoing clauses (i) - (iv) for a period of five (5) years after the Distribution Date, without the prior written consent of SpinCo, which consent shall not be unreasonably withheld, conditioned or delayed.",
            "target": "No",
            "document_name": "GarrettMotionInc_20181001_8-K_EX-2.4_11364532_EX-2.4_Intellectual Property Agreement.pdf",
            "index": 522
        },
        {
            "input": "This Agreement shall be governed by the laws of the State of Florida.",
            "target": "No",
            "document_name": "TURNKEYCAPITAL,INC_07_20_2017-EX-1.1-Strategic Alliance Agreement.PDF",
            "index": 523
        },
        {
            "input": "During the Cisco warranty period, DISTRIBUTOR may return failed Product to Cisco for replacement.",
            "target": "No",
            "document_name": "ScansourceInc_20190822_10-K_EX-10.38_11793958_EX-10.38_Distributor Agreement1.pdf",
            "index": 524
        },
        {
            "input": "This Agreement shall be governed by the laws of the State of California without giving effect to conflict or choice of law principles.",
            "target": "No",
            "document_name": "VitalibisInc_20180316_8-K_EX-10.2_11100168_EX-10.2_Hosting Agreement.pdf",
            "index": 525
        },
        {
            "input": "Talent agrees that Company shall, for a period of nine (9) months (Sell-Off Period) following the effective date of termination, have the right to continue to sell Product bearing the Property and/or utilize advertising materials and collateral bearing the Property.",
            "target": "No",
            "document_name": "LegacyEducationAllianceInc_20141110_8-K_EX-10.9_8828866_EX-10.9_Endorsement Agreement.pdf",
            "index": 526
        },
        {
            "input": "Monsanto and the Agent stipulate and agree that the injury which will be caused to the Agent by the termination of this Agreement under the circumstances which shall give rise to the payment of the Termination Fee are difficult or impossible of accurate estimation; that by establishing the Termination Fee they intend to provide for the payment of damages and not a penalty; and that the sum stipulated for the Termination Fee is a reasonable pre-estimate of the probable loss which will be suffered by the Agent in the event of such termination.",
            "target": "No",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 527
        },
        {
            "input": "Upon termination of the Agreement, VerticalNet and Impresse shall jointly own all User Data.",
            "target": "No",
            "document_name": "ImpresseCorp_20000322_S-1A_EX-10.11_5199234_EX-10.11_Co-Branding Agreement.pdf",
            "index": 528
        },
        {
            "input": "Any purported assignment or transfer not having our prior written consent as required by this Section 16 will be null and void and will also constitute a material breach of this Agreement, for which we may immediately terminate this Agreement without opportunity to cure, pursuant to Section 17.2.5 below.",
            "target": "No",
            "document_name": "GOOSEHEADINSURANCE,INC_04_02_2018-EX-10.6-Franchise Agreement.PDF",
            "index": 529
        },
        {
            "input": "The term of this Agreement shall commence on the Services Commencement Date and remain effective for ten (10) years (the \"Initial Term\") unless terminated in accordance with its terms.",
            "target": "No",
            "document_name": "SPIENERGYCO,LTD_03_09_2011-EX-99.5-OPERATIONS AND MAINTENANCE AGREEMENT.PDF",
            "index": 530
        },
        {
            "input": "Employers' Liability Insurance which limit shall be $1,000,000 per accident for Bodily injury and $1,000,000 per employee/aggregate for disease.",
            "target": "No",
            "document_name": "CardlyticsInc_20180112_S-1_EX-10.16_11002987_EX-10.16_Maintenance Agreement1.pdf",
            "index": 531
        },
        {
            "input": "Diplomat will be required to notify Tadeo at least five business days before the date of planned examination.",
            "target": "No",
            "document_name": "DYNTEKINC_07_30_1999-EX-10-ONLINE HOSTING AGREEMENT.PDF",
            "index": 532
        },
        {
            "input": "With respect to any Indemnified Party who is not a party to this Agreement, the Agents shall obtain and hold the rights and benefits of this Section 11 in trust for and on behalf of such Indemnified Party.",
            "target": "No",
            "document_name": "OLDAPIWIND-DOWNLTD_01_08_2016-EX-1.3-AGENCY AGREEMENT1.pdf",
            "index": 533
        },
        {
            "input": "[***] shall designate up to [***] ([***]) BLI employees or personnel as key persons (individually, a \"Key Person\" and collectively, \"Key Persons\").",
            "target": "No",
            "document_name": "BERKELEYLIGHTS,INC_06_26_2020-EX-10.12-COLLABORATION AGREEMENT.PDF",
            "index": 534
        },
        {
            "input": "Both Parties shall, at all times during the currency of this Agreement and for a period of one (1) year after the termination or expiration of this Agreement, maintain the following policies of insurance in effect: (i) a comprehensive general liability insurance policy, with minimum coverage of $1,000,000 per occurrence and in the annual aggregate for product liability and completed operations, covering bodily and personal injury, including death, and property damage, including loss of use; and (ii) an information and network technology blended liability insurance policy with an insured limit of at least $1,000,000 in the aggregate.",
            "target": "No",
            "document_name": "EhaveInc_20190515_20-F_EX-4.44_11678816_EX-4.44_License Agreement_ Reseller Agreement.pdf",
            "index": 535
        },
        {
            "input": "This Agreement and the legal relations among the Parties hereto shall be governed by and construed in accordance with the laws of the State of Florida, without regard to its conflict of law doctrine.",
            "target": "No",
            "document_name": "GLOBALTECHNOLOGIESLTD_06_08_2020-EX-10.16-CONSULTING AGREEMENT.PDF",
            "index": 536
        },
        {
            "input": "Distributor shall be entitled to advertise, promote, market or<omitted>solicit any Customers that have a business presence outside the Territory, except that Distributor shall not conduct solicitation activities in any outside territory where Hydraspin is bound to an exclusive distributor agreement with a third party, provided that Hydraspin has notified Distributor in writing of its arrangements with the other distributor and of the territory which is subject to exclusivity in favor of the other distributor.",
            "target": "No",
            "document_name": "WaterNowInc_20191120_10-Q_EX-10.12_11900227_EX-10.12_Distributor Agreement.pdf",
            "index": 537
        },
        {
            "input": "Upon 30 days prior written notice, such records shall be made available by the audited party for audit by an independent certified public accounting firm designated by the other party and reasonably acceptable to the party whose records are to be examined.",
            "target": "No",
            "document_name": "KINGPHARMACEUTICALSINC_08_09_2006-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 538
        },
        {
            "input": "Zogenix and Distributor shall each own an undivided right, title, and interest in and to any and all Inventions discovered, developed, identified, made, conceived or reduced to practice jointly by or on behalf of Zogenix under or in connection with this Agreement and by Distributor or its Affiliates or Sub-distributors or its other subcontractors in the Territory and under or in connection with this Agreement (\"Joint Invention\").",
            "target": "No",
            "document_name": "ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement.pdf",
            "index": 539
        },
        {
            "input": "Other System franchisees shall be deemed third party beneficiaries of such.",
            "target": "No",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 540
        },
        {
            "input": "This Agreement shall be interpreted and enforced in accordance with the laws of the State of California as applied to agreements made, entered into and performed entirely in California by California residents, notwithstanding the actual residence of the parties, without giving effect to any choice of laws of California that would require the application of the laws of a state other than California.",
            "target": "No",
            "document_name": "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.pdf",
            "index": 541
        },
        {
            "input": "Co-Host shall not have the right to assign or otherwise transfer this Agreement or any rights herein granted to any other person or entity, except by operation of law or in connection with the sale of all of its assets, or the acquisition of the Co-Host by a third party. Any such attempted assignment shall be void and the Agreement shall remain in effect.",
            "target": "No",
            "document_name": "BEYONDCOMCORP_08_03_2000-EX-10.2-CO-HOSTING AGREEMENT.PDF",
            "index": 542
        },
        {
            "input": "[***], Valeant hereby grants to Dova a fully paid-up, royalty free, non-transferable, non- exclusive license (with a limited right to sub-license to its Affiliates) to any Valeant Property that appears on, embodied on or contained in the Product materials or Product Labeling solely for use in connection with Dova's promotion or other commercialization of the Product in the Territory.",
            "target": "No",
            "document_name": "DovaPharmaceuticalsInc_20181108_10-Q_EX-10.2_11414857_EX-10.2_Promotion Agreement.pdf",
            "index": 543
        },
        {
            "input": "Even in case of agreements with foreign (non-German) Software Publishers and Affiliates, the law of the Federal Republic of Germany applies.",
            "target": "No",
            "document_name": "SouthernStarEnergyInc_20051202_SB-2A_EX-9_801890_EX-9_Affiliate Agreement.pdf",
            "index": 544
        },
        {
            "input": "Bachem shall make accessible for review by Magenta during an audit or inspection, or following Product release by Bachem's Quality Assurance Department, either onsite or on an electronic platform with restricted access rights only (as reasonably requested by Magenta), at a mutually agreeable time, all specific Batch and lot records relevant to Bachem's performance hereunder, including written investigations of any deviations and \"out-of-specification\" events that may have been generated from manufacturing, packaging, inspection, or testing processes.",
            "target": "No",
            "document_name": "Magenta Therapeutics, Inc. - Master Development and Manufacturing Agreement.PDF",
            "index": 545
        },
        {
            "input": "Valeant agrees to assign, and hereby does assign, to Dova (and shall cause its Affiliates and its and their respective employees and other representatives to assign to Dova) any and all right, title and interest that Valeant (or any such Affiliates, employees or other representatives) may have in or to any Invention.",
            "target": "No",
            "document_name": "DovaPharmaceuticalsInc_20181108_10-Q_EX-10.2_11414857_EX-10.2_Promotion Agreement.pdf",
            "index": 546
        },
        {
            "input": "In the event of the expiration of this Agreement or termination of this Agreement in whole or in part (including the termination of any Facility Addendum) by Customer in accordance with Section 7.3, 7.4, 7.5 or 7.6, Customer may, at its option within ninety (90) days immediately following the effective date of the expiration or termination of this Agreement, purchase any work in process and/or Product Materials that Manufacturer has purchased exclusively for Customer in accordance with this Agreement for the production of any terminated Product.",
            "target": "No",
            "document_name": "UpjohnInc_20200121_10-12G_EX-2.6_11948692_EX-2.6_Manufacturing Agreement_ Supply Agreement.pdf",
            "index": 547
        },
        {
            "input": "More particularly, said right and license to practice FCE Background Information and FCE Background Patents for Generation 2 Technology in any application outside of Carbon Capture Applications and Hydrogen Applications will include the right to use, reproduce, and create derivative works of FCE Background Information under applicable copyrights and the right to make, use, import, and sell or offer to sell under the claims of FCE Background Patents.",
            "target": "No",
            "document_name": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf",
            "index": 548
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, Todos hereby grants the Reseller a non-sublicensable, non-transferable, exclusive right to distribute and sell the Products to Customers in the Territory; provided, however, that Reseller may sub-license or transfer its distribution rights to a subsidiary or affiliate of the Reseller.",
            "target": "No",
            "document_name": "TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.pdf",
            "index": 549
        },
        {
            "input": "Magenta grants to Bachem a limited, non-exclusive license to use any Magenta Developed Intellectual Property to manufacture and release the Product for Magenta in accordance with the terms and conditions of this Agreement and any applicable Project Plan.",
            "target": "No",
            "document_name": "Magenta Therapeutics, Inc. - Master Development and Manufacturing Agreement.PDF",
            "index": 550
        },
        {
            "input": "EXCEPT WITH RESPECT TO THE PARTIES' LIABILITY FOR INDEMNIFICATION, OR LIABILITY FOR BREACH OF CONFIDENTIALITY, NEITHER PARTY SHALL BE LIABLE FOR ANY CONSEQUENTIAL, INCIDENTAL, INDIRECT, PUNITIVE, SPECIAL OR OTHER SIMILAR DAMAGES, WHETHER OR NOT CAUSED BY THE OTHER PARTY'S EMPLOYEES OR REPRESENTATIVES\u201e WHETHER UNDER TORT (INCLUDING NEGLIGENCE), CONTRACT OR OTHER THEORIES OF RECOVERY, EVEN IF THE OTHER PARTY WAS OR SHOULD HAVE BEEN AWARE OR WAS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 8. Arbitration.",
            "target": "No",
            "document_name": "KUBIENT,INC_07_02_2020-EX-10.14-MASTER SERVICES AGREEMENT_Part1.pdf",
            "index": 551
        },
        {
            "input": "We will have the right to observe the manner in which you are rendering your services and conducting your operations, to confer with your employees and customers, and to select Menu Items, ingredients, food and<omitted>non-food products, beverages, and other items, products, delivery vehicles, products and supplies for test of content and evaluation purposes to make certain that the Menu Items, ingredients, food and non-food products, beverages and other items, products, delivery vehicles, materials and supplies are satisfactory and meet our quality control provisions and performance standards.",
            "target": "No",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 552
        },
        {
            "input": "IN NO EVENT SHALL LICENSOR'S AGGREGATE CUMULATIVE TOTAL LIABILITY UNDER THIS AGREEMENT EXCEED ONE HALF OF THE AMOUNT PAID BY THE LICENSEE TO Licensor HEREUNDER.",
            "target": "No",
            "document_name": "SFGFINANCIALCORP_05_12_2009-EX-10.1-SOFTWARE LICENSE AND MAINTENANCE AGREEMENT.PDF",
            "index": 553
        },
        {
            "input": "The amount actually transferred from the Account to pay Royalty Fees and Advertising Fees will be based on the Franchise's gross revenues as reported in the Franchise's practice management software. If you have not properly input the Franchise's gross revenues for any reporting period, then we will be authorized to debit the Account in an amount equal to one hundred twenty percent (120%) of the Royalty Fee, Advertising Fee, and other amounts transferred from the Account for the last reporting period for which a report of the Franchise's gross revenues was provided to us.",
            "target": "No",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 554
        },
        {
            "input": "Boxlot hereby grants to theglobe a non-exclusive, worldwide license to use, reproduce, create derivative works of (only as necessary to build pages in a manner consistent with this Agreement), publicly display, publicly perform and digitally perform Boxlot Banners, and those elements of the Boxlot Content served from theglobe's servers (as denoted in Exhibit A), on theglobe Site or otherwise as reasonably appropriate to advertise and promote the Service and the Co-Branded Pages.",
            "target": "No",
            "document_name": "TheglobeComInc_19990503_S-1A_EX-10.20_5416126_EX-10.20_Co-Branding Agreement.pdf",
            "index": 555
        },
        {
            "input": "You must:<omitted>5.1.13 not engage, directly or indirectly, in any cross-marketing or cross-promotion of the Hotel with any Other Hotel or related business, without our prior written consent. You agree to refer guests and customers, wherever reasonably possible, only to System Hotels or Network Hotels.",
            "target": "No",
            "document_name": "HOSPITALITYINVESTORSTRUST,INC_04_07_2014-EX-10.26-FRANCHISE AGREEMENT.PDF",
            "index": 556
        },
        {
            "input": "JHU shall have the right to audit any and all Company records related to this Agreement.",
            "target": "No",
            "document_name": "VirtuosoSurgicalInc_20191227_1-A_EX1A-6 MAT CTRCT_11933379_EX1A-6 MAT CTRCT_License Agreement.pdf",
            "index": 557
        },
        {
            "input": "CONSULTANT agrees that during its consultancy for REIT and for a period of twelve (12) months immediately following the termination of its consultancy with the Company for any reason, whether with or without cause, it will not: (a) have any ownership interest in, or participate in the financing, operation, management or control of, any Competitor; or (b) engage in or perform services for any Competitor, if such services either (1) are the same as or similar to (individually or in the aggregate) the services CONSULTANT performed for the Company during its consultancy with the Company, or (2) are performed with respect to products or services of the Competitor that are competitive with the products or services provided by the Company with which CONSULTANT was involved during its consultancy with the Company or about which it received Proprietary Information during its consultancy with the Company.",
            "target": "No",
            "document_name": "MEDALISTDIVERSIFIEDREIT,INC_05_18_2020-EX-10.1-CONSULTING AGREEMENT.PDF",
            "index": 558
        },
        {
            "input": "Developer also shall carry such worker's compensation insurance as may be required by applicable law.",
            "target": "No",
            "document_name": "ElPolloLocoHoldingsInc_20200306_10-K_EX-10.16_12041700_EX-10.16_Development Agreement.pdf",
            "index": 559
        },
        {
            "input": "During the term of this Agreement and for a period [*] after any expiration or termination of this Agreement, each of INTERSECT and HOVIONE shall maintain in full force and effect a comprehensive general liability insurance policy, including Products Liability coverage, with minimum limits of [*] for bodily injury including death.",
            "target": "No",
            "document_name": "INTERSECTENT,INC_05_11_2020-EX-10.1-SUPPLY AGREEMENT.PDF",
            "index": 560
        },
        {
            "input": "Except as permitted pursuant to Article 13.1 hereof, neither Party shall assign or transfer this Agreement, or any and all related rights and obligations in the Joint Venture or all rights and all obligations in any related agreements, without the prior written consent of the other Party, which consent may not be unreasonably withheld or delayed; provided, however, any Party may assign any or all of its interests in this Agreement or the Operating Company to a wholly-owned subsidiary (which shall at all times remain a wholly-owned subsidiary, and such subsidiary may be a partnership, limited liability company, or corporation) or commonly-owned affiliate of Igene or T&L, as the case may be, provided that the ultimate parent company (e.g. Igene or T&L, as the case may be) shall guarantee such subsidiary's or affiliate's performance hereunder.",
            "target": "No",
            "document_name": "IGENEBIOTECHNOLOGYINC_05_13_2003-EX-1-JOINT VENTURE AGREEMENT.PDF",
            "index": 561
        },
        {
            "input": "In consideration of the remuneration to be paid to the NFLA-NC pursuant to this Agreement, the NFLA grants to Company and to its authorized distributors and sublicenses the right and license during the Contract Period to use the NFLA Identification solely in connection with the advertisement, marketing and promotion of the Products within the Contract Territory as set forth in this Agreement.",
            "target": "No",
            "document_name": "GridironBionutrientsInc_20171206_8-K_EX-10.1_10972555_EX-10.1_Endorsement Agreement.pdf",
            "index": 562
        },
        {
            "input": "The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor.",
            "target": "No",
            "document_name": "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.pdf",
            "index": 563
        },
        {
            "input": "Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of MusclePharm, its Products, and the Licensed Products.",
            "target": "No",
            "document_name": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.pdf",
            "index": 564
        },
        {
            "input": "In the event that the Software or eGain System is not Year 2000 Compliant, Customer's sole and exclusive remedy and eGain's sole and exclusive liability shall be for eGain, at no additional cost to Customer, to promptly modify the Software or the eGain System so that the Software or eGain System is Year 2000 Compliant.",
            "target": "No",
            "document_name": "WEBHELPCOMINC_03_22_2000-EX-10.8-HOSTING AGREEMENT.PDF",
            "index": 565
        },
        {
            "input": "Upon the entering into of the agreements referred to in Articles 3.5 and 3.6, the Operating Company shall capitalize the Manufacturing Company through the contribution of equity received by it from T&L pursuant to Article 3.1 in an amount equal to at least $21,614,000.",
            "target": "No",
            "document_name": "IGENEBIOTECHNOLOGYINC_05_13_2003-EX-1-JOINT VENTURE AGREEMENT.PDF",
            "index": 566
        },
        {
            "input": "Corio shall have the right to resell licenses for the Software to any Corio Customer according to the terms and conditions of Changepoint's standard Distribution Agreement (\"Changepoint's Distribution Agreement\").",
            "target": "No",
            "document_name": "CHANGEPOINTCORP_03_08_2000-EX-10.6-LICENSE AND HOSTING AGREEMENT.PDF",
            "index": 567
        },
        {
            "input": "Notwithstanding any other provision of this Agreement, Metavante's maximum liability with respect to any Professional Services performed shall be limited to the value of the Professional Services engagement giving rise to the claim for Damages.",
            "target": "No",
            "document_name": "OFGBANCORP_03_28_2007-EX-10.23-OUTSOURCING AGREEMENT.PDF",
            "index": 568
        },
        {
            "input": "The Company reserves the right in its sole and absolute discretion to give written notice to<omitted>terminate your employment forthwith and to make a payment to you in lieu of salary and the benefits set out in paragraph 5 of this Agreement for all or any unexpired part of the notice period.",
            "target": "No",
            "document_name": "BICYCLETHERAPEUTICSPLC_03_10_2020-EX-10.11-SERVICE AGREEMENT.PDF",
            "index": 569
        },
        {
            "input": "Further, Chase's aggregate liability arising under or with respect to this Agreement or the Affiliate Program shall in no event exceed the total Commissions paid or payable by Chase to Affiliate under this Agreement.",
            "target": "No",
            "document_name": "CreditcardscomInc_20070810_S-1_EX-10.33_362297_EX-10.33_Affiliate Agreement.pdf",
            "index": 570
        },
        {
            "input": "Client and its nominees, employees, agents and representatives shall have the right to enter upon and inspect, at all reasonable hours of the day, any and all such location(s) and to take, without payment, individual samples of any of the EFS Produced Merchandise and the Materials as Client reasonably requires for the purposes of such inspection.",
            "target": "No",
            "document_name": "PlayboyEnterprisesInc_20090220_10-QA_EX-10.2_4091580_EX-10.2_Content License Agreement_ Marketing Agreement_ Sales-Purchase Agreement1.pdf",
            "index": 571
        },
        {
            "input": "Inspections conducted under this Section 7.4 shall be at the expense of Array, unless a variation or error producing an underpayment in amounts payable exceeding [ * ] of the amount paid for a period covered by the inspection is established, in which case all reasonable costs relating to the inspection for such period and any unpaid amounts that are discovered shall be paid by Ono, together with interest on such unpaid amounts at the rate set forth in Section 7.1 above.",
            "target": "No",
            "document_name": "Array BioPharma Inc. - LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT.PDF",
            "index": 572
        },
        {
            "input": "Without limiting the terms set forth in Section 6.09 of the Separation Agreement, none of Nuance, SpinCo or any other member of either Group shall in any event have any Liability to the other or to any other member of the other's Group under this Agreement for any indirect, special, punitive or consequential damages, whether or not caused by or resulting from negligence or breach of obligations hereunder and whether or not informed of the possibility of the existence of such damages.",
            "target": "No",
            "document_name": "CerenceInc_20191002_8-K_EX-10.4_11827494_EX-10.4_Intellectual Property Agreement.pdf",
            "index": 573
        },
        {
            "input": "In addition to the foregoing, and subject to the terms and conditions of the applicable content agreement with such Licensor, COMPANY agrees to pay directly to each Licensor from whom CONTENT PROVIDER might obtain Content which CONTENT PROVIDER licenses to COMPANY pursuant hereto a royalty equal to that royalty which CONTENT PROVIDER might be obligated to pay to that Licensor with respect to the use and exploitation of that Content in the manner licensed to and actually used by COMPANY pursuant hereto provided, however, unless the Parties might agree in writing to the contrary, in no event will COMPANY be obligated to pay such Licensor for the use of such Content more than fifty percent (50.0%) of all revenues generated during the Term of this Agreement from banner advertising that appears on Web site pages that display that Content or any portion thereof and with respect to which at least a majority of the content (excluding advertisements) on such pages is composed of the Content (the \"Net Advertising Revenue\").",
            "target": "No",
            "document_name": "MidwestEnergyEmissionsCorp_20080604_8-K_EX-10.2_3093976_EX-10.2_Content License Agreement.pdf",
            "index": 574
        },
        {
            "input": "Upon the expiration or termination of either the Lease Agreement or the Franchise Agreement (attached), Lessor will cooperate with and assist Franchisor in securing possession of the Premises and if Franchisor does not elect to take an assignment of the Lessee's interest, Lessor will allow Franchisor to enter the Premises, without being guilty of trespass and without incurring any liability to Lessor, to remove all signs, awnings, and all other items identifying the Premises as a Franchised Business and to make other modifications (such as repainting) as are reasonably necessary to protect The Joint marks and system, and to distinguish the Premises from a Franchised Business.",
            "target": "No",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 575
        },
        {
            "input": "The term of this Agreement commences on the Effective Date and shall continue in effect until the later of (a) the fourth (4th) anniversary of the Effective Date, or (b) the completion or termination of the Research and receipt by LBIO of all deliverables due from MD Anderson hereunder, unless sooner terminated in accordance with the provisions of Section 2.2 or Section 9.14.",
            "target": "No",
            "document_name": "IOVANCEBIOTHERAPEUTICS,INC_08_03_2017-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 576
        },
        {
            "input": "MediWound shall have the right, for a period of [***] days following receipt, to reject any Bromelain SP sample which: 6.4.1 fails to comply with MediWound's purchase order; or 6.4.2 fails to comply with the sample incoming inspection Specifications.",
            "target": "No",
            "document_name": "MEDIWOUNDLTD_01_15_2014-EX-10.6-SUPPLY AGREEMENT.PDF",
            "index": 577
        },
        {
            "input": "For the avoidance of doubt, the license granted to Bellicum under this Section 10.2 conveys no right to Bellicum, its Subcontractors or Licensees to use Miltenyi Technology to make, have made, import, have imported, offer for sale and/or sell any Miltenyi Product.",
            "target": "No",
            "document_name": "BELLICUMPHARMACEUTICALS,INC_05_07_2019-EX-10.1-Supply Agreement.PDF",
            "index": 578
        },
        {
            "input": "If we conduct an inspection because you did not timely provide sales reports to us, or if an inspection discloses that you understated your sales, in any report to us (and/or underpaid your royalties), by three percent (3%) or more, or if you did not maintain and/or provide us with access to your records, then you agree (in addition to paying us the overdue amount and interest) to reimburse us for any and all costs and expenses we incur in connection with the inspection (including travel, lodging and wages expenses, and reasonable accounting and legal costs).",
            "target": "No",
            "document_name": "GOOSEHEADINSURANCE,INC_04_02_2018-EX-10.6-Franchise Agreement.PDF",
            "index": 579
        },
        {
            "input": "In the event that the Servicer resigns or is terminated hereunder, the Servicer shall use its commercially reasonable efforts to and shall cooperate with the Owner and take other reasonable steps requested by the Owner to assist in the orderly and efficient transfer of the administration of the Serviced Assets to the successor Servicer.",
            "target": "No",
            "document_name": "CUROGROUPHOLDINGSCORP_05_04_2020-EX-10.3-SERVICING AGREEMENT.PDF",
            "index": 580
        },
        {
            "input": "Network Affiliate may not assign or transfer, by operation of law or otherwise, any of its rights under this Agreement or delegate any of its duties under this Agreement to any third party without NCM's prior written consent, which consent shall not be unreasonably withheld, conditioned or delayed.",
            "target": "No",
            "document_name": "DigitalCinemaDestinationsCorp_20111220_S-1_EX-10.10_7346719_EX-10.10_Affiliate Agreement.pdf",
            "index": 581
        },
        {
            "input": "At any given time during this Agreement, Schoolpop's inactive Card inventory shall be limited to $3,000,000 in Card value as determined by the Point denomination on each Card.",
            "target": "No",
            "document_name": "LOYALTYPOINTINC_11_16_2004-EX-10.2-RESELLER AGREEMENT.PDF",
            "index": 582
        },
        {
            "input": "Such Party shall keep the JSC and the other Party informed of the status of all such Patent Prosecution and Trademark Prosecution activities. MacroGenics shall be responsible for undertaking the Patent Prosecution with respect to Patents jointly owned by the Parties (the \"Jointly Owned Patents\"), and shall do as directed by the JSC.",
            "target": "No",
            "document_name": "MACROGENICSINC_08_02_2013-EX-10-COLLABORATION AGREEMENT.PDF",
            "index": 583
        },
        {
            "input": "Any assignment or attempt to assign, or any delegation or attempt to delegate, not in accordance with this Section shall be void and without effect.",
            "target": "No",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 584
        },
        {
            "input": "This Agreement shall automatically terminate in the event the Management Agreement is assigned or otherwise terminated.",
            "target": "No",
            "document_name": "PFSFUNDS_06_26_2020-EX-99.H OTH MAT CONT-SERVICES AGREEMENT.PDF",
            "index": 585
        },
        {
            "input": "Except as provided in this Section 13.2, this Agreement may not be assigned or otherwise transferred, nor may any rights or obligations hereunder be assigned or transferred, by either Party, without the written consent of the other Party (such consent not to be unreasonably withheld); provided that a merger, sale of stock or comparable transaction shall not constitute an assignment.",
            "target": "No",
            "document_name": "DovaPharmaceuticalsInc_20181108_10-Q_EX-10.2_11414857_EX-10.2_Promotion Agreement.pdf",
            "index": 586
        },
        {
            "input": "This Agreement will be construed in accordance with and governed by the laws of the State of California, without regard to principles of conflicts of law.",
            "target": "No",
            "document_name": "CYBERIANOUTPOSTINC_07_09_1998-EX-10.13-PROMOTION AGREEMENT.PDF",
            "index": 587
        },
        {
            "input": "Vendor shall maintain commercial general liability (CGL) insurance with a limit of not less than $1 million each occurrence.",
            "target": "No",
            "document_name": "CURAEGISTECHNOLOGIES,INC_05_26_2010-EX-1-CORPORATE SPONSORSHIP AGREEMENT.PDF",
            "index": 588
        },
        {
            "input": "If a Product fails to comply with the foregoing warranty, the relevant Supplier shall, at its option, either [***]such Product, or, in the event the foregoing options are not commercially practicable, [***]to the Company any amounts paid for the applicable Product.",
            "target": "No",
            "document_name": "PhotronicsInc_20171219_10-QA_EX-10.28_10982650_EX-10.28_Outsourcing Agreement.pdf",
            "index": 589
        },
        {
            "input": "Each Significant Subsidiary that is required to be organized or licensed as an insurance company in its jurisdiction of incorporation (each, an \"Insurance Subsidiary\" and collectively, the \"Insurance Subsidiaries\") is licensed<omitted>as an insurance company in its respective jurisdiction of incorporation and is duly licensed or authorized as an insurer in each other jurisdiction where it is required to be so licensed or authorized to conduct its business, in each case with such exceptions as would not have, individually or in the aggregate, a Material Adverse Effect; except as otherwise described in the Disclosure Package, each Insurance Subsidiary has all other approvals, orders, consents, authorizations, licenses, certificates, permits, registrations and qualifications (collectively, the \"Approvals\") of and from all insurance regulatory authorities to conduct its business, with such exceptions as would not have, individually or in the aggregate, a Material Adverse Effect; there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or investigation that could reasonably be expected to lead to any revocation, termination or suspension of any such Approval, the revocation, termination or suspension of which would have, individually or in the aggregate, a Material Adverse Effect; and, to the knowledge of the Company, no insurance regulatory agency or body has issued any order or decree impairing, restricting or prohibiting the payment of dividends by any Insurance Subsidiary to its parent which would have, individually or in the aggregate, a Material Adverse Effect.",
            "target": "No",
            "document_name": "MetLife, Inc. - Remarketing Agreement.PDF",
            "index": 590
        },
        {
            "input": "The deposit accounts of the Bank are insured by the FDIC up to the applicable limits, and upon consummation of the Conversion, the liquidation accounts for the benefit of Eligible Account Holders will be duly established in accordance with the requirements of the Massachusetts Regulations.",
            "target": "No",
            "document_name": "BLUEHILLSBANCORP,INC_05_20_2014-EX-1.1-AGENCY AGREEMENT.PDF",
            "index": 591
        },
        {
            "input": "This Agreement and all rights and duties hereunder are personal to Diplomat and shall not, without the written consent of KI, Inc., be assigned, mortgaged, sublicensed or otherwise encumbered by Diplomat or by operation of law.",
            "target": "No",
            "document_name": "AMBASSADOREYEWEARGROUPINC_11_17_1997-EX-10.28-ENDORSEMENT AGREEMENT.PDF",
            "index": 592
        },
        {
            "input": "CSA shall have the right to request an independent audit of the sales of the Product containing the Property which the Company agrees to assist within a reasonable period of time of such request.",
            "target": "No",
            "document_name": "LegacyEducationAllianceInc_20141110_8-K_EX-10.9_8828866_EX-10.9_Endorsement Agreement.pdf",
            "index": 593
        },
        {
            "input": "In reliance upon the application and information furnished by the Franchisee, and subject to the terms and conditions contained in this Agreement, BKC grants to the Franchisee a license to use the Burger King System and the Burger King Marks in the operation of a Burger King Restaurant at that Location.",
            "target": "No",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 594
        },
        {
            "input": "Distributor shall not sell or otherwise transfer any of the rights granted pursuant to this Agreement to any third party without the prior written consent of Vendor; provided, however, Distributor may enter into distribution arrangements with regional distributors within the Territory in its efforts to promote, advertise and distribute the Products in accordance with this Agreement;",
            "target": "No",
            "document_name": "ENTERTAINMENTGAMINGASIAINC_02_15_2005-EX-10.5-DISTRIBUTOR AGREEMENT.PDF",
            "index": 595
        },
        {
            "input": "Any subcontractor, including any Permitted Third Party, who provides professional services to such Party for the Clinical Trials, will obtain Professional Liability Insurance in lieu of Clinical Trial Insurance, with a minimum limit of [***] dollars ($[***]) per occurrence.",
            "target": "No",
            "document_name": "PhasebioPharmaceuticalsInc_20200330_10-K_EX-10.21_12086810_EX-10.21_Development Agreement.pdf",
            "index": 596
        },
        {
            "input": "The Owner Trustee and the Indenture Trustee, for the benefit of the Secured Parties, will be third-party beneficiaries of this Agreement and may enforce this Agreement against the Depositor and the Servicer.",
            "target": "No",
            "document_name": "VerizonAbsLlc_20200123_8-K_EX-10.4_11952335_EX-10.4_Service Agreement.pdf",
            "index": 597
        },
        {
            "input": "This Agreement shall begin on the Effective Date and shall continue until December 31, 2020, unless extended or earlier terminated.",
            "target": "No",
            "document_name": "ADUROBIOTECH,INC_06_02_2020-EX-10.7-CONSULTING AGREEMENT.PDF",
            "index": 598
        },
        {
            "input": "As of the Termination Date, EFS shall not process any new orders placed through the Playboy Commerce Business. Notwithstanding the foregoing, EFS may fulfill any outstanding orders placed through the Playboy Commerce Business prior to the Termination Date and may continue collection activities related thereto, which shall be subject to Section 6 hereof.",
            "target": "No",
            "document_name": "PlayboyEnterprisesInc_20090220_10-QA_EX-10.2_4091580_EX-10.2_Content License Agreement_ Marketing Agreement_ Sales-Purchase Agreement1.pdf",
            "index": 599
        },
        {
            "input": "PB will notify SFJ in writing promptly (and in any event within [***]) following the entering into of a definitive agreement with respect to a Change of Control of PB.",
            "target": "No",
            "document_name": "PhasebioPharmaceuticalsInc_20200330_10-K_EX-10.21_12086810_EX-10.21_Development Agreement.pdf",
            "index": 600
        },
        {
            "input": "Should the price of fuel delivered to the Lima Project be above the Price Basis, the commission will be reduced on a sliding scale according to the following formula: C= BC+(PB-PI)*0.1094 Where: C = commission BC = Base Commission PI = price invoiced per MMBTU PB = Price Basis per MMBTU",
            "target": "No",
            "document_name": "USASYNTHETICFUELCORP_10_21_2010-EX-10.10-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 601
        },
        {
            "input": "Notwithstanding the provisions of Section 1 hereof, the Sponsor shall have the right at any time prior to December 31, 2010 to terminate this Agreement by giving written notice of such termination to Racing.",
            "target": "No",
            "document_name": "GAINSCOINC_01_21_2010-EX-10.41-SPONSORSHIP AGREEMENT.PDF",
            "index": 602
        },
        {
            "input": "Kitov shall have the right (at reasonable intervals, with reasonable prior written notice and during normal business hours, and not more often than annually) to inspect Dexcel's manufacturing facilities used in the manufacture, storage, testing, and/or release for shipment of the Product.",
            "target": "No",
            "document_name": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement.pdf",
            "index": 603
        },
        {
            "input": "Subject to Licensee's on\u00adgoing compliance with Section 3.2 and all other terms and conditions of this Agreement, Licensor grants to Licensee an exclusive (save for rights reserved to Licensor hereunder), non-transferable (except as provided in Section 11.7) and non- sublicensable license, during the License Term, to reproduce, perform, display, transmit and distribute the Licensed Content on the Licensee Siteand Related Media intended solely for use by End Usersin the Territory within the scope set forth in Schedule 1 (License Scope), which is attached hereto and incorporated herein by this reference.",
            "target": "No",
            "document_name": "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.pdf",
            "index": 604
        },
        {
            "input": "An accountant registered in China and independent of any Party shall be engaged by and at the expense of the Joint Venture Company as its auditor to examine and verify the Joint Venture Company's annual financial statements and report.",
            "target": "No",
            "document_name": "VALENCETECHNOLOGYINC_02_14_2003-EX-10-JOINT VENTURE CONTRACT.PDF",
            "index": 605
        },
        {
            "input": "This Agreement shall be governed by and construed in accordance with the laws of the State of California without regard to its conflict of laws provisions.",
            "target": "No",
            "document_name": "VIOLINMEMORYINC_12_12_2012-EX-10.14-SPONSORSHIP AGREEMENT.PDF",
            "index": 606
        },
        {
            "input": "Except as expressly set forth herein, ISO shall not assign or otherwise transfer this Agreement or any of its rights or obligations hereunder, by operation of law or otherwise, or contract with any third party (other than the third parties named herein) to perform any of its responsibilities or obligations relating to this Agreement without the prior written consent of SERVICERS, which consent will not be unreasonably withheld.",
            "target": "No",
            "document_name": "IPAYMENT,INC_05_14_2007-EX-10.1-SPONSORSHIP AGREEMENT.PDF",
            "index": 607
        },
        {
            "input": "After Fox or its assigns deducts its Distribution Fee, it shall remit the remainder to Licensee and Licensee shall pay to Fox or its assigns or such other party as Fox or its assigns may designate in writing, Royalties in the amounts set forth in the Agreement or this Amendment.",
            "target": "No",
            "document_name": "GluMobileInc_20070319_S-1A_EX-10.09_436630_EX-10.09_Content License Agreement2.pdf",
            "index": 608
        },
        {
            "input": "If you propose to Transfer this Agreement, the Franchise or its assets, or any Interest, or if any of your Principal Owners proposes to Transfer a controlling Interest in you or make a Transfer that is one of a series of Transfers which taken together would constitute the Transfer of a controlling Interest in you, then all of the following conditions must be met before or at the time of the Transfer: (a) the Proposed New Owner must have sufficient business experience, aptitude, and financial resources to operate the Franchise; (b) you must pay any amounts owed for purchases from us and our affiliates, and any other amounts owed to us or our affiliates which are unpaid; (c) the Proposed New Owner's directors and such other personnel as we may designate must have successfully completed our Initial Training program, and shall be legally authorized and have all licenses necessary to perform the services offered by the Franchise. The Proposed New Owner shall be responsible for any wages and compensation owed to, and the travel and living expenses (including all transportation costs, room, board and meals) incurred by, the attendees who attend the Initial Training program; (d) if your lease for the Premises requires it, the lessor must have consented to the assignment of the lease of the Premises to the Proposed New Owner; (e) you (or the Proposed New Owner) must pay us a Transfer fee equal to seventy-five percent (75%) of the then current initial franchise fee we charge to new Start-up Location franchisees, and must reimburse us for any reasonable expenses incurred by us in investigating and processing any Proposed New Owner where the Transfer is not consummated for any reason; (f) you and your Principal Owners and your and their spouses must execute a general release (in a form satisfactory to us) of any and all claims you and/or they may have against us, our affiliates, and our and our affiliates' respective officers, directors, employees, and agents;<omitted>(g) we must approve the material terms and conditions of the proposed Transfer, including without limitation that the price and terms of payment are not so burdensome as to adversely affect the operation of the Franchise; (h) the Franchise and the Premises shall have been placed in an attractive, neat and sanitary condition; (i) you and your Principal Owners must enter into an agreement with us providing that all obligations of the Proposed New Owner to make installment payments of the purchase price (and any interest on it) to you or your Principal Owners will be subordinate to the obligations of the Proposed New Owner to pay any amounts payable under this Agreement or any new Franchise Agreement that we may require the Proposed New Owner to sign in connection with the Transfer; (j) you and your Principal Owners must enter into a non-competition agreement wherein you agree not to engage in a competitive business for a period of two (2) years after the Transfer and within twenty-five (25) miles of your Franchise Premises or any other The Joint Corp. Location franchise location; (k) the Franchise shall have been determined by us to contain all equipment and fixtures in good working condition, as were required at the initial opening of the Franchise. The Proposed New Owner shall have agreed, in writing, to make such reasonable capital expenditures to remodel, equip, modernize and redecorate the interior and exterior of the premises in accordance with our then existing plans and specifications for a The Joint Corp. Location franchise, and shall have agreed to pay our expenses for plan preparation or review, and site inspection; (l) upon receiving our consent for the Transfer or sale of the Franchise, the Proposed New Owner shall agree to assume all of your obligations under this Agreement in a form acceptable to us, or, at our option, shall agree to execute a new Franchise Agreement with us in the form then being used by us. We may, at our option, require that you guarantee the performance, and obligations of the Proposed New Owner; and (m) you must have properly offered us the opportunity to exercise our right of first refusal as described below, and we must have then declined to exercise it.",
            "target": "No",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 609
        },
        {
            "input": "All insurers of a Party on such policies must have at all times an A.M. Best financial rating of at least \"A-Minus VII\".",
            "target": "No",
            "document_name": "ReynoldsConsumerProductsInc_20191115_S-1_EX-10.18_11896469_EX-10.18_Supply Agreement.pdf",
            "index": 610
        },
        {
            "input": "This Section states the entire obligation of Cisco and its suppliers, and the exclusive remedy of Distributor, in respect of any infringement or alleged infringement of any intellectual property rights or proprietary rights.",
            "target": "No",
            "document_name": "ScansourceInc_20190822_10-K_EX-10.38_11793958_EX-10.38_Distributor Agreement1.pdf",
            "index": 611
        },
        {
            "input": "Dolphin will provide photo-editing services exclusively, at DGT option, when the number of downloaded photos to be edited by Dolphin totals 50,000 in a single year;",
            "target": "No",
            "document_name": "HUBEIMINKANGPHARMACEUTICALLTD_09_19_2006-EX-10.1-OUTSOURCING AGREEMENT.PDF",
            "index": 612
        },
        {
            "input": "\"Distribution Term\" means the period commencing on the first Regulatory Approval of the Product in the Territory and continuing until [***], or if this Agreement is terminated earlier pursuant to Article 12, the effective date of such termination.<omitted>At any time following the expiration of the Distribution Term (as defined in Section 1.17), the Distributor may terminate this Agreement at will upon [***] prior written notice to Zogenix.",
            "target": "No",
            "document_name": "ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement.pdf",
            "index": 613
        },
        {
            "input": "All such photographs shall be deemed Playboy Content for purposes of this Agreement, for which EFS shall have a license to use during the Term solely in connection with the Playboy Commerce Business and as is necessary to promote the Websites.",
            "target": "No",
            "document_name": "PlayboyEnterprisesInc_20090220_10-QA_EX-10.2_4091580_EX-10.2_Content License Agreement_ Marketing Agreement_ Sales-Purchase Agreement1.pdf",
            "index": 614
        },
        {
            "input": "After the expiration of the Term or termination pursuant to Section 8.4 by either Party or Section 8.6 by Exact, based on cumulative Incremental Laboratory Services Revenue achieved during the Term or up to the termination date, Exact agrees to pay Pfizer the applicable royalty payment set forth below for twelve (12) consecutive Calendar Quarters following the expiration of the Term (the \"Tail Period\"); provided, however, the Tail Period shall be reduced to the number of full Calendar Quarters completed during the Term if less than twelve (12) Calendar Quarters if either Party terminates the Agreement without cause pursuant to Section 8.4 or Exact terminates as a result of a Change of Control pursuant to Section 8.6.",
            "target": "No",
            "document_name": "ExactSciencesCorp_20180822_8-K_EX-10.1_11331629_EX-10.1_Promotion Agreement.pdf",
            "index": 615
        },
        {
            "input": "In addition, from time to time during the Term, each Party shall increase their levels of insurance coverage if reasonably deemed prudent by such Party in light of the overall products supplied and/or activities performed under this Agreement.",
            "target": "No",
            "document_name": "BELLICUMPHARMACEUTICALS,INC_05_07_2019-EX-10.1-Supply Agreement.PDF",
            "index": 616
        },
        {
            "input": "This Agreement shall not be assignable by either Party, except with the written consent of the other Party hereto; provided, however, that either Party may assign this Agreement without the other Party's consent to an acquiring party in connection with the transfer or sale of all or substantially all of the business of such Party to which this Agreement relates to such acquiring party, whether by merger, sale of stock, sale of assets or otherwise, provided that in the event of such a sale or transfer (whether this Agreement is actually assigned or is assumed by the acquiring party by operation of law (e.g,. in the context of a reverse triangular merger)).",
            "target": "No",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 617
        },
        {
            "input": "On sales of products pursuant to this Agreement (less any returns) TL will pay to Integrity royalties in the amount of [**]/1/ ($[**]/1/) for each and every unit of the product sold by it pursuant to this Agreement.",
            "target": "No",
            "document_name": "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.pdf",
            "index": 618
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, as of the Distribution Date, Nuance hereby grants to SpinCo and the members of the SpinCo Group a worldwide, non-exclusive, fully paid-up, perpetual and irrevocable, transferable (subject to ARTICLE VIII), sublicensable (subject to Section 3.01(g)) license to continue to use any Nuance IP (other than Nuance Patents, Nuance Technology Assets, Nuance Trademarks and Nuance Data), in each case solely as and to the extent that it is used by the SpinCo Group in connection with products and services of the SpinCo Business within the SpinCo Field of Use, together with natural extensions and evolutions thereof.",
            "target": "No",
            "document_name": "CerenceInc_20191002_8-K_EX-10.4_11827494_EX-10.4_Intellectual Property Agreement.pdf",
            "index": 619
        },
        {
            "input": "The license granted to the Licensee under this Agreement shall continue perpetually",
            "target": "No",
            "document_name": "NmfSlfIInc_20200115_10-12GA_EX-10.5_11946987_EX-10.5_Trademark License Agreement.pdf",
            "index": 620
        },
        {
            "input": "THE LIABILITY OF EITHER PARTY FOR DAMAGES OR ALLEGED DAMAGES HEREUNDER (EXCEPT UNDER SECTIONS 15 AND 16), WHETHER IN CONTRACT, TORT OR ANY OTHER LEGAL THEORY, IS LIMITED TO, AND WILL NOT EXCEED, THE AMOUNTS TO BE PAID BY CLIENT TO INTUIT HEREUNDER.",
            "target": "No",
            "document_name": "STAMPSCOMINC_06_24_1999-EX-10.18-SPONSORSHIP AGREEMENT.PDF",
            "index": 621
        },
        {
            "input": "At the reasonable written request of Bellicum during the Term, Miltenyi shall enter into a direct supply agreement for Miltenyi Products with any Licensee nominated by Bellicum, materially consistent with the terms and conditions of this Agreement and the Quality Agreement (as applicable), except as agreed otherwise in writing between Miltenyi and the respective Bellicum Licensee.",
            "target": "No",
            "document_name": "BELLICUMPHARMACEUTICALS,INC_05_07_2019-EX-10.1-Supply Agreement.PDF",
            "index": 622
        },
        {
            "input": "Network hereby grants to Affiliate the exclusive right via Broadcast Television, and Affiliate hereby accepts such exclusive right and the obligation during the Term to broadcast the Service via Broadcast Television (i) over the transmission facilities of each Station identified on Exhibit A, which is licensed by the FCC to serve the community for each such Station (the \"Licensed Community\"), for receipt by TV Households in the DMA in which the Licensed Community is located, as such DMA is identified on Exhibit A, and (ii) over the transmission facilities of any Acquired Station, except to the extent that, as of the date Affiliate notifies Network in writing of its binding agreement to acquire such Acquired Station, (A) another Broadcast Television station in the same DMA as the Acquired Station has exclusive rights to broadcast the Service, or (B) the Acquired Station is obligated to broadcast other material that precludes it from also carrying the Service",
            "target": "No",
            "document_name": "TubeMediaCorp_20060310_8-K_EX-10.1_513921_EX-10.1_Affiliate Agreement.pdf",
            "index": 623
        },
        {
            "input": "The Minimum Cumulative Purchase Commitments for each of Contract Years [***] are binding commitments.",
            "target": "No",
            "document_name": "BERKELEYLIGHTS,INC_06_26_2020-EX-10.12-COLLABORATION AGREEMENT.PDF",
            "index": 624
        },
        {
            "input": "NCB agrees that NPC may use NCB's name and its BIN, ICA and any other Visa and MasterCard identification numbers to the extent necessary or appropriate to perform the Merchant Processing Services.",
            "target": "No",
            "document_name": "NATIONALPROCESSINGINC_07_18_1996-EX-10.4-SPONSORSHIP AGREEMENT.PDF",
            "index": 625
        },
        {
            "input": "This Agreement will automatically be renewed for periods of twelve (12) months unless either Party gives six (6) months written notice of its intent to terminate this Agreement.",
            "target": "No",
            "document_name": "MANUFACTURERSSERVICESLTD_06_05_2000-EX-10.14-OUTSOURCING AGREEMENT.PDF",
            "index": 626
        },
        {
            "input": "This Agreement shall not be assignable by either party to any third party without the written consent of the other party hereto; except that either party may assign this Agreement without the other party's consent to an entity that acquires substantially all of the business or assets of the assigning party within the Field, in each case whether by merger, transfer of assets, or otherwise.",
            "target": "No",
            "document_name": "FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.PDF",
            "index": 627
        },
        {
            "input": "Party A will deduct the expenses for fee collection at 15% (or the actual fee collection expense rate if such actual rate exceeds 15%) as provided in the agreement executed with the fee collection agent.",
            "target": "No",
            "document_name": "IDREAMSKYTECHNOLOGYLTD_07_03_2014-EX-10.39-Cooperation Agreement on Mobile Game Business.PDF",
            "index": 628
        },
        {
            "input": "For purposes of this Section 4.4, a \"Change of Control\" shall mean any transaction or series of related transactions that results in (including by way of merger or consolidation), or that is in connection with, the Village Media Company no longer being controlled (as defined in Section 1.2) by or under common control (as defined in Section 1.2) with HOFV.",
            "target": "No",
            "document_name": "GpaqAcquisitionHoldingsInc_20200123_S-4A_EX-10.6_11951677_EX-10.6_License Agreement.pdf",
            "index": 629
        },
        {
            "input": "Commencing six (6) months prior to the expiration of the Term of this Agreement, or upon any termination of this Agreement for any reason, M&I shall provide Customer, at Customer's expense, all necessary assistance to allow the Services to continue without interruption or adverse affect to Customer and to facilitate the orderly transition of Services to Customer or its designee (\"Termination Assistance\").",
            "target": "No",
            "document_name": "TRICITYBANKSHARESCORP_05_15_1998-EX-10-OUTSOURCING AGREEMENT.PDF",
            "index": 630
        },
        {
            "input": "The foregoing shall not preclude either party from employing any such employee (a) who seeks employment with the other party in response to any general advertisement or solicitation that is not specifically directed towards employees of such party or (b) who contacts the other party on his or her own initiative without any direct or indirect solicitation by such party.",
            "target": "No",
            "document_name": "OFGBANCORP_03_28_2007-EX-10.23-OUTSOURCING AGREEMENT.PDF",
            "index": 631
        },
        {
            "input": "If M&I terminates this Agreement following an Event of Default on the part of Customer, or if Customer terminates this Agreement in accordance with Section 11.1 above without complying with the notification requirements set forth in Section 11.1, then Customer shall pay M&I a termination fee (\"Termination for Cause Fee\") in an amount equal to REDACTED of the Estimated Remaining Value, payable as set forth in Section 11.1 above.",
            "target": "No",
            "document_name": "TRICITYBANKSHARESCORP_05_15_1998-EX-10-OUTSOURCING AGREEMENT.PDF",
            "index": 632
        },
        {
            "input": "Franchisee also acknowledges that Pretzel Time has granted the Franchise to Franchisee in consideration of and reliance upon Franchisee's agreement to deal exclusively with Pretzel Time. Franchisee therefore agrees that during the term of the Franchise Agreement, or the period of time which Franchisee operates a Unit under this Agreement, whichever is shorter, neither Franchisee nor any Affiliate, immediate family member, or in the event Franchisee is a corporation any Owner thereof and member of his immediate family or in the event Franchise is a partnership any partner (general or limited) thereof and any member of his immediate family, shall: (1) Have any direct or indirect interest as an owner, investor, partner, director, officer, employee, consultant, representative, agent or in any other capacity in any Competitive Business located or operating at the Site or within three (3) miles of any Pretzel Time Unit in operation or under development on the effective date of termination or expiration of this Agreement, except a Pretzel Time Unit operated by Franchisee under Franchise Agreements with Pretzel Time; or (2) Recruit or hire any employee who, within the immediately preceding six (6) month period, was employed by Pretzel Time or any Pretzel Time Unit operated by Pretzel Time, its Affiliates or another franchisee or licensee of Pretzel Time, without obtaining the prior written permission of Pretzel Time or such franchisee.",
            "target": "No",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 633
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, XSPA hereby grants to Calm, solely during the Term and in the Territory, a revocable (as set forth in \u200bSection \u200b\u200b12.04), royalty-free, assignable (solely as set forth in Section \u200b16.05), non-sublicensable (except as set forth in Section \u200b9.03), non-exclusive license to use the marks set forth on Exhibit E (\"XSPA's Marks\", and together with Calm's Marks, the \"Marks\"), solely to the extent necessary for Calm to exercise its rights or perform its obligations set forth in this Agreement.",
            "target": "No",
            "document_name": "XpresspaGroupInc_20190401_10-K_EX-10.28_11599457_EX-10.28_Marketing Agreement.pdf",
            "index": 634
        },
        {
            "input": "The Professional hereby grants to the Company an exclusive license to use her name, likeness, image and personal identification, singly or in any combination, in connection with the production, use, marketing and sale of a \"Kathy Whitworth\" signature line of women's golf clubs (the \"Products\"), as described more fully in Section 3 below.",
            "target": "No",
            "document_name": "WOMENSGOLFUNLIMITEDINC_03_29_2000-EX-10.13-ENDORSEMENT AGREEMENT.PDF",
            "index": 635
        },
        {
            "input": "This Agreement shall not be assignable by either party unless the assignee expressly assumes in writing the obligations of the assignor hereunder.",
            "target": "No",
            "document_name": "DigitalCinemaDestinationsCorp_20111220_S-1_EX-10.10_7346719_EX-10.10_Affiliate Agreement.pdf",
            "index": 636
        },
        {
            "input": "This Agreement shall become effective on the date on which it is signed and affixed with the corporate seals by the authorized representative of each Party and have a term of five (5) years commencing as of the effective date hereof.<omitted>November 24, 2009",
            "target": "No",
            "document_name": "PhoenixNewMediaLtd_20110421_F-1_EX-10.17_6958322_EX-10.17_Content License Agreement.pdf",
            "index": 637
        },
        {
            "input": "Upon reasonable prior notice of the other Party, but in any event at least [***] prior notice, each Party shall and shall cause its Affiliates and its and their Sublicensees to permit an independent auditor of international prominence, selected by the auditing Party and reasonably acceptable to the audited Party, to audit the books and records maintained pursuant to Section 9.8 for the sole purpose of verifying for the auditing Party the accuracy of the financial reports furnished by the audited Party pursuant to this Agreement or of any payments made, or required to be made, by or to the audited Party pursuant to this Agreement or any Ancillary Agreement. Such audit shall not occur more than [***] in a given Calendar Year, unless for cause, and shall not concern books and records relating to a period more than [***] preceding the current Calendar Year.",
            "target": "No",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 638
        },
        {
            "input": "Each Party will have the right, upon reasonable notice to the other Party, to visit any location where RESEARCH PROJECT activities are conducted for the purposes of evaluating RESEARCH PROJECT progress and outcomes, and particularly to make observations of any plants in growth chambers, greenhouses or fields that are a part of a RESEARCH<omitted>PROJECT.",
            "target": "No",
            "document_name": "CERES,INC_01_25_2012-EX-10.20-Collaboration Agreement.PDF",
            "index": 639
        },
        {
            "input": "This Agreement and any amendments thereto shall be construed according to the laws of the State of Colorado without regard to conflicts of law principles and any disputes hereunder shall be litigated in a state court in Colorado.",
            "target": "No",
            "document_name": "GRIDIRONBIONUTRIENTS,INC_02_05_2020-EX-10.3-SUPPLY AGREEMENT.PDF",
            "index": 640
        },
        {
            "input": "The Services Term of this Agreement shall be automatically renewed for successive two-year terms thereafter unless written notice is given by either party to the other, indicating that party's intention not to renew the Services Term of this Agreement, at least ninety (90) days prior to the end of the initial Services Term or any renewed Services Term.",
            "target": "No",
            "document_name": "EmeraldHealthBioceuticalsInc_20200218_1-A_EX1A-6 MAT CTRCT_11987205_EX1A-6 MAT CTRCT_Development Agreement.pdf",
            "index": 641
        },
        {
            "input": "The audit will be conducted at the expense of Pretzel Time, provided that if an audit disclosed an understatement of two percent (2%), as described above, Franchisee will bear the cost of the audit, including without limitation, the charges of attorneys and any independent accountants, their travel expenses, room and board, and compensation of Pretzel Time's representatives and independent accountants.",
            "target": "No",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 642
        },
        {
            "input": "The Parties shall reasonably cooperate in good faith to effect the transition to Janssen of all Product promotional activities to minimize disruptions to customers and patients.",
            "target": "No",
            "document_name": "IMMUNOMEDICSINC_08_07_2019-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 643
        },
        {
            "input": "Joint Improvements shall be owned jointly by the Parties, and PPI's interest therein shall be licensed to EKR hereunder.",
            "target": "No",
            "document_name": "PACIRA PHARMACEUTICALS, INC. - A&R STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT .PDF",
            "index": 644
        },
        {
            "input": "And Distributor, taken as a whole, shall be liable for physical damage to Airspan's property resulting from Distributor's negligence under or in connection with this Agreement up to a maximum aggregate amount of one million US Dollars (US$1,000,000).",
            "target": "No",
            "document_name": "AIRSPANNETWORKSINC_04_11_2000-EX-10.5-Distributor Agreement.PDF",
            "index": 645
        },
        {
            "input": "Aimmune shall procure and maintain insurance, including clinical trials insurance and product liability insurance, adequate to cover its obligations hereunder and which is consistent with normal business practices of prudent companies similarly situated at all times during which the Product is being clinically tested in human subjects or commercially distributed or sold by Aimmune pursuant to this Agreement; provided, that any such clinical trials insurance coverage shall, prior to the First Commercial Sale of a Product, in no event be less than [***] Dollars ($[***]) per loss occurrence, and product liability insurance coverage shall, after such First Commercial Sale, in no event be less than [***] Dollars ($[***]) per loss occurrence.",
            "target": "No",
            "document_name": "AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement.pdf",
            "index": 646
        },
        {
            "input": "If a Buyer receives a product that fails to conform to these representations and warranties, the sole remedies of Buyer for the breach of warranty will be to: (1) reject and return the non-conforming product to Seller for a refund or credit, or a replacement conforming product, in the manner and time period provided in the SOP; (2) obtain reimbursement from Seller for actual, reasonable, substantiated out-of-pocket expenses incurred by Buyer in the recovery, return or disposal of a non-conforming product that is the subject of a mandatory product recall required under Applicable Laws or a voluntary withdrawal declared by Seller or approved by Seller (such approval not to be unreasonably withheld, conditioned or delayed); and (3) obtain indemnification from Seller for any Indemnified Claim arising from or related to the non-conforming product as provided in Section 7.",
            "target": "No",
            "document_name": "ReynoldsConsumerProductsInc_20191115_S-1_EX-10.18_11896469_EX-10.18_Supply Agreement.pdf",
            "index": 647
        },
        {
            "input": "Integra shall use commercially reasonable efforts to Sell Treated Integra Products and Partially Treated Integra Products that generate payments to PcoMed of no less than the Minimum Payments applicable to each Minimum Payment Period.",
            "target": "No",
            "document_name": "SEASPINEHOLDINGSCORP_10_10_2018-EX-10.1-SUPPLY AGREEMENT.PDF",
            "index": 648
        },
        {
            "input": "Likewise, Dynamic Hearing may not assign or transfer any of its rights or obligations under this Agreement without the prior written consent of IntriCon.",
            "target": "No",
            "document_name": "INTRICONCORP_03_10_2009-EX-10.22-Strategic Alliance Agreement.PDF",
            "index": 649
        },
        {
            "input": "This Agreement shall be construed in accordance with and governed by the laws of the State of South Dakota.",
            "target": "No",
            "document_name": "AIRSPANNETWORKSINC_04_11_2000-EX-10.5-Distributor Agreement.PDF",
            "index": 650
        },
        {
            "input": "Without limiting ARTICLE VIII, the license granted to the SpinCo Group in Section 3.03(a) shall automatically terminate in the event (i) that any member of the SpinCo Group assigns, transfers, licenses or otherwise conveys any rights in or to the Honeywell Content to any third party or (ii) of (x) the sale of all or substantially all of the ownership interests<omitted>in, or the assets of, any member of the SpinCo Group in a single transaction or a series of related transactions to one or more third parties, (y) any direct or indirect acquisition, consolidation or merger of any member of the SpinCo Group by, with or into any third party or (z) any spin-off, public offering or other corporate reorganization or single transaction or series of related transactions in which direct or indirect control of any member of the SpinCo Group is transferred to one or more third parties, including by transferring an excess of fifty percent (50%) of such member of the SpinCo Group's voting power, shares or equity, through a merger, consolidation, tender offer or similar transaction to one or more third parties",
            "target": "No",
            "document_name": "GarrettMotionInc_20181001_8-K_EX-2.4_11364532_EX-2.4_Intellectual Property Agreement.pdf",
            "index": 651
        },
        {
            "input": "LeadersOnline shall have the option, subject to VerticalNet's approval exercised in its sole and absolute discretion, to extend the Term of this Agreement for an additional 12 months (a \"Renewal Term\") on such terms and conditions as may be mutually agreed upon by the Parties.",
            "target": "No",
            "document_name": "LeadersonlineInc_20000427_S-1A_EX-10.8_4991089_EX-10.8_Co-Branding Agreement.pdf",
            "index": 652
        },
        {
            "input": "Except as otherwise provided in Section 5 3 of the Development Agreement, by the fifteenth (15th) day of each month, the<omitted>Franchisee shall deliver to BKC a return of Gross Sales for the preceding month and pay to BKC or its designee a royalty for the use of the Burger King Marks an the Burger King System calculated by applying the percentage set forth in SCHEDULE 1 against the Gross Sales for the preceding calendar month.",
            "target": "No",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 653
        },
        {
            "input": "MediaNet Group Technologies tracks the customer sales coming from the reseller and at the end of every calendar month issues a check for 20% commission to the reseller on product sales and 10% the total amount of hosting/maintenance sales made.",
            "target": "No",
            "document_name": "OMINTO,INC_03_29_2004-EX-10-RESELLER AGREEMENT.PDF",
            "index": 654
        },
        {
            "input": "The Parties agree that this Agreement shall be governed by and construed in accordance with the laws of the State of Arizona without regard to conflicts of law provisions thereof or any other applicable law and that exclusive venue shall be in the federal or state courts located in Maricopa County, Arizona.",
            "target": "No",
            "document_name": "Zounds Hearing, Inc. - MANUFACTURING DESIGN MARKETING AGREEMENT.PDF",
            "index": 655
        },
        {
            "input": "Any transfer or assignment not permitted by this Section 11.8 shall be null and void.",
            "target": "No",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 656
        },
        {
            "input": "During the term of this Agreement, unless otherwise authorized at the sole discretion of ADAMS GOLF in writing, CONSULTANT shall not: A.give the right to use or permit the use of CONSULTANT'S name, facsimile signature, nickname, voice or likeness to any other manufacturer or seller of PRODUCT; B.sponsor or endorse PRODUCT made or sold by any other manufacturer or seller; or C.serve as a CONSULTANT or advisor of any other manufacturer or seller of PRODUCT.",
            "target": "No",
            "document_name": "ADAMSGOLFINC_03_21_2005-EX-10.17-ENDORSEMENT AGREEMENT.PDF",
            "index": 657
        },
        {
            "input": "The fees charged by such Certified Public Accountant will be paid by NetGrocer unless the audit finds a discrepancy of more than five percent (5%) with respect to the item being audited, in which case Excite shall be responsible for the payment of the reasonable fees for such inspection.",
            "target": "No",
            "document_name": "NETGROCERINC_07_31_1998-EX-10.15-SPONSORSHIP AGREEMENT.PDF",
            "index": 658
        },
        {
            "input": "Licensee shall develop and distribute the following Wireless Products in connection with the property \"ICE AGE 2\":<omitted>(iii) up to 5 MMS; (iv) up to 10 Wallpapers; (v) and up to 5 Voicetones (\"ICE AGE 2 Wireless Products\") in each of the following five (5) languages: English, French, German, Italian, Spanish, with Portuguese, Greek, Dutch and Swedish to be made available where practicable.",
            "target": "No",
            "document_name": "GluMobileInc_20070319_S-1A_EX-10.09_436630_EX-10.09_Content License Agreement2.pdf",
            "index": 659
        },
        {
            "input": "ENVISION will provide SIERRA with demand projections for the Product and SIERRA will produce enough Product to meet such demand projections.",
            "target": "No",
            "document_name": "LEGACYTECHNOLOGYHOLDINGS,INC_12_09_2005-EX-10.2-DISTRIBUTOR AGREEMENT.PDF",
            "index": 660
        },
        {
            "input": "The license under this Agreement is a non-exclusive, non-assignable and non-transferable license.",
            "target": "No",
            "document_name": "JINGWEIINTERNATIONALLTD_10_04_2007-EX-10.7-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 661
        },
        {
            "input": "The Franchisee will not attempt, directly or indirectly, to entice or induce any employee of BKC or of an Affiliate of BKC or of another franchisee of BKC to leave such employment, nor to employ such employee within six (6) months after his or her termination of employment with such employer, except with the prior written consent of such employer.",
            "target": "No",
            "document_name": "INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.PDF",
            "index": 662
        },
        {
            "input": "The total liability for either Party, regardless of the form of action, whether contract or tort, is limited to three percent (3%) of the value of the bill of materials contained in the Products delivered to IBM and IBM Customers by MSL in the period beginning with the Effective Date of the Agreement through the resolution of the action.",
            "target": "No",
            "document_name": "MANUFACTURERSSERVICESLTD_06_05_2000-EX-10.14-OUTSOURCING AGREEMENT.PDF",
            "index": 663
        },
        {
            "input": "The consideration for the licenses granted by Licensor to Licensee under this Agreement is the issuance of the IP Common Shares as defined in the Amended and Securities Purchase Agreement, dated as of December 21, 2015, by and among the Licensee and the Licensor (the \"Share Consideration\").",
            "target": "No",
            "document_name": "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.pdf",
            "index": 664
        },
        {
            "input": "All public liability and property damage policies shall contain a provision that El Pollo Loco, although named as an insured, shall nevertheless be entitled to recover under such policies on any loss incurred by El Pollo Loco, its affiliates, agents and/or employees, by reason of the negligence of Developer, its principals, contractors, agents and/or employees.",
            "target": "No",
            "document_name": "ElPolloLocoHoldingsInc_20200306_10-K_EX-10.16_12041700_EX-10.16_Development Agreement.pdf",
            "index": 665
        },
        {
            "input": "Except as otherwise provided herein, the term of this Agreement is three (3) years from the Execution Date (\"Cooperation Period\").",
            "target": "No",
            "document_name": "CHIPMOSTECHNOLOGIESBERMUDALTD_04_18_2016-EX-4.72-Strategic Alliance Agreement.PDF",
            "index": 666
        },
        {
            "input": "Except as otherwise expressly provided in the Business Plan, the Agent will at its sole expense<omitted>(f) meet with the Company at least once each quarter (starting with the quarter in which the Agent Launch Date occurs), at a mutually agreeable time and place to discuss and review the Agent's activities hereunder, at which meeting the Agent will make available to the Company information concerning the Agent's sale and marketing of the Products in the Territory during the quarter and year-to-date, such information to include details of sales efforts, Product sales volume and such other information as may be mutually agreed upon in each Business Plan;",
            "target": "No",
            "document_name": "BIOPURECORP_06_30_1999-EX-10.13-AGENCY AGREEMENT.PDF",
            "index": 667
        },
        {
            "input": "Allied grants Newegg a non-exclusive, royalty-free, non-assignable, non-transferable, and non- sublicensable worldwide license to use, publicly display, transmit, broadcast, stream, distribute and reproduce the Allied Marks in all approved forms and in manners for the purposes of this Agreement during the Term.",
            "target": "No",
            "document_name": "AlliedEsportsEntertainmentInc_20190815_8-K_EX-10.34_11788308_EX-10.34_Sponsorship Agreement.pdf",
            "index": 668
        },
        {
            "input": "Party A irrevocably undertakes that, without Party B's consent, Party A shall not conduct any other business or make any commercial arrangement, including without limitation being engaged in or otherwise participating in any commercial activities and businesses independently or together with any other person or entity, nor shall it carry out any activities that may be competitive with or cause adverse effect to Party B's business.",
            "target": "No",
            "document_name": "TUNIUCORP_03_06_2014-EX-10-COOPERATION AGREEMENT.PDF",
            "index": 669
        },
        {
            "input": "Party B shall not advertise, or make any statement favorable for, any competitor having the same or similar business scope as Party A in the services it provides.",
            "target": "No",
            "document_name": "IDREAMSKYTECHNOLOGYLTD_07_03_2014-EX-10.39-Cooperation Agreement on Mobile Game Business.PDF",
            "index": 670
        },
        {
            "input": "FMI agrees that the pricing terms for Products and Services provided by FMI to Roche herein, and services provided under the Molecular Information Platform Program, are, and will be, at least as favorable as the pricing terms granted by FMI to any existing customer or collaborator for such (or substantially similar) products or services.",
            "target": "No",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 671
        },
        {
            "input": "Integrity will hold exclusive worldwide rights to promote and sell the product to/through the following distribution channels: Christian retail (CBA or Christian Booksellers Association markets), direct mail (including continuity sales, church sales, digital and e-commerce sales.)",
            "target": "No",
            "document_name": "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.pdf",
            "index": 672
        },
        {
            "input": "JOINT VENTURE COMPANY'S TOTAL CUMULATIVE LIABILITY TO THE LOOP PARTIES WITH RESPECT TO A TRANSFERRED CONTRACT, IN ALL CIRCUMSTANCES AND REGARDLESS OF THE THEORY OF RECOVERY, SHALL BE LIMITED TO THE AMOUNT OF ACTUAL, DIRECT, AND DOCUMENTED DAMAGES THE APPLICABLE AUTHORIZED CUSTOMER ACTUALLY RECOVERS FROM THE LOOP PARTIES UNDER THE TRANSFERRED CONTRACT BASED SOLELY ON JOINT VENTURE COMPANY'S BREACH OF SUCH TRANSFERRED CONTRACT.",
            "target": "No",
            "document_name": "Loop Industries, Inc. - Marketing Agreement.PDF",
            "index": 673
        },
        {
            "input": "July 16, 2012<omitted>THIS SPONSORSHIP AGREEMENT (\"Agreement\") is entered into and effective as of the date first written above (\"Effective Date\") by and among PEEK Investments LLC, a Delaware limited liability company (\"Purchaser\"), and each other party hereto identified on the signature page(s) hereto (each, a \"Sponsor\").",
            "target": "No",
            "document_name": "LOOKSMARTLTD_07_20_2012-EX-99.(D)(I)-SPONSORSHIP AGREEMENT.PDF",
            "index": 674
        },
        {
            "input": "If the Executive's employment is terminated at any time by reason of any reconstruction or amalgamation of any Group Company, whether by winding up or otherwise, and the Executive is offered employment with any concern or undertaking involved in or resulting from the reconstruction or amalgamation on terms which (considered in their entirety) are no less favourable to any material extent than the terms of this Agreement, the Executive acknowledges and agrees that there shall be no claim against the Company or any undertaking arising out of or connected with such termination.",
            "target": "No",
            "document_name": "THERAVANCEBIOPHARMA,INC_05_08_2020-EX-10.2-SERVICE AGREEMENT.PDF",
            "index": 675
        },
        {
            "input": "Within ninety (90) days prior to the expiration of each Contract Year, the parties will discuss in good faith and agree on the Minimum Product Quantities for the successive Contract Year; provided, however, that, if the parties fail to reach agreement on or otherwise specify the Minimum Purchase Quantities for the successive Contract Year, the Minimum Product Quantities for such successive Contract Year shall be __________ percent (___%) of the Minimum Purchase Quantities for the existing Contract Year.",
            "target": "No",
            "document_name": "StaarSurgicalCompany_20180801_10-Q_EX-10.37_11289449_EX-10.37_Distributor Agreement.pdf",
            "index": 676
        },
        {
            "input": "You further acknowledge that the Intranet facility and all communications that are posted to it will become our property, free of any claims of privacy or privilege that you or any other person may assert.",
            "target": "No",
            "document_name": "SoupmanInc_20150814_8-K_EX-10.1_9230148_EX-10.1_Franchise Agreement1.pdf",
            "index": 677
        },
        {
            "input": "Except as otherwise provided herein, all the results of ABG's provision of CELEBRITY'S Services hereunder, including, but not limited to, Materials (but in all cases specifically excluding the Celebrity Endorsement and the Personality Rights), will be deemed a \"work made for hire\" under the provisions of the United States Copyright Act (17 U.S.C. Sec. 101) and will be owned by PAPA JOHN'S for all purposes.",
            "target": "No",
            "document_name": "PapaJohnsInternationalInc_20190617_8-K_EX-10.1_11707365_EX-10.1_Endorsement Agreement.pdf",
            "index": 678
        },
        {
            "input": "Owner shall deliver notice of any such assignment, pledge or transfer to Service Provider in writing as soon as reasonably practicable thereafter.",
            "target": "No",
            "document_name": "SPIENERGYCO,LTD_03_09_2011-EX-99.5-OPERATIONS AND MAINTENANCE AGREEMENT.PDF",
            "index": 679
        },
        {
            "input": "If, during any Quarter of the Contract Year, Shipper deliveries on the Pipeline exceed the applicable Quarterly Volume Commitment requirements, Shipper shall be permitted to apply Prepaid Transportation Credits against any amount due from Shipper and payable to MPL with respect to the transportation of volumes on the Pipeline for such Quarter.",
            "target": "No",
            "document_name": "MPLXLP_06_17_2015-EX-10.1-TRANSPORTATION SERVICES AGREEMENT.PDF",
            "index": 680
        },
        {
            "input": "Sponsor hereby grants to SDBF a limited license to display Sponsor's name, brand names, trademarks, service marks, logos and other identification in or on the Promotional Items, promotional materials prepared by SDBF with respect to the Promotional Items, and any advertisements or commercial messages to be furnished hereunder",
            "target": "No",
            "document_name": "RUBIOSRESTAURANTSINC_03_31_2008-EX-10.75-SPONSORSHIP AGREEMENT.PDF",
            "index": 681
        },
        {
            "input": "Fox grants to Licensee a limited, exclusive (except as otherwise may be provided in this Agreement), non-transferable (except as permitted in Paragraph 17(d)) right and license to use, make, have made (as set forth in Paragraph 1(a)(i) below), reproduce, modify, and create derivative works of<omitted>the PSM in each Property, solely for the purpose of developing the wireless applications specifically set forth for each of the Properties on Exhibits B through M attached hereto (\"Wireless Products\"), some of which Wireless Products are defined in the Glossary attached hereto as Exhibit N.",
            "target": "No",
            "document_name": "GluMobileInc_20070319_S-1A_EX-10.09_436630_EX-10.09_Content License Agreement1.pdf",
            "index": 682
        },
        {
            "input": "Zogenix shall have the right to terminate this Agreement immediately upon written notice to Distributor (i) if Distributor or any of its Affiliates or Sub-distributors, directly or indirectly through any Third Party, commences any interference or opposition proceeding with respect to, challenges the validity or enforceability of, or opposes any extension of or the grant of a supplementary protection certificate with respect to, any Zogenix Patent (or any related Patent owned or controlled by Zogenix outside the Territory); (ii) if Zogenix determines that Distributor or its Affiliates or Sub- distributors are, or have caused or shall cause any Zogenix Indemnitee to be, in violation of the FCPA or any other Applicable Laws; or (iii) if Zogenix decides to withdraw the Product from the market in the Territory or otherwise believes that the promotion of the Product in the Field in the Territory presents a substantial risk of harm or injury to consumers which risk is unacceptable according to established principles of medical ethics.",
            "target": "No",
            "document_name": "ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement.pdf",
            "index": 683
        },
        {
            "input": "As part of the exclusive distribution right granted in this Section 2, Vendor hereby grants Distributor the non- exclusive, non-transferable right to use and display Vendor's trademarks, logos, Product photographs and images, Product advertising and promotional copy, including but not limited to the materials contained in Vendor's website, in connection with the promotion, advertising and distribution of the Products.",
            "target": "No",
            "document_name": "ENTERTAINMENTGAMINGASIAINC_02_15_2005-EX-10.5-DISTRIBUTOR AGREEMENT.PDF",
            "index": 684
        },
        {
            "input": "Licensee shall, within [***] ([***]) days of the effective date of termination of the Agreement at the latest (and at no cost to Bioeq if this Agreement is terminated by Bioeq pursuant to Sections 15.2.1, 15.2.2, 15.2.3, 15.2.4, 15.2.8 or 15.2.9, or by Licensee pursuant to Section 15.2.5, or at Bioeq's cost and expense if this Agreement is terminated by Licensee pursuant to Sections 15.2.1, 15.2.6, 15.2.7 or 15.2.8, as applicable) transfer and assign to Bioeq or its designee all of Licensee's right, title and interest in and to any and all Biologics License Applications and Biologics License Application Approvals controlled by Licensee for the Licensed Products in the Field in the Territory as of the effective date of such termination, including any and all documentation pertaining to such filings and Biologics License Application Approvals (provided that the physical or electronic transfer of files and documentation in connection with such transfer and assignment of rights may occur after such [***] ([***]) day period without being deemed a breach of this Section 15.3.2 by Licensee)",
            "target": "No",
            "document_name": "CoherusBiosciencesInc_20200227_10-K_EX-10.29_12021376_EX-10.29_Development Agreement.pdf",
            "index": 685
        },
        {
            "input": "You hereby grant to us (and agree to obtain from your affiliates, owners, employees, and/or contractors), a perpetual, non-exclusive, and worldwide right to use any such ideas, concepts, methods, techniques and products in any businesses that we and/or our affiliates, franchisees and designees operate. We will have the right to use those ideas, concepts, methods, techniques, and/or products without making payment to you. You agree not to use or allow any other person or entity to use any such concept, method, technique or product",
            "target": "No",
            "document_name": "GOOSEHEADINSURANCE,INC_04_02_2018-EX-10.6-Franchise Agreement.PDF",
            "index": 686
        },
        {
            "input": "For a period of not less than two (2) years after the date of termination, each party shall maintain, and make available to the other party upon its request, for inspection and copying all books and records that pertain to performance of and compliance with obligations, warranties and representations under this Agreement.",
            "target": "No",
            "document_name": "AURASYSTEMSINC_06_16_2010-EX-10.25-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 687
        },
        {
            "input": "Sonos reserves the right to inspect any Sonos Tools in IAC's control at any time, provided it gives IAC at least forty-eight (48) hours advance notice.",
            "target": "No",
            "document_name": "Sonos, Inc. - Manufacturing Agreement .PDF",
            "index": 688
        },
        {
            "input": "The prices set forth in Section 2.4(a) shall be subject to adjustment annually on the first day of each Product Year beginning in the calendar year 2000 and on the first day of each succeeding Product Year for the remainder of the Term and all renewals of this Agreement in proportion to the increase or decrease in the Consumer Price Index (CPI) as compared to the CPI as it existed on the first day of the Term of this Agreement.",
            "target": "No",
            "document_name": "LIMEENERGYCO_09_09_1999-EX-10-DISTRIBUTOR AGREEMENT.PDF",
            "index": 689
        },
        {
            "input": "In the event Moelis Holdings proposes to undertake an issuance of Additional Units to which clause (x) of Section 12.2(a) applies, it shall give SMBC written notice of its intention describing the price and terms upon which Moelis Holdings proposes to issue the same.",
            "target": "Yes",
            "document_name": "MOELIS&CO_03_24_2014-EX-10.19-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 690
        },
        {
            "input": "Upon termination of this Agreement by Pretzel Time in accordance with its terms and conditions or by Franchisee without cause or upon expiration of this Agreement (unless the franchise has been renewed), Pretzel Time, its Affiliates or its assignee shall have the option (not the obligation), exercisable by giving written notice thereof within sixty (60) days from the date of such expiration or termination, to acquire from Franchisee all the assets in the Unit including the equipment, furnishings, signs, leasehold improvements, usable inventory of Products, materials, supplies and other tangible assets of the Unit and an assignment of the lease for the Unit.",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 691
        },
        {
            "input": "Any material change in the terms of an offer before closing will make it a new offer, revoking any previous approval or previously made election to purchase and giving us a new right of first refusal effective as of the day we receive formal notice of a material change in the terms.",
            "target": "Yes",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 692
        },
        {
            "input": "This Agreement shall be governed by and construed in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein, excluding its conflict-of-laws rules.",
            "target": "No",
            "document_name": "ASIANDRAGONGROUPINC_08_11_2005-EX-10.5-Reseller Agreement.PDF",
            "index": 693
        },
        {
            "input": "In the event of a Supply Failure, Miltenyi shall grant Bellicum's Second-Source Supplier a limited, non-exclusive, non-transferable, one-site production license, without the right to sublicense, under Miltenyi's Intellectual Property Rights solely to the extent reasonably necessary to manufacture the Affected Miltenyi Product for the Permitted Use by Bellicum at Bellicum's cost.",
            "target": "No",
            "document_name": "BELLICUMPHARMACEUTICALS,INC_05_07_2019-EX-10.1-Supply Agreement.PDF",
            "index": 694
        },
        {
            "input": "In addition, if Neoforma sells Advertising to a third party on the Neoforma Sites independently from VerticalNet and if Neoforma previously rejected Advertising by such party when proposed by VerticalNet pursuant to Section 7.1.3 [ADVERTISEMENTS ON THE NEOFORMA SITE], or terminated without cause a prior agreement with such third party that had resulted from such a proposal by VerticalNet, then Neoforma shall pay [*] of the Net Advertising Revenue resulting from such Advertising during the Term to VerticalNet.",
            "target": "No",
            "document_name": "NeoformaInc_19991202_S-1A_EX-10.26_5224521_EX-10.26_Co-Branding Agreement.pdf",
            "index": 695
        }
    ]
}